BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S, O'Donovan M, Bird-Lieberman E, Bhandari P, Jankowski JA, Attwood S, Parsons SL, Loft D, Lagergren J, Moayyedi P, Lyratzopoulos G, de Caestecker J; British Society of Gastroenterology. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut 2014;63:7-42. [PMID: 24165758 DOI: 10.1136/gutjnl-2013-305372] [Cited by in Crossref: 839] [Cited by in F6Publishing: 679] [Article Influence: 93.2] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Liu BL, Harpaz N, Zhu H, Polydorides AD, Liu Q. Aberrant p53 expression is associated with neoplastic progression in Barrett oesophagus diagnosed as indefinite for dysplasia. Histopathology 2023;82:454-65. [PMID: 36251540 DOI: 10.1111/his.14828] [Reference Citation Analysis]
2 Kamran U, King D, Abbasi A, Coupland B, Umar N, Chapman WC, Hebbar S, Trudgill NJ. A root cause analysis system to establish the most plausible explanation for post-endoscopy upper gastrointestinal cancer. Endoscopy 2023;55:109-18. [PMID: 36044914 DOI: 10.1055/a-1917-0192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Haddad JD, Sawas T. Surveillance Intervals for Barrett’s Esophagus Need to be Changed-Surveillance Intervals are Too Long and Should be Shortened. Foregut: The Journal of the American Foregut Society 2023. [DOI: 10.1177/26345161221148829] [Reference Citation Analysis]
4 Stawinski PM, Dziadkowiec KN, Kuo LA, Echavarria J, Saligram S. Barrett's Esophagus: An Updated Review. Diagnostics (Basel) 2023;13. [PMID: 36673131 DOI: 10.3390/diagnostics13020321] [Reference Citation Analysis]
5 Ghimire B, Landy R, Maroni R, Smith SG, Debiram-Beecham I, Sasieni PD, Fitzgerald RC, Rubin G, Walter FM, Waller J, Offman J; BEST3 Consortium. Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial. BMC Gastroenterol 2023;23:7. [PMID: 36627580 DOI: 10.1186/s12876-022-02630-1] [Reference Citation Analysis]
6 Bojarski C. Barrettösophagus. Springer Reference Medizin 2023. [DOI: 10.1007/978-3-662-61724-3_92-1] [Reference Citation Analysis]
7 Holzwanger EA, Liu AY, Iyer PG. Improving Dysplasia Detection in Barrett's Esophagus. Techniques and Innovations in Gastrointestinal Endoscopy 2023. [DOI: 10.1016/j.tige.2023.01.002] [Reference Citation Analysis]
8 Genta RM. Gastro-oesophageal junction: a conceptual agreement at last? Frontline Gastroenterol 2022. [DOI: 10.1136/flgastro-2022-102310] [Reference Citation Analysis]
9 Barroux M, Horstmann J, Fricke L, Schömig L, Werner M, Kraynova E, Kamarádová K, Fléjou J, Maerkel B, Kumarasinghe MP, Vieth M, Westerhoff M, Patil DT, Steiger K, Becker K, Weichert W, Schmid RM, Quante M, Slotta-huspenina J. Histological evaluation of PAXgene tissue fixation in Barrett’s esophagus and esophageal adenocarcinoma diagnostics. Virchows Arch 2022. [DOI: 10.1007/s00428-022-03471-9] [Reference Citation Analysis]
10 Samo S, Bansal A. The Risk of Barrett’s Esophagus Transforming to Esophageal Cancer. Foregut: The Journal of the American Foregut Society 2022. [DOI: 10.1177/26345161221143140] [Reference Citation Analysis]
11 Tomaszewski KJ, Neyaz A, Sauder K, Rickelt S, Zhang ML, Yilmaz O, Crotty R, Shroff S, Odze R, Mattia A, Patil DT, Deshpande V. Defining an abnormal p53 immunohistochemical stain in Barrett's oesophagus-related dysplasia: a single-positive crypt is a sensitive and specific marker of dysplasia. Histopathology 2022. [PMID: 36458877 DOI: 10.1111/his.14848] [Reference Citation Analysis]
12 Corbett FS, Odze RD, Mckinley MJ. Utility of wide-area transepithelial sampling with 3-dimensional computer-assisted analysis as an adjunct to forceps biopsy sampling in the surveillance of patients with Barrett’s esophagus after endoscopic eradication therapy. iGIE 2022;1:33-43. [DOI: 10.1016/j.igie.2022.10.011] [Reference Citation Analysis]
13 Iyer PG, Codipilly DC, Chandar AK, Agarwal S, Wang KK, Leggett CL, Latuche LR, Schulte PJ. Prediction of Progression in Barrett's Esophagus Using a Tissue Systems Pathology Test: A Pooled Analysis of International Multicenter Studies. Clin Gastroenterol Hepatol 2022;20:2772-2779.e8. [PMID: 35217151 DOI: 10.1016/j.cgh.2022.02.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
14 Muthusamy VR, Wani S, Gyawali CP, Komanduri S; CGIT Barrett’s Esophagus Consensus Conference Participants. AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett's Esophagus: Expert Review. Clin Gastroenterol Hepatol 2022;20:2696-2706.e1. [PMID: 35788412 DOI: 10.1016/j.cgh.2022.06.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Soliman M, Kapur K. Barrett’s Oesophagus Surveillance: Can We Do Better? EMJ Gastroenterol 2022. [DOI: 10.33590/emjgastroenterol/10163417] [Reference Citation Analysis]
16 Holmberg D, Lagergren J. Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma. Foregut: The Journal of the American Foregut Society 2022. [DOI: 10.1177/26345161221138045] [Reference Citation Analysis]
17 Szachnowicz S, Duarte AF, Nasi A, da Rocha JRM, Seguro FB, Bianchi ET, Tustumi F, de Moura EGH, Sallum RAA, Cecconello I. Laparoscopic total fundoplication is superior to medical treatment for reducing the cancer risk in Barrett's esophagus: a long-term analysis. Dis Esophagus 2022;35:doac026. [PMID: 35641160 DOI: 10.1093/dote/doac026] [Reference Citation Analysis]
18 Shaheen NJ, Falk GW, Iyer PG, Souza RF, Yadlapati RH, Sauer BG, Wani S. Response to Rajendra. Am J Gastroenterol 2022;117:1881-2. [PMID: 36327439 DOI: 10.14309/ajg.0000000000002012] [Reference Citation Analysis]
19 Frederiks CN, Overwater A, Alvarez Herrero L, Alkhalaf A, Schenk E, Repici A, Bergman JJGHM, Pouw RE, Bisschops R, Haidry RJ, Beyna T, Neuhaus H, Weusten BLAM. Comparison of focal cryoballoon ablation with 10- and 8-second doses for treatment of Barrett's esophagus-related neoplasia: results from a prospective European multicenter study (with video). Gastrointest Endosc 2022;96:743-751.e4. [PMID: 35724692 DOI: 10.1016/j.gie.2022.06.017] [Reference Citation Analysis]
20 Eluri S, Reddy S, Ketchem CC, Tappata M, Nettles HG, Watts AE, Cotton CC, Dellon ES, Shaheen NJ. Low Prevalence of Endoscopic Screening for Barrett's Esophagus in a Screening-Eligible Primary Care Population. Am J Gastroenterol 2022;117:1764-71. [PMID: 35971219 DOI: 10.14309/ajg.0000000000001935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Verheij EPD, van Munster SN, Pouw RE. Follow-up after successful endoscopic therapy for early Barrett's neoplasia: Is it time to talk money yet? Endosc Int Open 2022;10:E1331-2. [PMID: 36262508 DOI: 10.1055/a-1931-3841] [Reference Citation Analysis]
22 Uno K, Koike T, Hatta W, Saito M, Tanabe M, Masamune A. Development of Advanced Imaging and Molecular Imaging for Barrett's Neoplasia. Diagnostics (Basel) 2022;12:2437. [PMID: 36292126 DOI: 10.3390/diagnostics12102437] [Reference Citation Analysis]
23 Lin Y, Wang HL, Fang K, Zheng Y, Wu J. International trends in esophageal cancer incidence rates by histological subtype (1990-2012) and prediction of the rates to 2030. Esophagus 2022;19:560-8. [PMID: 35689719 DOI: 10.1007/s10388-022-00927-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sato H, Shimamura Y, Tanaka S, Shiwaku H, Minami H, Sato C, Ogawa R, Inoue H. Reply: Need for evidence on surveillance endoscopy in achalasia-related Barret esophagus and adenocarcinoma in Asian population. J Gastroenterol 2022;57:813-4. [PMID: 36001161 DOI: 10.1007/s00535-022-01917-0] [Reference Citation Analysis]
25 Sarem M, Martínez Cerezo FJ, Salvia Favieres ML, Corti R. Low-grade dysplasia in Barrett's esophagus: A problematic diagnosis. Gastroenterología y Hepatología 2022. [DOI: 10.1016/j.gastrohep.2022.10.002] [Reference Citation Analysis]
26 Trindade AJ. Centralized care for the management of Barrett's esophagus: the path forward or just an academic dream? Endoscopy 2022;54:945-7. [PMID: 35668662 DOI: 10.1055/a-1843-9682] [Reference Citation Analysis]
27 Luu LDW, Singh H, Castaño-rodríguez N, Leach ST, Riordan SM, Tedla N, Krishnan U, Kaakoush NO. Changes to the upper gastrointestinal microbiotas of children with reflux oesophagitis and oesophageal metaplasia. Microbial Genomics 2022;8. [DOI: 10.1099/mgen.0.000870] [Reference Citation Analysis]
28 Lee YK. Barrett's Esophagus. Korean J Helicobacter Up Gastrointest Res 2022;22:177-188. [DOI: 10.7704/kjhugr.2022.0015] [Reference Citation Analysis]
29 Copetti H, Copetti L, Copetti L, Felin GD, Felin GD, Felin CD, Felin FD, Chiesa V. RISK OF PRENEOPLASTIC LESIONS IN MUCOSAL PROJECTIONS OF DIFFERENT SIZES OF THE COLUMNAR EPITHELIUM IN THE LOWER ESOPHAGUS. Arq Bras Cir Dig 2022;35:e1674. [PMID: 36102485 DOI: 10.1590/0102-672020220002e1674] [Reference Citation Analysis]
30 Cui M, Yi X, Cao Z, Zhu D, Wu J, Raghavamenon AC. Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review. Journal of Oncology 2022;2022:1-27. [DOI: 10.1155/2022/4257359] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Souza RF, Spechler SJ. Mechanisms and pathophysiology of Barrett oesophagus. Nat Rev Gastroenterol Hepatol 2022;19:605-20. [PMID: 35672395 DOI: 10.1038/s41575-022-00622-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Wani S, Souza RF, Durkalski VL, Serrano J, Hamilton F, Shaheen NJ; SURVENT Trial Consortium. Multicenter Randomized Controlled Trial of Surveillance Versus Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia: The SURVENT Trial: Study Rationale, Methodology, Innovation, and Implications. Gastroenterology 2022;163:556-562.e4. [PMID: 35679951 DOI: 10.1053/j.gastro.2022.05.051] [Reference Citation Analysis]
33 Desai M, Lieberman D, Srinivasan S, Nutalapati V, Challa A, Kalgotra P, Sundaram S, Repici A, Hassan C, Kaminski MF, Sharma P. Post-endoscopy Barrett's neoplasia after a negative index endoscopy: a systematic review and proposal for definitions and performance measures in endoscopy. Endoscopy 2022;54:881-9. [PMID: 34979570 DOI: 10.1055/a-1729-8066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Ma S, Guo X, Wang C, Yin Y, Xu G, Chen H, Qi X. Association of Barrett's esophagus with Helicobacter pylori infection: a meta-analysis. Ther Adv Chronic Dis 2022;13:20406223221117971. [PMID: 36034104 DOI: 10.1177/20406223221117971] [Reference Citation Analysis]
35 Sawas T, Zamani SA, Killcoyne S, Dullea A, Wang KK, Iyer PG, Fitzgerald RC, Katzka DA. Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol 2022;20:1709-18. [PMID: 34757196 DOI: 10.1016/j.cgh.2021.10.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Shaheen NJ, Falk GW, Iyer PG, Souza RF, Wani S. Guideline to Practice: Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Am J Gastroenterol 2022;117:1177-80. [PMID: 35467555 DOI: 10.14309/ajg.0000000000001788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Berman AG, Tan WK, O'donovan M, Markowetz F, Fitzgerald RC. Quantification of TFF3 expression from a non-endoscopic device predicts clinically relevant Barrett's oesophagus by machine learning. eBioMedicine 2022;82:104160. [DOI: 10.1016/j.ebiom.2022.104160] [Reference Citation Analysis]
38 Wolfson P, Ho KMA, Wilson A, McBain H, Hogan A, Lipman G, Dunn J, Haidry R, Novelli M, Olivo A, Lovat LB; UK RFA Study Group. Endoscopic eradication therapy for Barrett's esophagus-related neoplasia: a final 10-year report from the UK National HALO Radiofrequency Ablation Registry. Gastrointest Endosc 2022;96:223-33. [PMID: 35189088 DOI: 10.1016/j.gie.2022.02.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
39 Srinivasan S, Sharma P. Real-world data for endoscopic therapy in LGD: not looking so good. Gut 2022;71:1457-8. [PMID: 34330785 DOI: 10.1136/gutjnl-2021-324544] [Reference Citation Analysis]
40 Eusebi LH, Telese A, Cirota GG, Haidry R, Zagari RM, Bazzoli F, Ford AC. Effect of gastro-esophageal reflux symptoms on the risk of Barrett's esophagus: A systematic review and meta-analysis. J Gastroenterol Hepatol 2022;37:1507-16. [PMID: 35614860 DOI: 10.1111/jgh.15902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Loughrey MB, Wong NACS. Clinical utility of GI pathology data: implications for practising pathologists. J Clin Pathol 2022;75:519-24. [PMID: 35853655 DOI: 10.1136/jclinpath-2021-207472] [Reference Citation Analysis]
42 Sugano K, Spechler SJ, El-Omar EM, McColl KEL, Takubo K, Gotoda T, Fujishiro M, Iijima K, Inoue H, Kawai T, Kinoshita Y, Miwa H, Mukaisho KI, Murakami K, Seto Y, Tajiri H, Bhatia S, Choi MG, Fitzgerald RC, Fock KM, Goh KL, Ho KY, Mahachai V, O'Donovan M, Odze R, Peek R, Rugge M, Sharma P, Sollano JD, Vieth M, Wu J, Wu MS, Zou D, Kaminishi M, Malfertheiner P. Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction. Gut 2022;71:1488-514. [PMID: 35725291 DOI: 10.1136/gutjnl-2022-327281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
43 Ness-Jensen E. Epidemiology and prevention of oesophageal adenocarcinoma. Scand J Gastroenterol 2022;57:891-5. [PMID: 35234549 DOI: 10.1080/00365521.2022.2042594] [Reference Citation Analysis]
44 Ma SZ, Chen HX, Liang ZD, Qi XS. Risk factors for Barrett's esophagus: Recent advances. Shijie Huaren Xiaohua Zazhi 2022; 30(14): 605-613 [DOI: 10.11569/wcjd.v30.i14.605] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Wang SE, Hodge A, Dashti SG, Dixon-suen SC, Castaño-rodríguez N, Thomas R, Giles G, Boussioutas A, Kendall B, English DR. Diet and risk of Barrett’s oesophagus: Melbourne collaborative cohort study. Br J Nutr 2022. [DOI: 10.1017/s0007114522002112] [Reference Citation Analysis]
46 O’dowd D, O’sullivan J, Marcone S. Prognostic, Diagnostic and Predictive Biomarkers in the Barrett’s Oesophagus-Adenocarcinoma Disease Sequence. Cancers 2022;14:3427. [DOI: 10.3390/cancers14143427] [Reference Citation Analysis]
47 Huibertse LJ, Peters Y, Westendorp D, Siersema PD. Unsedated transnasal endoscopy for the detection of Barrett's esophagus: systematic review and meta-analysis. Dis Esophagus 2022:doac045. [PMID: 35830873 DOI: 10.1093/dote/doac045] [Reference Citation Analysis]
48 Ten Kate CA, van Hal ARL, Erler NS, Doukas M, Nikkessen S, Vlot J, IJsselstijn H, Wijnhoven BPL, Wijnen RMH, Spaander MCW. Recommendations for endoscopic surveillance after esophageal atresia repair in adults. Dis Esophagus 2022;35:doab095. [PMID: 35034110 DOI: 10.1093/dote/doab095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Emura F, Chandrasekar VT, Hassan C, Armstrong D, Messmann H, Arantes V, Araya R, Barrera-Leon O, Bergman JJGHM, Bandhari P, Bourke MJ, Cerisoli C, Chiu PW, Desai M, Dinis-Ribeiro M, Falk GW, Fujishiro M, Gaddam S, Goda K, Gross S, Haidry R, Ho L, Iyer PG, Kashin S, Kothari S, Lee YY, Matsuda K, Neuhaus H, Oyama T, Ragunath K, Repici A, Shaheen N, Singh R, Sobrino-Cossio S, Wang KK, Waxman I, Sharma P. Rio de Janeiro Global Consensus on Landmarks, Definitions, and Classifications in Barrett's Esophagus: World Endoscopy Organization Delphi Study. Gastroenterology 2022;163:84-96.e2. [PMID: 35339464 DOI: 10.1053/j.gastro.2022.03.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Martínez-domínguez SJ, Lanas Á, Domper-arnal MJ. Barrett’s esophagus, towards improved clinical practice. Medicina Clínica (English Edition) 2022;159:92-100. [DOI: 10.1016/j.medcle.2022.07.003] [Reference Citation Analysis]
51 Rubenstein JH, Omidvari AH, Lauren BN, Hazelton WD, Lim F, Tan SX, Kong CY, Lee M, Ali A, Hur C, Inadomi JM, Luebeck G, Lansdorp-Vogelaar I. Endoscopic Screening Program for Control of Esophageal Adenocarcinoma in Varied Populations: A Comparative Cost-Effectiveness Analysis. Gastroenterology 2022;163:163-73. [PMID: 35364064 DOI: 10.1053/j.gastro.2022.03.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 West J, Card TR, Crooks CJ. Editorial: seeing the light at the end of gastroscope - complications after elective procedures are ready for NICE, bright decision aid tools - authors' reply. Aliment Pharmacol Ther 2022;56:157. [PMID: 35689325 DOI: 10.1111/apt.16987] [Reference Citation Analysis]
53 Salminen P, Grönroos S, Helmiö M, Hurme S, Juuti A, Juusela R, Peromaa-Haavisto P, Leivonen M, Nuutila P, Ovaska J. Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial. JAMA Surg 2022. [PMID: 35731535 DOI: 10.1001/jamasurg.2022.2229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
54 Nguyen TH, Thrift AP, Ketwaroo GA, Du XL, Leon Novelo L, George R, Rosen DG, El-Serag HB. External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans. Gastrointest Endosc 2022;95:1113-22. [PMID: 34998796 DOI: 10.1016/j.gie.2021.12.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Kim TH, Chandrasoma P. Intestinal Metaplasia of the Cardia is Associated With Barrett Esophagus and Esophageal Adenocarcinoma. Foregut 2022;2:101-110. [DOI: 10.1177/26345161211063451] [Reference Citation Analysis]
56 Gotink AW, Peters Y, Bruno MJ, Siersema PD, Koch AD. Nonthermal resection device for ablation of Barrett's esophagus: a feasibility and safety study. Endoscopy 2022;54:545-52. [PMID: 34521118 DOI: 10.1055/a-1644-4326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Helminen O, Melkko J, Saarnio J, Sihvo E, Kuopio T, Ohtonen P, Kauppila JH, Karttunen TJ, Huhta H. Predictive value of p53, Ki67 and TLR5 in neoplastic progression of Barrett's esophagus: a matched case-control study. Virchows Arch 2022. [PMID: 35614270 DOI: 10.1007/s00428-022-03340-5] [Reference Citation Analysis]
58 Sundaram S, Kim EN, Jones GM, Sivagnanam S, Tripathi M, Miremadi A, Di Pietro M, Coussens LM, Fitzgerald RC, Chang YH, Zhuang L. Deciphering the Immune Complexity in Esophageal Adenocarcinoma and Pre-Cancerous Lesions With Sequential Multiplex Immunohistochemistry and Sparse Subspace Clustering Approach. Front Immunol 2022;13:874255. [PMID: 35663986 DOI: 10.3389/fimmu.2022.874255] [Reference Citation Analysis]
59 Johari Y, Budiman K, Catchlove W, Laurie C, Hebbard G, Norden S, Brown WA, Burton P. Tubularized and Effaced Gastric Cardia Mimicking Barrett Esophagus following Sleeve Gastrectomy: Protocolized Endoscopic and Histological Assessment with High-Resolution Manometry Analysis. Ann Surg 2022. [PMID: 35703462 DOI: 10.1097/SLA.0000000000005493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Martínez-domínguez SJ, Lanas Á, Domper-arnal MJ. Esófago de Barrett, hacia la mejora de la práctica clínica. Medicina Clínica 2022. [DOI: 10.1016/j.medcli.2022.02.012] [Reference Citation Analysis]
61 Kolb JM, Chen M, Tavakkoli A, Singal AG, Vajravelu RK, Wani S; SCREEN-BE Study Group. Understanding Compliance, Practice Patterns, and Barriers Among Gastroenterologists and Primary Care Providers Is Crucial for Developing Strategies to Improve Screening for Barrett's Esophagus. Gastroenterology 2022;162:1568-1573.e4. [PMID: 35150724 DOI: 10.1053/j.gastro.2022.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Roumans CAM, Spaander MCW, Lansdorp-vogelaar I, Biermann K, Bruno MJ, Steyerberg EW, Rizopoulos D, on behalf of the ProBar study group. A personalized and dynamic risk estimation model: The new paradigm in Barrett’s esophagus surveillance. PLoS ONE 2022;17:e0267503. [DOI: 10.1371/journal.pone.0267503] [Reference Citation Analysis]
63 Axley P, Mitchell R, Council L, Patel C, Tracht J, Collingwood R, Harrison D, Redden D, Beasely M, Kabir Baig KKR, Al Diffalha S, Peter S. Videoconference microscopy is a reliable alternative to conventional microscopy in the evaluation of Barrett's esophagus: Zooming into a new era. Dis Esophagus 2022;35:doab064. [PMID: 34553220 DOI: 10.1093/dote/doab064] [Reference Citation Analysis]
64 Puthenpura MM, Sanaka KO, Qin Y, Thota PN. Management of nondysplastic Barrett’s esophagus: When to survey? When to ablate? Therapeutic Advances in Chronic Disease 2022;13:204062232210867. [DOI: 10.1177/20406223221086760] [Reference Citation Analysis]
65 Maroni R, Barnes J, Offman J, Scheibl F, Smith SG, Debiram-Beecham I, Waller J, Sasieni P, Fitzgerald RC, Rubin G, Walter FM; BEST3 Consortium. Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial. BMJ Open 2022;12:e054258. [PMID: 35393308 DOI: 10.1136/bmjopen-2021-054258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Evans JA, Carlotti E, Lin ML, Hackett RJ, Haughey MJ, Passman AM, Dunn L, Elia G, Porter RJ, McLean MH, Hughes F, ChinAleong J, Woodland P, Preston SL, Griffin SM, Lovat L, Rodriguez-Justo M, Huang W, Wright NA, Jansen M, McDonald SAC. Clonal Transitions and Phenotypic Evolution in Barrett's Esophagus. Gastroenterology 2022;162:1197-1209.e13. [PMID: 34973296 DOI: 10.1053/j.gastro.2021.12.271] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
67 Kuribayashi S, Hosaka H, Nakamura F, Nakata K, Sato K, Itoi Y, Hashimoto Y, Kasuga K, Tanaka H, Uraoka T. The role of endoscopy in the management of gastroesophageal reflux disease. DEN Open 2022;2. [DOI: 10.1002/deo2.86] [Reference Citation Analysis]
68 Sijben J, Peters Y, van der Velden K, Rainey L, Siersema PD, Broeders MJ. Public acceptance and uptake of oesophageal adenocarcinoma screening strategies: A mixed-methods systematic review. eClinicalMedicine 2022;46:101367. [DOI: 10.1016/j.eclinm.2022.101367] [Reference Citation Analysis]
69 Shaheen NJ, Falk GW, Iyer PG, Souza RF, Yadlapati RH, Sauer BG, Wani S. Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Am J Gastroenterol 2022;117:559-87. [PMID: 35354777 DOI: 10.14309/ajg.0000000000001680] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 30.0] [Reference Citation Analysis]
70 Ishimura N, Okimoto E, Shibagaki K, Ishihara S. Endoscopic diagnosis and screening of Barrett's esophagus: Inconsistency of diagnostic criteria between Japan and Western countries. DEN Open 2022;2. [DOI: 10.1002/deo2.73] [Reference Citation Analysis]
71 Koike T, Saito M, Ohara Y, Hatta W, Masamune A. Current status of surveillance for Barrett's esophagus in Japan and the West. DEN Open 2022;2. [DOI: 10.1002/deo2.94] [Reference Citation Analysis]
72 Dong J, Grant C, Vuong B, Nishioka N, Gao AH, Beatty M, Baldwin G, Baillargeon A, Bablouzian A, Grahmann P, Bhat N, Ryan E, Barrios A, Giddings S, Ford T, Beaulieu-Ouellet E, Hosseiny SH, Lerman I, Trasischker W, Reddy R, Singh K, Gora M, Hyun D, Quénéhervé L, Wallace M, Wolfsen H, Sharma P, Wang KK, Leggett CL, Poneros J, Abrams JA, Lightdale C, Leeds S, Rosenberg M, Tearney GJ. Feasibility and Safety of Tethered Capsule Endomicroscopy in Patients With Barrett's Esophagus in a Multi-Center Study. Clin Gastroenterol Hepatol 2022;20:756-765.e3. [PMID: 33549871 DOI: 10.1016/j.cgh.2021.02.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
73 Katz-Summercorn AC, Jammula S, Frangou A, Peneva I, O'Donovan M, Tripathi M, Malhotra S, di Pietro M, Abbas S, Devonshire G, Januszewicz W, Blasko A, Nowicki-Osuch K, MacRae S, Northrop A, Redmond AM, Wedge DC, Fitzgerald RC. Multi-omic cross-sectional cohort study of pre-malignant Barrett's esophagus reveals early structural variation and retrotransposon activity. Nat Commun 2022;13:1407. [PMID: 35301290 DOI: 10.1038/s41467-022-28237-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Dunn JM, Reyhani A, Santaolalla A, Zylstra J, Gimson E, Pennington M, Baker C, Kelly M, Van Hemelrijck M, Lagergren J, Zeki SS, Gossage JA, Davies AR. Transition from esophagectomy to endoscopic therapy for early esophageal cancer. Dis Esophagus 2022;35:doab047. [PMID: 34260693 DOI: 10.1093/dote/doab047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Choi WT, Lauwers GY, Montgomery EA. Utility of ancillary studies in the diagnosis and risk assessment of Barrett's esophagus and dysplasia. Mod Pathol 2022. [PMID: 35260826 DOI: 10.1038/s41379-022-01056-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Frederiks CN, van de Water JMW, Ebrahimi G, Weusten BLAM. Cryoballoon ablation as salvage therapy after nonradical resection of a high-risk T1b esophageal adenocarcinoma: a case report. Eur J Gastroenterol Hepatol 2022;34:354-7. [PMID: 34231521 DOI: 10.1097/MEG.0000000000002242] [Reference Citation Analysis]
77 Ratcliffe E, Britton J, Hamdy S, McLaughlin J, Ang Y. Developing patient-orientated Barrett's oesophagus services: the role of dedicated services. BMJ Open Gastroenterol 2022;9:e000829. [PMID: 35193888 DOI: 10.1136/bmjgast-2021-000829] [Reference Citation Analysis]
78 Ramay FH, Greenwald BD, Sharma VK, Dumot JA. Mucosal Ablation Techniques. Successful Training in Gastrointestinal Endoscopy 2022. [DOI: 10.1002/9781119529675.ch20] [Reference Citation Analysis]
79 Dutta AK. Are we Missing Barrett's Esophagus in Our Busy Endoscopy Practice? Improving Detection. Journal of Digestive Endoscopy. [DOI: 10.1055/s-0041-1741465] [Reference Citation Analysis]
80 van de Ven SEM, Spaander MCW, Pouw RE, Tang TJ, Houben MHMG, Schoon EJ, de Jonge PJF, Bruno MJ, Koch AD. Favorable effect of endoscopic reassessment of clinically staged T2 esophageal adenocarcinoma: a multicenter prospective cohort study. Endoscopy 2022;54:163-9. [PMID: 33530109 DOI: 10.1055/a-1380-8899] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Saller J, Jiang K, Xiong Y, Yoder SJ, Neill K, Pimiento JM, Pena L, Corbett FS, Magliocco A, Coppola D. A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and Cancer. Dig Dis Sci 2022;67:516-23. [PMID: 33713247 DOI: 10.1007/s10620-021-06863-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Pilonis ND, Killcoyne S, Tan WK, O'Donovan M, Malhotra S, Tripathi M, Miremadi A, Debiram-Beecham I, Evans T, Phillips R, Morris DL, Vickery C, Harrison J, di Pietro M, Ortiz-Fernandez-Sordo J, Haidry R, Kerridge A, Sasieni PD, Fitzgerald RC. Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot. Lancet Oncol 2022;23:270-8. [PMID: 35030332 DOI: 10.1016/S1470-2045(21)00667-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
83 Sawas T, Majzoub AM, Haddad J, Tielleman T, Nayfeh T, Yadlapati R, Singh S, Kolb J, Vajravelu RK, Katzka DA, Wani S; Post-Endoscopy Esophageal Adenocarcinoma Consensus Panel. Magnitude and Time-Trend Analysis of Postendoscopy Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2022;20:e31-50. [PMID: 33901662 DOI: 10.1016/j.cgh.2021.04.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
84 Gotink AW, van de Ven SEM, Ten Kate FJC, Nieboer D, Suzuki L, Weusten BLAM, Brosens LAA, van Hillegersberg R, Alvarez Herrero L, Seldenrijk CA, Alkhalaf A, Moll FCP, Schoon EJ, van Lijnschoten I, Tang TJ, van der Valk H, Nagengast WB, Kats-Ugurlu G, Plukker JTM, Houben MHMG, van der Laan JS, Pouw RE, Bergman JJGHM, Meijer SL, van Berge Henegouwen MI, Wijnhoven BPL, de Jonge PJF, Doukas M, Bruno MJ, Biermann K, Koch AD. Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study. Endoscopy 2022;54:109-17. [PMID: 33626582 DOI: 10.1055/a-1399-4989] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
85 Schmidt M, Hackett RJ, Baker AM, McDonald SAC, Quante M, Graham TA. Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy. Nat Rev Gastroenterol Hepatol 2022;19:95-111. [PMID: 34728819 DOI: 10.1038/s41575-021-00531-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
86 Liu Z, Guo L. Comments on: "Endoscopic prediction of submucosal invasion in Barrett's cancer with the use of artificial intelligence: a pilot study". Endoscopy 2022;54:224. [PMID: 35086158 DOI: 10.1055/a-1707-2265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Maev IV, Barkalova EV, Andreev DN, Ovsepian MA, Movtaeva PR, Zayratyants OV. Complex assessment of esophageal acidification and motor function in patients with Barrett's esophagus on antisecretory therapy. Terapevticheskii arkhiv 2022;93:1463-9. [DOI: 10.26442/00403660.2021.12.201278] [Reference Citation Analysis]
88 Mitra S, Paramaguru R, Das P, Katti SV. Preneoplastic Lesions and Polyps of the Gastrointestinal Tract. Surgical Pathology of the Gastrointestinal System 2022. [DOI: 10.1007/978-981-16-6395-6_16] [Reference Citation Analysis]
89 Paulose R, Viswanath N, Gopalakrishna R. Nonneoplastic Pathologies of the Esophagus. Surgical Pathology of the Gastrointestinal System 2022. [DOI: 10.1007/978-981-16-6395-6_7] [Reference Citation Analysis]
90 Sekaran A, Dey D, Singh A, Das P. Pathology of Malignant Lesions of the Gastrointestinal Tract. Surgical Pathology of the Gastrointestinal System 2022. [DOI: 10.1007/978-981-16-6395-6_17] [Reference Citation Analysis]
91 Tomizawa Y, Waxman I. Diagnostic and Interventional Endoscopy. Atlas of Esophageal Surgery 2022. [DOI: 10.1007/978-3-031-12790-8_3] [Reference Citation Analysis]
92 Nieuwenhuis EA, Bergman JJGHM, Pouw RE. Radiofrequency Ablation of Barrett’s Epithelium. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy 2022. [DOI: 10.1007/978-3-030-56993-8_6] [Reference Citation Analysis]
93 Overwater A, van Munster SN, Nagengast WB, Pouw RE, Bergman JJGHM, Schoon EJ, Weusten BLAM. Novel cryoballoon 180° ablation system for treatment of Barrett's esophagus-related neoplasia: a first-in-human study. Endoscopy 2022;54:64-70. [PMID: 33662991 DOI: 10.1055/a-1381-7562] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Shaheen NJ, Komanduri S, Muthusamy VR, Wani S, O'Donovan M, Kaushal R, Haydek JM. Acceptability and Adequacy of a Non-endoscopic Cell Collection Device for Diagnosis of Barrett's Esophagus: Lessons Learned. Dig Dis Sci 2022;67:177-86. [PMID: 33532971 DOI: 10.1007/s10620-021-06833-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
95 Pech O, Alqahtani SSA. Resection Techniques in Barrett’s Esophagus. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy 2022. [DOI: 10.1007/978-3-030-56993-8_8] [Reference Citation Analysis]
96 Han S, Low DE. LAPAROSCOPIC ANTIREFLUX SURGERY: ARE OLD QUESTIONS ANSWERED? SHOULD IT BE USED CONJOINED WITH ENDOSCOPIC THERAPY FOR BARRETT’S ESOPHAGUS? ABCD, arq bras cir dig 2022;35. [DOI: 10.1590/0102-672020210002e1664] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Pan W, Li X, Wang W, Zhou L, Wu J, Ren T, Liu C, Lv M, Su S, Tang Y. Identification of Barrett's esophagus in endoscopic images using deep learning. BMC Gastroenterol 2021;21:479. [PMID: 34920705 DOI: 10.1186/s12876-021-02055-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
98 Offman J, Pesola F, Fitzgerald RC, Hamilton W, Sasieni P. Impact of Barrett oesophagus diagnoses and endoscopies on oesophageal cancer survival in the UK: A cohort study. Cancer Med 2021. [PMID: 34913599 DOI: 10.1002/cam4.4484] [Reference Citation Analysis]
99 Maslyonkina KS, Konyukova AK, Alexeeva DY, Sinelnikov MY, Mikhaleva LM. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. Cancer Med 2021. [PMID: 34870375 DOI: 10.1002/cam4.4447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 Chang K, Jackson CS, Vega KJ. Barrett's Esophagus: Diagnosis, Management, and Key Updates. Gastroenterol Clin North Am 2021;50:751-68. [PMID: 34717869 DOI: 10.1016/j.gtc.2021.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 White JR, Ortiz-Fernández-Sordo J, Santiago-García J, Reddiar D, Learoyd A, De Caestecker J, Cole A, Kaye P, Ragunath K. Endoscopic management of Barrett's dysplasia and early neoplasia: efficacy, safety and long-term outcomes in a UK tertiary centre. Eur J Gastroenterol Hepatol 2021;33:e413-22. [PMID: 33731587 DOI: 10.1097/MEG.0000000000002121] [Reference Citation Analysis]
102 Wei JP, Cui HL. Progress in understanding of influence of bariatric surgery on reflux esophagitis. Shijie Huaren Xiaohua Zazhi 2021; 29(22): 1298-1303 [DOI: 10.11569/wcjd.v29.i22.1298] [Reference Citation Analysis]
103 Busslinger GA, de Barbanson B, Oka R, Weusten BLA, de Maat M, van Hillegersberg R, Brosens LAA, van Boxtel R, van Oudenaarden A, Clevers H. Molecular characterization of Barrett's esophagus at single-cell resolution. Proc Natl Acad Sci U S A 2021;118:e2113061118. [PMID: 34795059 DOI: 10.1073/pnas.2113061118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
104 Tan PO, Soh AYS, Kusano C, Lee YY, Gotoda T. Is There an Increasing Incidence of Gastroesophageal Junctional Adenocarcinoma and Barrett Esophagus in Asia? A Review of Diagnostic Conundrums. Digestion 2022;103:37-44. [PMID: 34781299 DOI: 10.1159/000519922] [Reference Citation Analysis]
105 Norita K, Koike T, Saito M, Shinkai H, Ami R, Abe Y, Dairaku N, Inomata Y, Kayaba S, Ishiyama F, Oikawa T, Ohyauchi M, Ito H, Asonuma S, Hoshi T, Kato K, Ohara S, Shimodaira Y, Watanabe K, Shimosegawa T, Masamune A, Iijima K. Long-term endoscopic surveillance for Barrett's esophagus in Japan: Multicenter prospective cohort study. Dig Endosc 2021;33:1085-92. [PMID: 33277694 DOI: 10.1111/den.13910] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
106 Li J, Xu J, Zheng Y, Gao Y, He S, Li H, Zou K, Li N, Tian J, Chen W, He J. Esophageal cancer: Epidemiology, risk factors and screening. Chin J Cancer Res 2021;33:535-47. [PMID: 34815628 DOI: 10.21147/j.issn.1000-9604.2021.05.01] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
107 Li N, Jin SZ. Artificial intelligence and early esophageal cancer. Artif Intell Gastrointest Endosc 2021; 2(5): 198-210 [DOI: 10.37126/aige.v2.i5.198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Salimian KJ, Birkness-Gartman J, Waters KM. The path(ology) from reflux oesophagitis to Barrett oesophagus to oesophageal adenocarcinoma. Pathology 2021:S0031-3025(21)00482-7. [PMID: 34711413 DOI: 10.1016/j.pathol.2021.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Waterhouse DJ, Bano S, Januszewicz W, Stoyanov D, Fitzgerald RC, di Pietro M, Bohndiek SE. First-in-human pilot study of snapshot multispectral endoscopy for early detection of Barrett's-related neoplasia. J Biomed Opt 2021;26. [PMID: 34628734 DOI: 10.1117/1.JBO.26.10.106002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
110 Elkassem S. Gastroesophageal Reflux Disease, Esophagitis, and Barrett's Esophagus 3 to 4 Years Post Sleeve Gastrectomy. Obes Surg 2021;31:5148-55. [PMID: 34599728 DOI: 10.1007/s11695-021-05688-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
111 Peters Y, van Grinsven E, Siersema PD. Systematic review with meta-analysis: the effects of family history on the risk of Barrett's oesophagus and oesophageal adenocarcinoma. Aliment Pharmacol Ther 2021;54:868-79. [PMID: 34383966 DOI: 10.1111/apt.16558] [Reference Citation Analysis]
112 Hajelssedig OE, Zorron Cheng Tao Pu L, Thompson JY, Lord A, El Sayed I, Meyer C, Shaukat Ali F, Abdulazeem HM, Kheir AO, Siepmann T, Singh R. Diagnostic accuracy of narrow-band imaging endoscopy with targeted biopsies compared with standard endoscopy with random biopsies in patients with Barrett's esophagus: A systematic review and meta-analysis. J Gastroenterol Hepatol 2021;36:2659-71. [PMID: 34121232 DOI: 10.1111/jgh.15577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
113 Hussein M, Sehgal V, Sami S, Bassett P, Sweis R, Graham D, Telese A, Morris D, Rodriguez-Justo M, Jansen M, Novelli M, Banks M, Lovat LB, Haidry R. The natural history of low-grade dysplasia in Barrett's esophagus and risk factors for progression. JGH Open 2021;5:1019-25. [PMID: 34584970 DOI: 10.1002/jgh3.12625] [Reference Citation Analysis]
114 Killcoyne S, Fitzgerald RC. Evolution and progression of Barrett's oesophagus to oesophageal cancer. Nat Rev Cancer 2021;21:731-41. [PMID: 34545238 DOI: 10.1038/s41568-021-00400-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
115 Karamchandani DM, Gonzalez RS, Westerhoff M, Westbrook LM, Panarelli NC, Al-Nuaimi M, King T, Arnold CA. Measuring depth of invasion of submucosa - invasive adenocarcinoma in oesophageal endoscopic specimens: how good are we?☆. Histopathology 2021. [PMID: 34519098 DOI: 10.1111/his.14566] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
116 Teufel A, Quante M, Kandulski A, Hirth M, Zhan T, Eckardt M, Thieme R, Kusnik A, Yesmembetov K, Wiest I, Riemann JF, Schlitt HJ, Gockel I, Malfertheiner P, Ebert MP. [Prevention of gastrointestinal cancer]. Z Gastroenterol 2021;59:964-82. [PMID: 34507375 DOI: 10.1055/a-1540-7539] [Reference Citation Analysis]
117 Mastracci L, Grillo F, Parente P, Unti E, Battista S, Spaggiari P, Campora M, Scaglione G, Fassan M, Fiocca R. Gastro-esophageal reflux disease and Barrett's esophagus: an overview with an histologic diagnostic approach. Pathologica 2020;112:117-27. [PMID: 33179616 DOI: 10.32074/1591-951X-162] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
118 Peters Y, Huibertse LJ, Schrauwen RWM, Tan AC, van der Post RS, Siersema PD. Increased risk of Barrett's oesophagus and related neoplasia in individuals with a positive family history. Eur J Cancer 2021;155:116-26. [PMID: 34375895 DOI: 10.1016/j.ejca.2021.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
119 Tullie L, Kelay A, Bethell GS, Major C, Hall NJ. Barrett's oesophagus and oesophageal cancer following oesophageal atresia repair: a systematic review. BJS Open 2021;5:zrab069. [PMID: 34370830 DOI: 10.1093/bjsopen/zrab069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
120 Omidvari AH, Hazelton WD, Lauren BN, Naber SK, Lee M, Ali A, Seguin C, Kong CY, Richmond E, Rubenstein JH, Luebeck GE, Inadomi JM, Hur C, Lansdorp-Vogelaar I. The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett's Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness Analysis. Gastroenterology 2021;161:487-494.e4. [PMID: 33974935 DOI: 10.1053/j.gastro.2021.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
121 Phillips R, Januszewicz W, Pilonis ND, O'Donovan M, Sawas T, Katzka DA, Fitzgerald RC, di Pietro M. The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study. Gastrointest Endosc 2021;94:263-270.e2. [PMID: 33548281 DOI: 10.1016/j.gie.2021.01.042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
122 Peleg N, Schmilovitz-Weiss H, Shamah S, Schwartz A, Dotan I, Sapoznikov B. Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett's esophagus. Endoscopy 2021;53:774-81. [PMID: 33075822 DOI: 10.1055/a-1292-8747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
123 Curtius K, Rubenstein JH, Chak A, Inadomi JM. Computational modelling suggests that Barrett's oesophagus may be the precursor of all oesophageal adenocarcinomas. Gut 2020;70:1435-40. [PMID: 33234525 DOI: 10.1136/gutjnl-2020-321598] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
124 Rozenfel’d II. Laparoscopic plasty of giant diaphragmatic hernia using a biocarbonic implant. Medical Journal of the Russian Federation 2021;27:139-144. [DOI: 10.17816/0869-2106-2021-27-2-139-144] [Reference Citation Analysis]
125 Tan WK, Sharma AN, Chak A, Fitzgerald RC. Progress in Screening for Barrett's Esophagus: Beyond Standard Upper Endoscopy. Gastrointest Endosc Clin N Am 2021;31:43-58. [PMID: 33213799 DOI: 10.1016/j.giec.2020.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
126 Leclercq P, Bisschops R. Optimizing Outcomes with Radiofrequency Ablation of Barrett's Esophagus: Candidates, Efficacy and Durability. Gastrointest Endosc Clin N Am 2021;31:131-54. [PMID: 33213792 DOI: 10.1016/j.giec.2020.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Elias PS, Spechler SJ. Barrett's Esophagus. The Esophagus 2021. [DOI: 10.1002/9781119599692.ch29] [Reference Citation Analysis]
128 Fateen W, Johnson PJ, Wood HM, Zhang H, He S, El-Meteini M, Wyatt JI, Aithal GP, Quirke P. Characterisation of dysplastic liver nodules using low-pass DNA sequencing and detection of chromosome arm-level abnormalities in blood-derived cell-free DNA. J Pathol 2021;255:30-40. [PMID: 34028025 DOI: 10.1002/path.5734] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
129 Stingl C, Bureo Gonzalez A, Güzel C, Phoa KYN, Doukas M, Breimer GE, Meijer SL, Bergman JJ, Luider TM. Alteration of protein expression and spliceosome pathway activity during Barrett's carcinogenesis. J Gastroenterol 2021;56:791-807. [PMID: 34227026 DOI: 10.1007/s00535-021-01802-2] [Reference Citation Analysis]
130 Barret M. Pediatric Barrett's Esophagus: A Fifth Column? Dig Dis Sci 2021;66:2143-4. [PMID: 32945985 DOI: 10.1007/s10620-020-06595-7] [Reference Citation Analysis]
131 Alsahafi M, Mimish H, Salem F, Hijazi M, Aljahdli E, Jawa H, Bazarah S, Bokhary R, Qari Y, Mosli M. The Prevalence of Barrett's Esophagus Among a Saudi Arabian Population. Dig Dis Sci 2021;66:2311-6. [PMID: 32749640 DOI: 10.1007/s10620-020-06503-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
132 Meyer C, Hejazi R, Bansal A. How extent of Barrett's metaplasia influences the risk of esophageal adenocarcinoma. Curr Opin Gastroenterol 2021;37:378-83. [PMID: 33883421 DOI: 10.1097/MOG.0000000000000743] [Reference Citation Analysis]
133 Killcoyne S, Yusuf A, Fitzgerald RC. Genomic instability signals offer diagnostic possibility in early cancer detection. Trends Genet 2021:S0168-9525(21)00165-7. [PMID: 34218956 DOI: 10.1016/j.tig.2021.06.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
134 Twohig-Bennett L, Coleman HG, Cairnduff V, McManus DT, Murray LJ, Gavin AT, Johnston BT. Esophageal Columnar Metaplasia in Childhood: A Population-Based Case Series Analysis. Dig Dis Sci 2021;66:2317-22. [PMID: 32683588 DOI: 10.1007/s10620-020-06462-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
135 Zhang L, Sun B, Zhou X, Wei Q, Liang S, Luo G, Li T, Lü M. Barrett's Esophagus and Intestinal Metaplasia. Front Oncol 2021;11:630837. [PMID: 34221959 DOI: 10.3389/fonc.2021.630837] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
136 Zhao Z, Yin Z, Zhang C. Lifestyle interventions can reduce the risk of Barrett's esophagus: a systematic review and meta-analysis of 62 studies involving 250,157 participants. Cancer Med 2021;10:5297-320. [PMID: 34128354 DOI: 10.1002/cam4.4061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
137 Asreah RH, Abdullhameed A. Risk factors of erosive esophagitis and barrett's esophagus in patients with reflux symptoms. Med J Islam Repub Iran 2021;35:75. [PMID: 34290999 DOI: 10.47176/mjiri.35.75] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
138 Chen Y, Wang J, Zhou H, Huang Z, Qian L, Shi W. Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma. Biomed Res Int 2021;2021:6628391. [PMID: 34222478 DOI: 10.1155/2021/6628391] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
139 Yang H, Hu B. Recent advances in early esophageal cancer: diagnosis and treatment based on endoscopy. Postgrad Med 2021;133:665-73. [PMID: 34030580 DOI: 10.1080/00325481.2021.1934495] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
140 Kunzmann AT, Coleman HG, Johnston BT, Turkington RC, McManus D, Anderson LA, Thrift AP. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies? Dig Dis Sci 2021;66:1965-73. [PMID: 32734400 DOI: 10.1007/s10620-020-06483-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
141 Clauditz TS, Lauwers GY, Wallace MB, Mattia AR. Epithelial Metaplastic, Polypoid, and Neoplastic Conditions of the Esophagus. Gastrointestinal Pathology 2021. [DOI: 10.1002/9781119073048.ch3] [Reference Citation Analysis]
142 Jones B, Williams JL, Komanduri S, Muthusamy VR, Shaheen NJ, Wani S. Racial Disparities in Adherence to Quality Indicators in Barrett's Esophagus: An Analysis Using the GIQuIC National Benchmarking Registry. Am J Gastroenterol 2021;116:1201-10. [PMID: 33767105 DOI: 10.14309/ajg.0000000000001230] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
143 Weismüller J, Thieme R, Hoffmeister A, Weismüller T, Gockel I. Barrett-Screening: Rationale, aktuelle Konzepte und Perspektiven. TumorDiagnostik & Therapie 2021;42:345-353. [DOI: 10.1055/a-1466-9727] [Reference Citation Analysis]
144 Waterhouse DJ, Januszewicz W, Ali S, Fitzgerald RC, di Pietro M, Bohndiek SE. Spectral Endoscopy Enhances Contrast for Neoplasia in Surveillance of Barrett's Esophagus. Cancer Res 2021;81:3415-25. [PMID: 34039635 DOI: 10.1158/0008-5472.CAN-21-0474] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
145 Sunakawa H, Yoda Y, Takeshita N, Hasegawa H, Takashima K, Kadota T, Fujita T, Akimoto T, Fujii S, Yano T. Endoscopic resection combined with the Cryoballoon focal ablation system in the porcine normal esophagus: a preclinical study. BMC Gastroenterol 2021;21:234. [PMID: 34022798 DOI: 10.1186/s12876-021-01819-0] [Reference Citation Analysis]
146 Groulx S, Limburg H, Doull M, Klarenbach S, Singh H, Wilson BJ, Thombs B; Canadian Task Force on Preventive Health Care. Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease. CMAJ 2020;192:E768-77. [PMID: 32631908 DOI: 10.1503/cmaj.190814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
147 Lin PH, Hsieh JG, Yu HC, Jeng JH, Hsu CL, Chen CH, Wu PC. Risk Prediction of Barrett's Esophagus in a Taiwanese Health Examination Center Based on Regression Models. Int J Environ Res Public Health 2021;18:5332. [PMID: 34067792 DOI: 10.3390/ijerph18105332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
148 Rozenfel'd II. Current issues of surgical treatment of large and giant hiatal hernias. Medical Journal of the Russian Federation 2021;27:291-298. [DOI: 10.17816/0869-2106-2021-27-3-291-298] [Reference Citation Analysis]
149 Peng W, Tu G, Zhao Z, He B, Cai Q, Zhang P, Peng X, Shi S, Wang X. DNA methylome and transcriptome analysis established a model of four differentially methylated positions (DMPs) as a diagnostic marker in esophageal adenocarcinoma early detection. PeerJ 2021;9:e11355. [PMID: 34012728 DOI: 10.7717/peerj.11355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
150 Eusebi LH, Telese A, Cirota GG, Haidry R, Zagari RM, Bazzoli F, Ford AC. Systematic review with meta-analysis: risk factors for Barrett's oesophagus in individuals with gastro-oesophageal reflux symptoms. Aliment Pharmacol Ther 2021;53:968-76. [PMID: 33705573 DOI: 10.1111/apt.16321] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
151 Rubenstein JH, Raghunathan T, Doan C, Schneider J, Zhao W, Metko V, Nofz K, Khodadost M, Corley DA. Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction. Am J Gastroenterol 2021;116:949-57. [PMID: 33852454 DOI: 10.14309/ajg.0000000000001255] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
152 Vosko S, Gupta S, Shahidi N, Hourigan LF, van Hattem WA, Bar-Yishay I, Schoeman S, Sidhu M, Burgess NG, Lee EYT, Bourke MJ. Snare-tip soft coagulation is effective and efficient as a first-line modality for treating intraprocedural bleeding during Barrett's mucosectomy. Endoscopy 2021;53:511-6. [PMID: 32659800 DOI: 10.1055/a-1218-6089] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
153 Cao JS, Lu ZY, Chen MY, Zhang B, Juengpanich S, Hu JH, Li SJ, Topatana W, Zhou XY, Feng X, Shen JL, Liu Y, Cai XJ. Artificial intelligence in gastroenterology and hepatology: Status and challenges. World J Gastroenterol 2021; 27(16): 1664-1690 [PMID: 33967550 DOI: 10.3748/wjg.v27.i16.1664] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
154 Kew GS, Soh AYS, Lee YY, Gotoda T, Li YQ, Zhang Y, Chan YH, Siah KTH, Tong D, Law SYK, Ruszkiewicz A, Tseng PH, Lee YC, Chang CY, Quach DT, Kusano C, Bhatia S, Wu JCY, Singh R, Sharma P, Ho KY. Multinational survey on the preferred approach to management of Barrett’s esophagus in the Asia-Pacific region. World J Gastrointest Oncol 2021; 13(4): 279-294 [PMID: 33889279 DOI: 10.4251/wjgo.v13.i4.279] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
155 Gehrung M, Crispin-Ortuzar M, Berman AG, O'Donovan M, Fitzgerald RC, Markowetz F. Triage-driven diagnosis of Barrett's esophagus for early detection of esophageal adenocarcinoma using deep learning. Nat Med 2021;27:833-41. [PMID: 33859411 DOI: 10.1038/s41591-021-01287-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
156 Liu Y. Artificial intelligence-assisted endoscopic detection of esophageal neoplasia in early stage: The next step? World J Gastroenterol 2021; 27(14): 1392-1405 [PMID: 33911463 DOI: 10.3748/wjg.v27.i14.1392] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
157 Evans JA, Carlotti E, Lin M, Hackett RJ, Passman A, Dunn L, Elia G, Porter RJ, Mcclean MH, Hughes F, Chinaleong J, Woodland P, Preston SL, Griffin SM, Lovat L, Rodriguez-justo M, Wright NA, Jansen M, Mcdonald SA. Clonal transitions and phenotypic evolution in Barrett esophagus.. [DOI: 10.1101/2021.03.31.21252894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
158 Diseases of the Esophagus. Non-Neoplastic Disorders of the Gastrointestinal Tract 2021. [DOI: 10.55418/9781933477930-02] [Reference Citation Analysis]
159 Frei NF, Khoshiwal AM, Konte K, Bossart EA, Stebbins K, Zhang Y, Pouw RE, Ten Kate FJW, Seldenrijk KA, Meijer SL, Critchley-Thorne RJ, Bergman JJGHM. Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia. Am J Gastroenterol 2021;116:675-82. [PMID: 33982936 DOI: 10.14309/ajg.0000000000001037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
160 Xie Y, Shi L, He X, Luo Y. Gastrointestinal cancers in China, the USA, and Europe. Gastroenterol Rep (Oxf) 2021;9:91-104. [PMID: 34026216 DOI: 10.1093/gastro/goab010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
161 Yusuf A, Fitzgerald RC. Screening for Barrett's Oesophagus: Are We Ready for it? Curr Treat Options Gastroenterol 2021;:1-16. [PMID: 33746508 DOI: 10.1007/s11938-021-00342-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
162 Konda VJ, Ellison A. The Utility of Biomarkers for Risk Stratification in Barrett’s Esophagus. Foregut 2021;1:41-47. [DOI: 10.1177/2634516121995027] [Reference Citation Analysis]
163 Scarpignato C, Hunt RH. Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers. Curr Treat Options Gastro 2021;19:94-132. [DOI: 10.1007/s11938-020-00330-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
164 Spechler SJ, Souza RF. Implications of Recent Revelations from Basic and Clinical Studies of Barrett’s Esophagus for Screening and Surveillance Strategies. Foregut 2021;1:86-92. [DOI: 10.1177/2634516121990959] [Reference Citation Analysis]
165 Walradt T, Bilal M, Pleskow DK. Evaluation of Barrett's Esophagus. Digestive Disease Interventions 2021;05:009-016. [DOI: 10.1055/s-0041-1726325] [Reference Citation Analysis]
166 Komanduri S, Farina DA. A Practical Approach to Screening and Surveillance of Barrett’s Esophagus. Foregut 2021;1:25-31. [DOI: 10.1177/2634516121993675] [Reference Citation Analysis]
167 Chandrasoma P. The Evolution of the Definition and Diagnosis of Barrett Esophagus: A Historical Perspective. Foregut 2021;1:16-23. [DOI: 10.1177/2634516121989879] [Reference Citation Analysis]
168 Dumoulin FL, Hildenbrand R, Oyama T, Steinbrück I. Current Trends in Endoscopic Diagnosis and Treatment of Early Esophageal Cancer. Cancers (Basel) 2021;13:752. [PMID: 33670208 DOI: 10.3390/cancers13040752] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
169 Magee CG, Graham D, Gordon C, Dunn J, Penman I, Willert R, Smart H, Ortiz-Fernandez-Sordo J, Ragunath K, Everson M, Alzoubaidi D, Banks M, Morris D, Sami S, Morris AJ, Bhandari P, Narayanasamy R, Di Pietro M, Lovat LB, Haidry R. Radiofrequency ablation for Barrett's oesophagus related neoplasia with the 360 Express catheter: initial experience from the United Kingdom and Ireland-preliminary results. Surg Endosc 2021. [PMID: 33547491 DOI: 10.1007/s00464-021-08325-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
170 Wronska E, Polkowski M, Orlowska J, Mroz A, Wieszczy P, Regula J. Argon plasma coagulation for Barrett's esophagus with low-grade dysplasia: a randomized trial with long-term follow-up on the impact of power setting and proton pump inhibitor dose. Endoscopy 2021;53:123-32. [PMID: 32650347 DOI: 10.1055/a-1203-5930] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
171 Desai M, Hamade N, Sharma P. Screening for Barrett's esophagus: challenges in identifying the population at risk. Gastrointest Endosc 2021;93:420-1. [PMID: 33478664 DOI: 10.1016/j.gie.2020.11.002] [Reference Citation Analysis]
172 Nguyen TH, Thrift AP, Rugge M, El-Serag HB. Prevalence of Barrett's esophagus and performance of societal screening guidelines in an unreferred primary care population of U.S. veterans. Gastrointest Endosc 2021;93:409-419.e1. [PMID: 32565183 DOI: 10.1016/j.gie.2020.06.032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
173 Grady WM, Yu M, Markowitz SD. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer. Gastroenterology 2021;160:690-709. [PMID: 33279516 DOI: 10.1053/j.gastro.2020.09.058] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 26.5] [Reference Citation Analysis]
174 Walker R, Wiggins T, Blencowe NS, Findlay JM, Wilson M, Currie AC, Hornby S, Markar SR, Rahman S, Lloyd M, Hollyman M, Jaunoo S; ARROW Study Group. A multicenter prospective audit to investigate the current management of patients undergoing anti-reflux surgery in the UK: Audit & Review of Anti-Reflux Operations & Workup. Dis Esophagus 2021;34. [PMID: 33458741 DOI: 10.1093/dote/doaa129] [Reference Citation Analysis]
175 Yung E, Li X, Chandrasoma P. Intestinal Metaplasia of the "Cardia": Accurate Differentiation of Gastric or Esophageal Origin With an Expanded Biopsy Protocol. Am J Surg Pathol 2021;45:945-50. [PMID: 33739789 DOI: 10.1097/PAS.0000000000001665] [Reference Citation Analysis]
176 Kolb JM, Wani S. Barrett's esophagus: current standards in advanced imaging. Transl Gastroenterol Hepatol 2021;6:14. [PMID: 33409408 DOI: 10.21037/tgh.2020.02.10] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
177 Swanson E, Naini BV. Barrett Esophagus. Practical Gastrointestinal Pathology 2021. [DOI: 10.1007/978-3-030-51268-2_3] [Reference Citation Analysis]
178 van Munster SN, Nieuwenhuis EA, Weusten BLAM, Herrero LA, Bogte A, Alkhalaf A, Schenk BE, Schoon EJ, Curvers W, Koch AD, van de Ven SEM, de Jonge PJF, Tang T, Nagengast WB, Peters FTM, Westerhof J, Houben MHMG, Bergman JJGHM, Pouw RE; Dutch Barrett Expert Centers. Endoscopic Resection Without Subsequent Ablation Therapy for Early Barrett's Neoplasia: Endoscopic Findings and Long-Term Mortality. J Gastrointest Surg 2021;25:67-76. [PMID: 33140322 DOI: 10.1007/s11605-020-04836-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
179 Singh R, Zorron Cheng Tao Pu L, Choi KC. Diagnosis of Superficial Esophageal Neoplasia: Classification. Endoscopy in Early Gastrointestinal Cancers, Volume 1 2021. [DOI: 10.1007/978-981-10-6769-3_4] [Reference Citation Analysis]
180 Chandrasoma P. Pathophysiology of Lower Esophageal Sphincter Damage: A New Method of Diagnosis of Gastroesophageal Reflux Disease. Multidisciplinary Management of Gastroesophageal Reflux Disease 2021. [DOI: 10.1007/978-3-030-53751-7_1] [Reference Citation Analysis]
181 Zagari RM, Eusebi LH, Galloro G, Rabitti S, Neri M, Pasquale L, Bazzoli F. Attending Training Courses on Barrett's Esophagus Improves Adherence to Guidelines: A Survey from the Italian Society of Digestive Endoscopy. Dig Dis Sci 2021;66:2888-96. [PMID: 32984930 DOI: 10.1007/s10620-020-06615-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
182 Suzuki H, Yoshitaka T, Yoshio T, Tada T. Artificial intelligence for cancer detection of the upper gastrointestinal tract. Dig Endosc 2021;33:254-62. [PMID: 33222330 DOI: 10.1111/den.13897] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
183 Hollenbach M, Hoffmeister A. Endoskopisches Management und interventionelle Therapie der Barrett-Metaplasie und der intraepithelialen Neoplasie des Ösophagus. Benigne Ösophaguserkrankungen 2021. [DOI: 10.1007/978-3-662-60455-7_25] [Reference Citation Analysis]
184 Jackson T, Faugno-fusci D, Wogsland A, Marks J. Endoscopic Mucosal Resection. Benign Esophageal Disease 2021. [DOI: 10.1007/978-3-030-51489-1_19] [Reference Citation Analysis]
185 Loughrey MB, Shepherd NA. The indications for biopsy in routine upper gastrointestinal endoscopy. Histopathology 2021;78:215-27. [PMID: 33382487 DOI: 10.1111/his.14213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
186 Anishchenko VV, Titov SE, Poloz TL, Veryaskina YA, Arkhipova AA, Bubnov IV. DINAMIC SCREENING OF PRECANCEROUS ESOPHAGUS USING MOLECULAR GENETIC ANALYSIS. Sib onkol ž 2020;19:38-45. [DOI: 10.21294/1814-4861-2020-19-6-38-45] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
187 Kumarasinghe MP, Armstrong M, Foo J, Raftopoulos SC. The modern management of Barrett's oesophagus and related neoplasia: role of pathology. Histopathology 2021;78:18-38. [PMID: 33382493 DOI: 10.1111/his.14285] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
188 Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal Reflux Disease: A Review. JAMA 2020;324:2536-47. [PMID: 33351048 DOI: 10.1001/jama.2020.21360] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 19.3] [Reference Citation Analysis]
189 Curtius K, Dewanji A, Hazelton WD, Rubenstein JH, Luebeck GE. Optimal Timing for Cancer Screening and Adaptive Surveillance Using Mathematical Modeling. Cancer Res 2021;81:1123-34. [PMID: 33293425 DOI: 10.1158/0008-5472.CAN-20-0335] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
190 FalcÃo AM, Nasi A, Szachnowicz S, Santa-Cruz F, Seguro FCBC, Sena BF, Duarte A, Sallum RA, Cecconello I. Does the nissen fundoplication procedure improve esophageal dysmotility in patients with barrett's esophagus? Rev Col Bras Cir 2020;47:e20202637. [PMID: 33263652 DOI: 10.1590/0100-6991e-20202637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
191 Marques de Sá I, Pereira AD, Sharma P, Dinis-Ribeiro M. Systematic review of the published guidelines on Barrett's esophagus: should we stress the consensus or the differences? Dis Esophagus 2020:doaa115. [PMID: 33249488 DOI: 10.1093/dote/doaa115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
192 Spechler SJ. Screening for Barrett's oesophagus: are we looking for the right thing? Gut 2020:gutjnl-2020-323378. [PMID: 33239343 DOI: 10.1136/gutjnl-2020-323378] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
193 Katzka DA, Kahrilas PJ. Advances in the diagnosis and management of gastroesophageal reflux disease. BMJ. [DOI: 10.1136/bmj.m3786] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
194 Sehgal V, Ragunath K, Haidry R. Measuring Quality in Barrett's Esophagus: Time to Embrace Quality Indicators. Gastrointest Endosc Clin N Am 2021;31:219-36. [PMID: 33213797 DOI: 10.1016/j.giec.2020.09.006] [Reference Citation Analysis]
195 Kroupa R, Katinova I, Pavlik T, Kunovsky L, Prochazka V, Borilova Linhartova P, Packova B, Kala Z, Dolina J. Incidence trends of esophageal cancer in the Czech Republic by histological subtype and stage and prescription rate of acid suppressing drugs. Cancer Epidemiol 2020;69:101853. [PMID: 33161372 DOI: 10.1016/j.canep.2020.101853] [Reference Citation Analysis]
196 Chen T, Lin R, Wang W, Lee C, Tseng C, Hsu W, Tai W, Wang H, Chang C. Validation of simplified classification of magnifying endoscopy for diagnosis of Barrett's dysplasia with blue laser imaging. Adv in Digestive Medicine 2022;9:10-6. [DOI: 10.1002/aid2.13233] [Reference Citation Analysis]
197 Deissová T, Kala Z, Slabý O, Dolina J, Kroupa R, Kunovský L, Izakovičová Hollá L, Bořilová Linhartová P. Biomarkers for non-endoscopic examination of esophageal mucosa. Vnitr Lek 2020;66:e13-e19. [DOI: 10.36290/vnl.2020.133] [Reference Citation Analysis]
198 Iwaya Y, Inoue H, Rodríguez de Santiago E, Abad MRA, Fujiyoshi Y, Ueno A, Tanabe M, Sumi K, Tomida H, Ominami M, Ikeda H, Onimaru M, Shimamura Y. Endoscopic pressure study integrated system reflects gastroesophageal junction competence in patients with erosive esophagitis and Barrett´s esophagus. Dig Endosc 2020;32:1050-6. [PMID: 32012362 DOI: 10.1111/den.13644] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
199 Maitra I, Morais CL, Lima KM, Ashton KM, Bury D, Date RS, Martin FL. Discrimination of oesophageal transformation stages to adenocarcinoma in human tissue samples using Raman microspectroscopy. Vibrational Spectroscopy 2020;111:103141. [DOI: 10.1016/j.vibspec.2020.103141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
200 Woods YL, Carey FA. Pathology of the oesophagus and stomach. Surgery (Oxford) 2020;38:687-693. [DOI: 10.1016/j.mpsur.2020.08.007] [Reference Citation Analysis]
201 Wani S, Williams JL, Falk GW, Komanduri S, Muthusamy VR, Shaheen NJ. An Analysis of the GIQuIC Nationwide Quality Registry Reveals Unnecessary Surveillance Endoscopies in Patients With Normal and Irregular Z-Lines. Am J Gastroenterol 2020;115:1869-78. [PMID: 33156106 DOI: 10.14309/ajg.0000000000000960] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
202 Otaki F, Iyer PG. Gastroesophageal Reflux Disease and Barrett Esophagus in the Elderly. Clin Geriatr Med 2021;37:17-29. [PMID: 33213770 DOI: 10.1016/j.cger.2020.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
203 Souza RF, Spechler SJ. Advances in Biomarkers for Risk Stratification in Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:105-15. [PMID: 33213790 DOI: 10.1016/j.giec.2020.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
204 Gabre J, Chak A, Rustgi A. Familial Barrett’s Esophagus and Esophageal Adenocarcinoma. Curr Treat Options Gastro 2020;18:616-22. [DOI: 10.1007/s11938-020-00313-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
205 Wang W, Chen D, Sang Y, Chen C, Zhang Y, Mao Y, Chen Y. Endoscopic resection versus esophagectomy for patients with small-sized T1N0 esophageal cancer: A propensity-matched study. Clin Res Hepatol Gastroenterol 2021;45:101543. [PMID: 33554864 DOI: 10.1016/j.clinre.2020.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
206 Grady WM, Yu M, Markowitz SD, Chak A. Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers. Cancer Epidemiol Biomarkers Prev 2020;29:2486-94. [PMID: 33093162 DOI: 10.1158/1055-9965.EPI-20-0223] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
207 Triggs JR, Falk GW. Best Practices in Surveillance for Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:59-75. [PMID: 33213800 DOI: 10.1016/j.giec.2020.08.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
208 Cook MB, Thrift AP. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance. Gastrointest Endosc Clin N Am 2021;31:1-26. [PMID: 33213789 DOI: 10.1016/j.giec.2020.08.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
209 Huang LM, Yang WJ, Huang ZY, Tang CW, Li J. Artificial intelligence technique in detection of early esophageal cancer. World J Gastroenterol 2020; 26(39): 5959-5969 [PMID: 33132647 DOI: 10.3748/wjg.v26.i39.5959] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
210 Kamboj AK, Katzka DA, Iyer PG. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges. Gastrointest Endosc Clin N Am 2021;31:27-41. [PMID: 33213798 DOI: 10.1016/j.giec.2020.08.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
211 Amano Y, Ishimura N, Ishihara S. Is Malignant Potential of Barrett’s Esophagus Predictable by Endoscopy Findings? Life 2020;10:244. [DOI: 10.3390/life10100244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
212 O'Byrne LM, Witherspoon J, Verhage RJJ, O'Brien M, Muldoon C, Ryan C, Buckley M, Murphy T, Reynolds R, Patchett S, Kay E, Azam H, Robb W, Arumugasamy M, Mathuna PM, Leyden J, Gargan S, Doherty G, Sheahan K, Collins C, Nath A, O'Sullivan J, Donohoe CL, Ravi N, O'Toole D, Reynolds JV. Barrett's Registry Collaboration of academic centers in Ireland reveals high progression rate of low-grade dysplasia and low risk from nondysplastic Barrett's esophagus: report of the RIBBON network. Dis Esophagus 2020;33:doaa009. [PMID: 32193532 DOI: 10.1093/dote/doaa009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
213 Alves JR, Graffunder FP, Rech JVT, Ternes CMP, Koerich-Silva I. DIAGNOSIS, TREATMENT AND FOLLOW-UP OF BARRETT'S ESOPHAGUS: A SYSTEMATIC REVIEW. Arq Gastroenterol 2020;57:289-95. [PMID: 33027480 DOI: 10.1590/S0004-2803.202000000-53] [Reference Citation Analysis]
214 Ali S, Bailey A, East JE, Leedham SJ, Haghighat M, Lu X, Rittscher J, Braden B, TGU Investigators. Artificial intelligence-driven real-time 3D surface quantification of Barrett’s oesophagus for risk stratification and therapeutic response monitoring.. [DOI: 10.1101/2020.10.04.20206482] [Reference Citation Analysis]
215 . Ueg Week 2020 Poster Presentations. United European Gastroenterol j 2020;8:144-887. [DOI: 10.1177/2050640620927345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
216 Wani S, Han S, Kushnir V, Early D, Mullady D, Hammad H, Brauer B, Thaker A, Simon V, Ezekwe E, Hollander T, Wood M, Rastogi A, Edmundowicz S, Muthusamy VR, Komanduri S. Recurrence Is Rare Following Complete Eradication of Intestinal Metaplasia in Patients With Barrett's Esophagus and Peaks at 18 Months. Clin Gastroenterol Hepatol 2020;18:2609-2617.e2. [PMID: 31982610 DOI: 10.1016/j.cgh.2020.01.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
217 Ireland CJ, Thrift AP, Esterman A. Risk Prediction Models for Barrett's Esophagus Discriminate Well and Are Generalizable in an External Validation Study. Dig Dis Sci 2020;65:2992-9. [PMID: 31897894 DOI: 10.1007/s10620-019-06018-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
218 Kuwayama N, Hoshino I, Gunji H, Tonooka T, Soda H, Eto R, Takiguchi N, Nabeya Y. Adenocarcinoma originating from long-segment Barrett's esophagus over 15 cm: a series of 3 cases. Surg Case Rep 2020;6:230. [PMID: 32990834 DOI: 10.1186/s40792-020-00995-7] [Reference Citation Analysis]
219 Ivashkin VT, Maev IV, Trukhmanov AS, Lapina TL, Storonova OA, Zayratyants OV, Dronova OB, Kucheryavyy YA, Pirogov SS, Sayfutdinov RG, Uspenskiy YP, Sheptulin AA, Andreev DN, Rumyantseva DE. Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2020;30:70-97. [DOI: 10.22416/1382-4376-2020-30-4-70-97] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 11.7] [Reference Citation Analysis]
220 Killcoyne S, Gregson E, Wedge DC, Woodcock DJ, Eldridge MD, de la Rue R, Miremadi A, Abbas S, Blasko A, Kosmidou C, Januszewicz W, Jenkins AV, Gerstung M, Fitzgerald RC. Genomic copy number predicts esophageal cancer years before transformation. Nat Med 2020;26:1726-32. [PMID: 32895572 DOI: 10.1038/s41591-020-1033-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 15.7] [Reference Citation Analysis]
221 Saunders JH, Al-Zubaidi S, Waller RC, Ortiz-Fernandez-Sordo J, Parsons SL, Ragunath K, Kaye PV; Trent Oesophago-Gastric Unit. The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma. Dis Esophagus 2020;33:doz097. [PMID: 32090253 DOI: 10.1093/dote/doz097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
222 Barrie J, Yanni F, Sherif M, Dube AK, Tamhankar AP. Length of Barrett's esophagus in the presence of low-grade dysplasia, high-grade dysplasia, and adenocarcinoma. Surg Endosc 2021;35:4756-62. [PMID: 32880012 DOI: 10.1007/s00464-020-07950-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
223 Lipman G, Markar S, Gupta A, Haidry RJ, Lovat LB; UK RFA Registry Working Group. Learning curves and the influence of procedural volume for the treatment of dysplastic Barrett's esophagus. Gastrointest Endosc 2020;92:543-550.e1. [PMID: 32145288 DOI: 10.1016/j.gie.2020.02.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
224 Gibbens Y, Iyer PG. What Is the Optimal Surveillance Strategy for Non-dysplastic Barrett’s Esophagus? Curr Treat Options Gastro 2020;18:369-383. [DOI: 10.1007/s11938-020-00297-9] [Reference Citation Analysis]
225 van Munster SN, Bergman JJGHM, Pouw RE. Successful endoscopic treatment of Barrett's dysplasia is not just about the destination; it is about the journey. Gastrointest Endosc 2020;92:551-3. [PMID: 32838905 DOI: 10.1016/j.gie.2020.04.057] [Reference Citation Analysis]
226 Piloiu C, Dumitrascu DL. Barrett’s Esophagus in Romania: what do we know? Romanian Journal of Internal Medicine 2020;58:111-118. [DOI: 10.2478/rjim-2020-0007] [Reference Citation Analysis]
227 Oda M, Kalloo A, Mizukami K, Murakami K, Sawa A. Endoscopy and Barrett's Esophagus: Current Perspectives in the US and Japan. Intern Med 2021;60:327-35. [PMID: 32863360 DOI: 10.2169/internalmedicine.4400-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
228 Snider EJ, Kaz AM, Inadomi JM, Grady WM. Chemoprevention of esophageal adenocarcinoma. Gastroenterol Rep (Oxf) 2020;8:253-60. [PMID: 32843972 DOI: 10.1093/gastro/goaa040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
229 Fitzgerald RC, di Pietro M, O'Donovan M, Maroni R, Muldrew B, Debiram-Beecham I, Gehrung M, Offman J, Tripathi M, Smith SG, Aigret B, Walter FM, Rubin G, Sasieni P; BEST3 Trial team. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet 2020;396:333-44. [PMID: 32738955 DOI: 10.1016/S0140-6736(20)31099-0] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 26.3] [Reference Citation Analysis]
230 Badgery H, Read M, Winter NN, Taylor ACF, Hii MW. The role of esophagectomy in the management of Barrett's esophagus with high-grade dysplasia. Ann N Y Acad Sci 2020;1481:72-89. [PMID: 32812261 DOI: 10.1111/nyas.14439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
231 Brosnan C, Hannan E, Duggan W, Harding T, Maguire D, Stafford AT. Diagnostic Inaccuracies of Barrett's Oesophagus on Gastroscopy: Are We Performing Unnecessary Surveillance? Cureus 2020;12:e9850. [PMID: 32953357 DOI: 10.7759/cureus.9850] [Reference Citation Analysis]
232 Pech O, Alqahtani SA. Update on endoscopic treatment of Barrett's oesophagus and Barrett's oesophagus-related neoplasia. Ther Adv Gastrointest Endosc 2020;13:2631774520935241. [PMID: 32783025 DOI: 10.1177/2631774520935241] [Reference Citation Analysis]
233 di Pietro M, Bertani H, OʼDonovan M, Santos P, Alastal H, Phillips R, Ortiz-Fernández-Sordo J, Iacucci M, Modolell I, Reggiani Bonetti L, Ragunath K, Wernisch L. Development and Validation of Confocal Endomicroscopy Diagnostic Criteria for Low-Grade Dysplasia in Barrett's Esophagus. Clin Transl Gastroenterol 2019;10:e00014. [PMID: 30985335 DOI: 10.14309/ctg.0000000000000014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
234 Peters Y, van Grinsven E, van de Haterd M, van Lankveld D, Verbakel J, Siersema PD. Individuals’ Preferences for Esophageal Cancer Screening: A Discrete Choice Experiment. Value in Health 2020;23:1087-95. [DOI: 10.1016/j.jval.2020.03.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
235 Hanada Y, Wang KK. Screening for Barrett's oesophagus: is now the time? Lancet 2020;396:292-3. [PMID: 32738941 DOI: 10.1016/S0140-6736(20)31531-2] [Reference Citation Analysis]
236 Iyer PG, Taylor WR, Johnson ML, Lansing RL, Maixner KA, Hemminger LL, Cayer FK, Yab TC, Devens ME, Slettedahl SW, Broderick BT, Mahoney DW, McGlinch MC, Berger CK, Foote PH, Giakomopoulos M, Allawi H, Smyrk TC, Wang KK, Katzka DA, Wolfsen HC, Burke JA, Ahlquist DA, Kisiel JB. Accurate Nonendoscopic Detection of Barrett's Esophagus by Methylated DNA Markers: A Multisite Case Control Study. Am J Gastroenterol 2020;115:1201-9. [PMID: 32558685 DOI: 10.14309/ajg.0000000000000656] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
237 Kunovský L, Kala Z, Kroupa R, Grolich T, Dolina J, Dastych M, Vaculová J, Vlažný J, Moravčík P, Izakovičová Hollá L, Bořilová Linhartová P, Jabandžiev P, Procházka V. Confocal laser endomicroscopy in the diagnostics of esophageal diseases: a pilot study. Vnitr Lek 2020;66:e26-e32. [DOI: 10.36290/vnl.2020.094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
238 Tokuyama M, Geisler D, Deitrick C, Fasanella KE, Chennat JS, McGrath KM, Pai RK, Davison JM. Use of p53 immunohistochemistry in conjunction with routine histology improves risk stratification of patients with Barrett's oesophagus during routine clinical care. Histopathology 2020;77:481-91. [PMID: 32431062 DOI: 10.1111/his.14143] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
239 Januszewicz W, Subhash VV, Waldock W, Fernando DI, Bartalucci G, Chettouh H, Miremadi A, O'Donovan M, Fitzgerald RC, di Pietro M. The utility of a methylation panel in the assessment of clinical response to radiofrequency ablation for Barrett's esophagus. EBioMedicine 2020;58:102877. [PMID: 32707444 DOI: 10.1016/j.ebiom.2020.102877] [Reference Citation Analysis]
240 Gehrung M, Crispin-ortuzar M, Berman AG, O’donovan M, Fitzgerald RC, Markowetz F. Triage-driven diagnosis for early detection of esophageal cancer using deep learning.. [DOI: 10.1101/2020.07.16.20154732] [Reference Citation Analysis]
241 Badgery H, Chong L, Iich E, Huang Q, Georgy SR, Wang DH, Read M. Recent insights into the biology of Barrett's esophagus. Ann N Y Acad Sci 2020;1481:198-209. [PMID: 32681541 DOI: 10.1111/nyas.14432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
242 Feakins RM. Complications of Inflammatory Bowel Disease. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.024] [Reference Citation Analysis]
243 Andrews T, Campbell F. Assessment of Gastric Biopsies. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.013] [Reference Citation Analysis]
244 Feakins RM. Inflammatory Bowel Disease and the Upper Gastrointestinal Tract. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.017] [Reference Citation Analysis]
245 Feakins RM. Normal Lower Gastrointestinal Mucosa. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.018] [Reference Citation Analysis]
246 Preface. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.001] [Reference Citation Analysis]
247 Non-Neoplastic Pathology of the Gastrointestinal Tract. 2020. [DOI: 10.1017/9781316823026] [Reference Citation Analysis]
248 M. Ho-yen C, Chang F. Coeliac Disease. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.016] [Reference Citation Analysis]
249 Borralho-nunes P. Paediatric Conditions. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.008] [Reference Citation Analysis]
250 Adamczyk LA, Shepherd NA. Diverticular Disease, Mucosal Prolapse, and Related Conditions. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.027] [Reference Citation Analysis]
251 Geboes K, Jouret-mourin A. Jejunitis and Ileitis. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.020] [Reference Citation Analysis]
252 M. Feakins R. Radiation and the Gastrointestinal Tract. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.004] [Reference Citation Analysis]
253 Panarelli NC. Infectious Disorders of the Lower Gastrointestinal Tract. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.019] [Reference Citation Analysis]
254 Parisinos C, Sehgal V, Parkes G. The Value of Gastrointestinal Biopsy. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.002] [Reference Citation Analysis]
255 Celli R, Zhang X. Gastrointestinal Ischemia and Vascular Disorders. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.007] [Reference Citation Analysis]
256 Moorghen M. Non-Neoplastic Diseases of the Anal Canal. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.028] [Reference Citation Analysis]
257 Svrcek M, Feakins RM. Gastrointestinal Dysplasia. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.009] [Reference Citation Analysis]
258 Wong N. Transplantation, Immunodeficiency, and Immunosuppression. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.005] [Reference Citation Analysis]
259 Loughrey MB. Microscopic Colitis. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
260 Walsh SV. Infections of the Oesophagus and Rare Forms of Oesophagitis. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.012] [Reference Citation Analysis]
261 Walsh SV, Feakins RM. Ileal Pouch Anal Anastomosis. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.026] [Reference Citation Analysis]
262 Mccarthy A, Sheahan K. Drug-Induced Gastrointestinal Disease. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.006] [Reference Citation Analysis]
263 Bateman AC. Gastrointestinal Involvement by Systemic Disease. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.003] [Reference Citation Analysis]
264 Index. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.029] [Reference Citation Analysis]
265 Feakins RM. Normal Oesophageal, Gastric and Duodenal Mucosa. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.010] [Reference Citation Analysis]
266 Assarzadegan N, Pezhouh MK. Histology of Gastroesophageal Reflux Disease and Barrett’s Oesophagus. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.011] [Reference Citation Analysis]
267 Andrews T, Campbell F. Types of Gastritis. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.014] [Reference Citation Analysis]
268 Feakins RM. Approach to Reporting Inflammatory Bowel Disease Biopsies. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
269 Feakins RM. Mimics of Inflammatory Bowel Disease. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
270 Feakins RM. Inflammatory Bowel Disease Diagnosis. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
271 Clarke L, Feakins RM. Duodenitis. Non-Neoplastic Pathology of the Gastrointestinal Tract 2020. [DOI: 10.1017/9781316823026.015] [Reference Citation Analysis]
272 Nian YY, Meng XM, Wu J, Jing FC, Wang XQ, Dang T, Zhang J. Postprandial proximal gastric acid pocket and its association with gastroesophageal acid reflux in patients with short-segment Barrett's esophagus. J Zhejiang Univ Sci B 2020;21:581-9. [PMID: 32633112 DOI: 10.1631/jzus.B1900498] [Reference Citation Analysis]
273 Omidvari AH, Roumans CAM, Naber SK, Kroep S, Wijnhoven BPL, Gaast AV, de Jonge PJ, Spaander MCW, Lansdorp-Vogelaar I. The Impact of the Policy-Practice Gap on Costs and Benefits of Barrett's Esophagus Management. Am J Gastroenterol 2020;115:1026-35. [PMID: 32618653 DOI: 10.14309/ajg.0000000000000578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
274 Cotton CC, Shaheen NJ. Overutilization of Endoscopic Surveillance in Barrett's Esophagus: The Perils of Too Much of a Good Thing. Am J Gastroenterol 2020;115:1019-21. [PMID: 32618650 DOI: 10.14309/ajg.0000000000000650] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
275 Peters Y, Schrauwen RWM, Tan AC, Bogers SK, de Jong B, Siersema PD. Detection of Barrett's oesophagus through exhaled breath using an electronic nose device. Gut 2020;69:1169-72. [PMID: 32098798 DOI: 10.1136/gutjnl-2019-320273] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 10.3] [Reference Citation Analysis]
276 Karmakova TA, Pirogov SS, Kaprin AD. Biological markers of Barrett’s esophagus progression to adenocarcinoma. jour 2020;174:91-98. [DOI: 10.31146/1682-8658-ecg-177-5-91-98] [Reference Citation Analysis]
277 Alzoubaidi D, Ragunath K, Wani S, Penman ID, Trudgill NJ, Jansen M, Banks M, Bhandari P, Morris AJ, Willert R, Boger P, Smart HL, Ravi N, Dunn J, Gordon C, Mannath J, Mainie I, di Pietro M, Veitch AM, Thorpe S, Magee C, Everson M, Sami S, Bassett P, Graham D, Attwood S, Pech O, Sharma P, Lovat LB, Haidry R. Quality indicators for Barrett's endotherapy (QBET): UK consensus statements for patients undergoing endoscopic therapy for Barrett's neoplasia. Frontline Gastroenterol 2020;11:259-71. [PMID: 32587669 DOI: 10.1136/flgastro-2019-101247] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
278 Enslin S, Kaul V. Barrett's Esophagus Management in the Elderly: Principles and Best Practice. Curr Gastroenterol Rep 2020;22:37. [PMID: 32542508 DOI: 10.1007/s11894-020-00774-2] [Reference Citation Analysis]
279 Gokon Y, Fujishima F, Taniyama Y, Ishida H, Yamagata T, Sawai T, Uzuki M, Ichikawa H, Itakura Y, Takahashi K, Yajima N, Hagiwara M, Nishida A, Ozawa Y, Sakuma T, Kanba R, Sakamoto K, Zuguchi M, Saito M, Kamei T, Sasano H. Immune microenvironment in Barrett's esophagus adjacent to esophageal adenocarcinoma: possible influence of adjacent mucosa on cancer development and progression. Virchows Arch 2020;477:825-34. [PMID: 32533341 DOI: 10.1007/s00428-020-02854-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
280 Maitra I, Date RS, Martin FL. Towards screening Barrett's oesophagus: current guidelines, imaging modalities and future developments.Clin J Gastroenterol. 2020;13:635-649. [PMID: 32495144 DOI: 10.1007/s12328-020-01135-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
281 Hashimoto R, Requa J, Dao T, Ninh A, Tran E, Mai D, Lugo M, El-Hage Chehade N, Chang KJ, Karnes WE, Samarasena JB. Artificial intelligence using convolutional neural networks for real-time detection of early esophageal neoplasia in Barrett's esophagus (with video). Gastrointest Endosc 2020;91:1264-1271.e1. [PMID: 31930967 DOI: 10.1016/j.gie.2019.12.049] [Cited by in Crossref: 96] [Cited by in F6Publishing: 91] [Article Influence: 32.0] [Reference Citation Analysis]
282 Davison JM, Goldblum J, Grewal US, McGrath K, Fasanella K, Deitrick C, DeWard AD, Bossart EA, Hayward SL, Zhang Y, Critchley-Thorne RJ, Thota PN. Independent Blinded Validation of a Tissue Systems Pathology Test to Predict Progression in Patients With Barrett's Esophagus. Am J Gastroenterol 2020;115:843-52. [PMID: 32079863 DOI: 10.14309/ajg.0000000000000556] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
283 Rubenstein JH, McConnell D, Waljee AK, Metko V, Nofz K, Khodadost M, Jiang L, Raghunathan T. Validation and Comparison of Tools for Selecting Individuals to Screen for Barrett's Esophagus and Early Neoplasia. Gastroenterology 2020;158:2082-92. [PMID: 32119928 DOI: 10.1053/j.gastro.2020.02.037] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
284 Hadjinicolaou AV, van Munster SN, Achilleos A, Santiago Garcia J, Killcoyne S, Ragunath K, Bergman JJGHM, Fitzgerald RC, di Pietro M. Aneuploidy in targeted endoscopic biopsies outperforms other tissue biomarkers in the prediction of histologic progression of Barrett's oesophagus: A multi-centre prospective cohort study. EBioMedicine 2020;56:102765. [PMID: 32460165 DOI: 10.1016/j.ebiom.2020.102765] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
285 Adil MT, Al-Taan O, Rashid F, Munasinghe A, Jain V, Whitelaw D, Jambulingam P, Mahawar K. A Systematic Review and Meta-Analysis of the Effect of Roux-en-Y Gastric Bypass on Barrett's Esophagus. Obes Surg 2019;29:3712-21. [PMID: 31309524 DOI: 10.1007/s11695-019-04083-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
286 Curtius K, Rubenstein JH, Chak A, Inadomi JM. Barrett’s esophagus is the precursor of all esophageal adenocarcinomas.. [DOI: 10.1101/2020.05.14.096826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
287 Januszewicz W, Kaminski MF. Quality indicators in diagnostic upper gastrointestinal endoscopy. Therap Adv Gastroenterol 2020;13:1756284820916693. [PMID: 32477426 DOI: 10.1177/1756284820916693] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
288 Watts AE, Cotton CC, Shaheen NJ. Radiofrequency Ablation of Barrett's Esophagus: Have We Gone Too Far, or Not Far Enough? Curr Gastroenterol Rep 2020;22:29. [PMID: 32383077 DOI: 10.1007/s11894-020-00766-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
289 Usui G, Sato H, Shinozaki T, Jinno T, Fujibayashi K, Ishii K, Horiuchi H, Morikawa T, Gunji T, Matsuhashi N. Association Between Helicobacter pylori Infection and Short-segment/Long-segment Barrett's Esophagus in a Japanese Population: A Large Cross-Sectional Study. J Clin Gastroenterol 2020;54:439-44. [PMID: 31524650 DOI: 10.1097/MCG.0000000000001264] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
290 de Caestecker J, Barr H, Bhandari P, Lovat L, Peerally MF, Ragunath K, Smart H. Randomized studies for Barrett's ablation: identifying the most cost-effective solutions by keeping an open mind. Gastrointest Endosc 2020;91:1218-20. [PMID: 32327125 DOI: 10.1016/j.gie.2020.01.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
291 Ishihara R, Arima M, Iizuka T, Oyama T, Katada C, Kato M, Goda K, Goto O, Tanaka K, Yano T, Yoshinaga S, Muto M, Kawakubo H, Fujishiro M, Yoshida M, Fujimoto K, Tajiri H, Inoue H; Japan Gastroenterological Endoscopy Society Guidelines Committee of ESD/EMR for Esophageal Cancer. Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig Endosc 2020;32:452-93. [PMID: 32072683 DOI: 10.1111/den.13654] [Cited by in Crossref: 113] [Cited by in F6Publishing: 88] [Article Influence: 37.7] [Reference Citation Analysis]
292 van der Wel MJ, Coleman HG, Bergman JJGHM, Jansen M, Meijer SL; BOLERO working group. Histopathologist features predictive of diagnostic concordance at expert level among a large international sample of pathologists diagnosing Barrett's dysplasia using digital pathology. Gut 2020;69:811-22. [PMID: 31852770 DOI: 10.1136/gutjnl-2019-318985] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
293 Britton J, Taxiarchi P, Martin G, Willert R, Horne M, Hamdy S, McLaughlin J, Ang Y. Comparative quantitative survey of patient experience in Barrett's oesophagus and other gastrointestinal disorders. BMJ Open Gastroenterol 2020;7:e000357. [PMID: 32337055 DOI: 10.1136/bmjgast-2019-000357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
294 Franklin J, Jankowski J. Recent advances in understanding and preventing oesophageal cancer. F1000Res 2020;9:276. [DOI: 10.12688/f1000research.21971.1] [Reference Citation Analysis]
295 Hoefnagel SJM, Mostafavi N, Timmer MR, Lau CT, Meijer SL, Wang KK, Krishnadath KK. A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts. PLoS One 2020;15:e0231419. [PMID: 32282835 DOI: 10.1371/journal.pone.0231419] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
296 Ahmadi N, Mbuagbaw L, Hanna WC, Finley C, Agzarian J, Wen CK, Coret M, Schieman C, Shargall Y. Development of a clinical score to distinguish malignant from benign esophageal disease in an undiagnosed patient population referred to an esophageal diagnostic assessment program. J Thorac Dis 2020;12:191-8. [PMID: 32274084 DOI: 10.21037/jtd.2020.02.07] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
297 Bonavina L, Fisichella PM, Gavini S, Lee YY, Tatum RP. Clinical course of gastroesophageal reflux disease and impact of treatment in symptomatic young patients. Ann N Y Acad Sci 2020;1481:117-26. [PMID: 32266986 DOI: 10.1111/nyas.14350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
298 Ron LM, Domínguez-muñoz J. Esófago de Barrett. Neoplasias esofágicas. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:392-400. [DOI: 10.1016/j.med.2020.05.004] [Reference Citation Analysis]
299 Gokon Y, Fujishima F, Taniyama Y, Ishida H, Yamagata T, Sawai T, Uzuki M, Ichikawa H, Itakura Y, Takahashi K, Yajima N, Hagiwara M, Nishida A, Ozawa Y, Sakuma T, Sakamoto K, Zuguchi M, Saito M, Kamei T, Sasano H. Glucocorticoid receptor and serum- and glucocorticoid-induced kinase-1 in esophageal adenocarcinoma and adjacent Barrett's esophagus. Pathol Int 2020;70:355-63. [PMID: 32173971 DOI: 10.1111/pin.12922] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
300 Struyvenberg MR, van der Sommen F, Swager AF, de Groof AJ, Rikos A, Schoon EJ, Bergman JJ, de With PHN, Curvers WL. Improved Barrett's neoplasia detection using computer-assisted multiframe analysis of volumetric laser endomicroscopy. Dis Esophagus 2020;33:doz065. [PMID: 31364700 DOI: 10.1093/dote/doz065] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
301 Elsheaita A, El-Bially MA, Shamseya MM, Ahmed SS, Madkour MA, Shamseya AM, Nouh HH. Seattle protocol vs narrow band imaging guided biopsy in screening of Barrett's esophagus in gastroesophageal reflux disease patients. Medicine (Baltimore) 2020;99:e19261. [PMID: 32080134 DOI: 10.1097/MD.0000000000019261] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
302 Moyo K, Khong TK. High-dose PPI and aspirin as chemoprevention in Barrett’s oesophagus. DTB 2020;58:39-40. [DOI: 10.1136/dtb.2019.000085] [Reference Citation Analysis]
303 Fitzgerald RC, di Pietro M. Diseases of the oesophagus. Oxford Textbook of Medicine 2020. [DOI: 10.1093/med/9780198746690.003.0294] [Reference Citation Analysis]
304 Podboy A, Kolahi KS, Friedland S, Louie CY. Endoscopic submucosal dissection is associated with less pathologic uncertainty than endoscopic mucosal resection in diagnosing and staging Barrett's-related neoplasia. Dig Endosc 2020;32:346-54. [PMID: 31306525 DOI: 10.1111/den.13487] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 4.3] [Reference Citation Analysis]
305 Killcoyne S, Gregson E, Wedge DC, Woodcock DJ, Eldridge M, de la Rue R, Miremadi A, Abbas S, Blasko A, Januszewicz W, Varanou Jenkins A, Gerstung M, Fitzgerald RC. Genomic copy number predicts oesophageal cancer years before transformation.. [DOI: 10.1101/2020.02.27.967612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
306 Curtius K, Dewanji A, Hazelton WD, Rubenstein JH, Luebeck EG. Optimal timing for cancer screening and adaptive surveillance using mathematical modeling.. [DOI: 10.1101/2020.02.11.927475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
307 Sharma P, Shaheen NJ, Katzka D, Bergman JJGHM. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review. Gastroenterology 2020;158:760-9. [PMID: 31730766 DOI: 10.1053/j.gastro.2019.09.051] [Cited by in Crossref: 95] [Cited by in F6Publishing: 95] [Article Influence: 31.7] [Reference Citation Analysis]
308 Yamasaki A, Shimizu T, Kawachi H, Yamamoto N, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Hirasawa T, Tsuchida T, Sasaki Y, Fujisaki J. Endoscopic features of esophageal adenocarcinoma derived from short-segment versus long-segment Barrett's esophagus. J Gastroenterol Hepatol 2020;35:211-7. [PMID: 31396997 DOI: 10.1111/jgh.14827] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
309 Subramaniam S, Kandiah K, Schoon E, Aepli P, Hayee B, Pischel A, Stefanovic M, Alkandari A, Coron E, Omae M, Baldaque-Silva F, Maselli R, Bisschops R, Sharma P, Repici A, Bhandari P. Development and validation of the international Blue Light Imaging for Barrett's Neoplasia Classification. Gastrointest Endosc 2020;91:310-20. [PMID: 31586576 DOI: 10.1016/j.gie.2019.09.035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
310 Atkin C, Reddy-Kolanu V, Drayson MT, Sapey E, Richter AG. The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions. Br J Haematol 2020;189:1127-35. [PMID: 31999849 DOI: 10.1111/bjh.16487] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
311 Yamamoto K, Ohnishi S, Mizushima T, Kodaira J, Ono M, Hatanaka Y, Hatanaka KC, Kuriki Y, Kamiya M, Ehira N, Shinada K, Takahashi H, Shimizu Y, Urano Y, Sakamoto N. Detection of early adenocarcinoma of the esophagogastric junction by spraying an enzyme-activatable fluorescent probe targeting Dipeptidyl peptidase-IV. BMC Cancer 2020;20:64. [PMID: 31992267 DOI: 10.1186/s12885-020-6537-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
312 Kollar M, Krajciova J, Prefertusova L, Sticova E, Maluskova J, Vackova Z, Martinek J. Probe-based confocal laser endomicroscopy versus biopsies in the diagnostics of oesophageal and gastric lesions: A prospective, pathologist-blinded study. United European Gastroenterol J 2020;8:436-43. [PMID: 32213027 DOI: 10.1177/2050640620904865] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
313 Tan WK, Ragunath K, White JR, Santiago J, Fernandez-Sordo JO, Pana M, Alias B, Hadjinicolaou AV, Sujendran V, di Pietro M. Standard versus simplified radiofrequency ablation protocol for Barrett's esophagus: comparative analysis of the whole treatment pathway. Endosc Int Open 2020;8:E189-95. [PMID: 32010753 DOI: 10.1055/a-1005-6331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
314 Itani MI, Farha J, Marrache MK, Fayad L, Badurdeen D, Kumbhari V. The Effects of Bariatric Surgery and Endoscopic Bariatric Therapies on GERD: An Update. Curr Treat Options Gastro 2020;18:97-108. [DOI: 10.1007/s11938-020-00278-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
315 Kumarasinghe MP, Bourke MJ, Brown I, Draganov PV, McLeod D, Streutker C, Raftopoulos S, Ushiku T, Lauwers GY. Pathological assessment of endoscopic resections of the gastrointestinal tract: a comprehensive clinicopathologic review. Mod Pathol 2020;33:986-1006. [PMID: 31907377 DOI: 10.1038/s41379-019-0443-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
316 Jung N, Mayet W, Mertens P, Meyer (federführend) J, Müller O, Pfeifer M, Schellinger P, Weiss N, Wendtner C. ERKRANKUNGEN DER VERDAUUNGSORGANE. Rationelle Diagnostik und Therapie in der Inneren Medizin 2020. [DOI: 10.1016/b978-3-437-06282-7.50008-5] [Reference Citation Analysis]
317 Serha TV, Kuryk OH, Yakovenko VO, Tkachenko RP. RISK OF ADENOCARCINOMA IN BARRETT'S ESOPHAGUS. WOMAB 2020;16:120. [DOI: 10.26724/2079-8334-2020-1-71-120-124] [Reference Citation Analysis]
318 Levink I, Wallace M. Barrett's Esophagus. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.65929-9] [Reference Citation Analysis]
319 Machicado JD, Kolb JM, Wani SB. Endoscopic Lesion Recognition and Advanced Imaging Modalities. Gastrointestinal Interventional Endoscopy 2020. [DOI: 10.1007/978-3-030-21695-5_1] [Reference Citation Analysis]
320 Katzka DA, Fitzgerald RC. Time to Challenge Current Strategies for Detection of Barrett's Esophagus and Esophageal Adenocarcinoma. Dig Dis Sci 2020;65:18-21. [PMID: 31754994 DOI: 10.1007/s10620-019-05965-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
321 Mohy-ud-din N, Krill TS, Shah AR, Chatila AT, Singh S, Bilal M, Parupudi S. Barrett's esophagus: What do we need to know? Disease-a-Month 2020;66:100850. [DOI: 10.1016/j.disamonth.2019.02.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
322 Tracht J, Robinson BS, Krasinskas AM. Pathology of Premalignant and Malignant Disease of the Esophagus. Esophageal Cancer 2020. [DOI: 10.1007/978-3-030-29832-6_3] [Reference Citation Analysis]
323 Habib M, Bhatti S, ur Rehman S, Javed N, Shahbaz Aslam M, Shahzad N, Abbas Z. Hepatoprotective role of swimming against arsenic induced oxidative stress in mice. Journal of King Saud University - Science 2020;32:822-7. [DOI: 10.1016/j.jksus.2019.02.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
324 Campos VJ, Mazzini GS, Juchem JF, Gurski RR. Neutrophil-Lymphocyte Ratio as a Marker of Progression from Non-Dysplastic Barrett's Esophagus to Esophageal Adenocarcinoma: a Cross-Sectional Retrospective Study. J Gastrointest Surg 2020;24:8-18. [PMID: 31745889 DOI: 10.1007/s11605-019-04456-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
325 Suzuki K, Akazawa N, Fujisaki J. Esophageal Cancer: Barrett’s Esophageal Adenocarcinoma (BEA). Endoscopic Treatment Strategy for Upper GI Tract Neoplasms 2020. [DOI: 10.1007/978-981-32-9737-1_1] [Reference Citation Analysis]
326 Mcmanus D. Oesophageal Carcinoma. Histopathology Reporting 2020. [DOI: 10.1007/978-3-030-27828-1_2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
327 Patti MG, Di Corpo M, Schlottmann F. Esophageal Cancer Surveillance and Screening: Barrett's Esophagus and GERD. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.66059-2] [Reference Citation Analysis]
328 Kuvaev R, Nikonov E, Vidyayeva N, Kashin S, Zharova M. Analysis of the ASGE guideline on screening and surveillance of Barrett’s esophagus. Dok gastroenterol 2020;9:30. [DOI: 10.17116/dokgastro2020902130] [Reference Citation Analysis]
329 Pech O, Alqahtani SSA. Resection Techniques in Barrett’s Esophagus. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy 2020. [DOI: 10.1007/978-3-030-29964-4_8-1] [Reference Citation Analysis]
330 Nieuwenhuis EA, Bergman JJGHM, Pouw RE. Radiofrequency Ablation of Barrett’s Epithelium. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy 2020. [DOI: 10.1007/978-3-030-29964-4_6-1] [Reference Citation Analysis]
331 Clermont MP, Willingham FF. Role of Endoscopy in the Diagnosis, Staging, and Management of Esophageal Cancer. Esophageal Cancer 2020. [DOI: 10.1007/978-3-030-29832-6_8] [Reference Citation Analysis]
332 Nachiappan A, Ragunath K, Card T, Kaye P. Diagnosing dysplasia in Barrett's oesophagus still requires Seattle protocol biopsy in the era of modern video endoscopy: results from a tertiary centre Barrett's dysplasia database. Scand J Gastroenterol 2020;55:9-13. [PMID: 31880176 DOI: 10.1080/00365521.2019.1706762] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
333 Maev I, Zayratyants O, Kucheryavy Y, Barkalova E, Andreev D, Movtaeva P, Shaburov R, Ovsepyan M. The importance of esophageal function tests in patients with Barrett’s esophagus. Dok gastroenterol 2020;9:41. [DOI: 10.17116/dokgastro2020901141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
334 Templeton A, Kaz A, Snider E, Grady WM. Barrett’s Esophagus: Diagnosis and Management. Esophageal Cancer 2020. [DOI: 10.1007/978-3-030-29832-6_4] [Reference Citation Analysis]
335 Kaibysheva V, Kashin S, Karasev A, Merkulova A, Krainova E, Fedorov E, Shapovalyants S. Update on Barrett’s esophagus diagnosis and treatment. Dok gastroenterol 2020;9:33. [DOI: 10.17116/dokgastro2020904133] [Reference Citation Analysis]
336 Bademler S, Üçüncü MM, Serilmez M. IGF-1 ve IGFBP3’ün Özofagus Kanseri’nin Tanı ve Tedaviye Yanıtındaki Yerinin Araştırılması. İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi 2019. [DOI: 10.38079/igusabder.586721] [Reference Citation Analysis]
337 Alnasser S, Agnihotram R, Martel M, Mayrand S, Franco E, Ferri L. Predictors of dysplastic and neoplastic progression of Barrett’s esophagus. Can J Surg 2019;62:93-9. [PMID: 30907564 DOI: 10.1503/cjs.008716] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
338 Degiovani M, Ribas CAPM, Czeczko NG, Parada AA, Fronchetti JA, Malafaia O. IS THERE A RELATION BETWEEN HELYBACTER PYLORI AND INTESTINAL METAPLASIA IN SHORT COLUMN EPITELIZATION UP TO 10 MM IN THE DISTAL ESOPHAGUS? Arq Bras Cir Dig 2019;32:e1480. [PMID: 31859933 DOI: 10.1590/0102-672020190001e1480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
339 Dilworth MP, Nieto T, Stockton JD, Whalley CM, Tee L, James JD, Noble F, Underwood TJ, Hallissey MT, Hejmadi R, Trudgill N, Tucker O, Beggs AD. Whole Genome Methylation Analysis of Nondysplastic Barrett Esophagus that Progresses to Invasive Cancer. Ann Surg 2019;269:479-85. [PMID: 29384778 DOI: 10.1097/SLA.0000000000002658] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
340 Porter RJ, Murray GI, Brice DP, Petty RD, McLean MH. Novel biomarkers for risk stratification of Barrett's oesophagus associated neoplastic progression-epithelial HMGB1 expression and stromal lymphocytic phenotype. Br J Cancer 2020;122:545-54. [PMID: 31831860 DOI: 10.1038/s41416-019-0685-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
341 McGoran J, Bennett A, Cooper J, De Caestecker J, Lovat LB, Guha N, Ragunath K, Sami SS. Acceptability to patients of screening disposable transnasal endoscopy: qualitative interview analysis. BMJ Open 2019;9:e030467. [PMID: 31831531 DOI: 10.1136/bmjopen-2019-030467] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
342 Zhang J, Ma W, Wu H, Wang J, Lin Y, Wang X, Zhang C. Analysis of Homogeneous and Heterogeneous Factors for Bone Metastasis in Esophageal Cancer. Med Sci Monit 2019;25:9416-25. [PMID: 31821313 DOI: 10.12659/MSM.920483] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
343 Paterson AL, Gehrung M, Fitzgerald RC, O'Donovan M. Role of TFF3 as an adjunct in the diagnosis of Barrett's esophagus using a minimally invasive esophageal sampling device-The CytospongeTM. Diagn Cytopathol 2020;48:253-64. [PMID: 31814330 DOI: 10.1002/dc.24354] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
344 Rosenfeld A, Graham DG, Jevons S, Ariza J, Hagan D, Wilson A, Lovat SJ, Sami SS, Ahmad OF, Novelli M, Rodriguez Justo M, Winstanley A, Heifetz EM, Ben-Zecharia M, Noiman U, Fitzgerald RC, Sasieni P, Lovat LB; BEST2 study group. Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approach. Lancet Digit Health 2020;2:E37-48. [PMID: 32133440 DOI: 10.1016/S2589-7500(19)30216-X] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
345 Liotta L, Quante M. Pathophysiologie des Adenokarzinoms am ösophagogastralen Übergang (AEG). Onkologe 2019;25:1055-1064. [DOI: 10.1007/s00761-019-00666-9] [Reference Citation Analysis]
346 Duits LC, Klaver E, Bureo Gonzalez A, Boerwinkel DF, Ten Kate FJW, Offerhaus GJA, Meijer SL, Visser M, Seldenrijk CA, Krishnadath KK, Schoon EJ, Weusten BLAM, Mallant-Hent RC, Pouw RE, Bergman JJGHM. The Amsterdam ReBus progressor cohort: identification of 165 Barrett's surveillance patients who progressed to early neoplasia and 723 nonprogressor patients. Dis Esophagus 2019;32:doy037. [PMID: 29873685 DOI: 10.1093/dote/doy037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
347 Cattelan L, Ghazawi FM, Le M, Lagacé F, Savin E, Zubarev A, Gantchev J, Tomaszewski M, Sasseville D, Waschke K, Litvinov IV. Epidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population-based study. Cancer Med 2020;9:401-17. [PMID: 31715645 DOI: 10.1002/cam4.2700] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
348 Wani S, Williams JL, Komanduri S, Muthusamy VR, Shaheen NJ. Endoscopists systematically undersample patients with long-segment Barrett's esophagus: an analysis of biopsy sampling practices from a quality improvement registry. Gastrointest Endosc 2019;90:732-741.e3. [PMID: 31085185 DOI: 10.1016/j.gie.2019.04.250] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 10.5] [Reference Citation Analysis]
349 Iyer PG. Dysplasia detection in Barrett's esophagus: Is the glass half full or half empty? Gastrointest Endosc 2019;90:742-4. [PMID: 31635713 DOI: 10.1016/j.gie.2019.06.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
350 Soh YSA, Lee YY, Gotoda T, Sharma P, Ho KY; Asian Barrett's Consortium. Challenges to diagnostic standardization of Barrett's esophagus in Asia. Dig Endosc 2019;31:609-18. [PMID: 30892742 DOI: 10.1111/den.13402] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
351 Chhabra P, Bhasin DK. Risk assessment for Barrett's esophagus: so near, yet so far! Gastrointest Endosc 2019;90:718-20. [PMID: 31635712 DOI: 10.1016/j.gie.2019.07.024] [Reference Citation Analysis]
352 Dugalic P, Djuranovic S, Pavlovic-Markovic A, Dugalic V, Tomasevic R, Gluvic Z, Obradovic M, Bajic V, Isenovic ER. Proton Pump Inhibitors and Radiofrequency Ablation for Treatment of Barrett's Esophagus. Mini Rev Med Chem 2020;20:975-87. [PMID: 31644405 DOI: 10.2174/1389557519666191015203636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
353 . UEG Week 2019 Poster Presentations. United European Gastroenterol J 2019;7:189-1030. [PMID: 32213001 DOI: 10.1177/2050640619854671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
354 Everson M, Magee C, Alzoubaidi D, Brogden S, Graham D, Lovat LB, Novelli M, Haidry R. Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett's Esophagus-Related Neoplasia: A Feasibility Study. Dig Dis Sci 2019;64:2815-22. [PMID: 30982210 DOI: 10.1007/s10620-019-05607-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
355 Ramai D, Lai JK, Ofori E, Linn S, Reddy M. Evaluation and Management of Premalignant Conditions of the Esophagus: A Systematic Survey of International Guidelines. J Clin Gastroenterol 2019;53:627-34. [PMID: 31403982 DOI: 10.1097/MCG.0000000000001247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
356 Bhatia SJ, Makharia GK, Abraham P, Bhat N, Kumar A, Reddy DN, Ghoshal UC, Ahuja V, Rao GV, Devadas K, Dutta AK, Jain A, Kedia S, Dama R, Kalapala R, Alvares JF, Dadhich S, Dixit VK, Goenka MK, Goswami BD, Issar SK, Leelakrishnan V, Mallath MK, Mathew P, Mathew P, Nandwani S, Pai CG, Peter L, Prasad AVS, Singh D, Sodhi JS, Sud R, Venkataraman J, Midha V, Bapaye A, Dutta U, Jain AK, Kochhar R, Puri AS, Singh SP, Shimpi L, Sood A, Wadhwa RT. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol 2019;38:411-40. [PMID: 31802441 DOI: 10.1007/s12664-019-00979-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
357 Gockel I, Hoffmeister A. Endoscopic or Surgical Resection for Gastro-Esophageal Cancer. Dtsch Arztebl Int 2018;115:513-9. [PMID: 30149830 DOI: 10.3238/arztebl.2018.0513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
358 Qumseya B, Sultan S, Bain P, Jamil L, Jacobson B, Anandasabapathy S, Agrawal D, Buxbaum JL, Fishman DS, Gurudu SR, Jue TL, Kripalani S, Lee JK, Khashab MA, Naveed M, Thosani NC, Yang J, DeWitt J, Wani S; ASGE STANDARDS OF PRACTICE COMMITTEE, ASGE Standards of Practice Committee Chair. ASGE guideline on screening and surveillance of Barrett's esophagus. Gastrointest Endosc 2019;90:335-359.e2. [PMID: 31439127 DOI: 10.1016/j.gie.2019.05.012] [Cited by in Crossref: 151] [Cited by in F6Publishing: 120] [Article Influence: 37.8] [Reference Citation Analysis]
359 Wallner B, Björ O, Andreasson A, Vieth M, Schmidt PT, Hellström PM, Forsberg A, Talley NJ, Agreus L. Z-line alterations and gastroesophageal reflux: an endoscopic population-based prospective cohort study. Scand J Gastroenterol 2019;54:1065-9. [PMID: 31453726 DOI: 10.1080/00365521.2019.1656775] [Reference Citation Analysis]
360 Hiu-jun Tao D, Vadgama B. Paediatric gastrointestinal pathology: selected topics. Diagnostic Histopathology 2019;25:333-340. [DOI: 10.1016/j.mpdhp.2019.06.002] [Reference Citation Analysis]
361 Iyer PG, Kaul V. Barrett Esophagus. Mayo Clinic Proceedings 2019;94:1888-901. [DOI: 10.1016/j.mayocp.2019.01.032] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
362 Mahawar KK, Carr WRJ, Borg CM, Aminian A. Does Sleeve Gastrectomy Cause Barrett's Oesophagus? Obes Surg 2018;28:4049-50. [PMID: 30280332 DOI: 10.1007/s11695-018-3541-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
363 Serha T, Kuryk O, Yakovenko V, Solovyova G, Tkachenko R. Prevalence of barrett's esophagus, its relationship with chronic Helicobacter pylori-associated gastritis, atrophy and metaplasia of gastric mucosa. Clin and prev med 2019;2:77-89. [DOI: 10.31612/2616-4868.2(8).2019.09] [Reference Citation Analysis]
364 Holmberg D, Ness-Jensen E, Mattsson F, Lagergren J. Adherence to clinical guidelines for Barrett's esophagus. Scand J Gastroenterol 2019;54:945-52. [PMID: 31314608 DOI: 10.1080/00365521.2019.1641740] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
365 Que J, Garman KS, Souza RF, Spechler SJ. Pathogenesis and Cells of Origin of Barrett's Esophagus. Gastroenterology 2019;157:349-364.e1. [PMID: 31082367 DOI: 10.1053/j.gastro.2019.03.072] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 20.3] [Reference Citation Analysis]
366 Pech O. Screening and Prevention of Barrett's Esophagus. Visc Med 2019;35:210-4. [PMID: 31602381 DOI: 10.1159/000501918] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
367 Li S, Chung DC, Mullen JT. Screening high-risk populations for esophageal and gastric cancer. J Surg Oncol. 2019;120:831-846. [PMID: 31373005 DOI: 10.1002/jso.25656] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
368 Wani S, Williams JL, Komanduri S, Muthusamy VR, Shaheen NJ. Over-Utilization of Repeat Upper Endoscopy in Patients with Non-dysplastic Barrett's Esophagus: A Quality Registry Study. Am J Gastroenterol 2019;114:1256-64. [PMID: 30865017 DOI: 10.14309/ajg.0000000000000184] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
369 Codipilly DC, Iyer PG. Novel Screening Tests for Barrett's Esophagus. Curr Gastroenterol Rep 2019;21:42. [PMID: 31346777 DOI: 10.1007/s11894-019-0710-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
370 Kline AD, Moss JF, Selicorni A, Bisgaard AM, Deardorff MA, Gillett PM, Ishman SL, Kerr LM, Levin AV, Mulder PA, Ramos FJ, Wierzba J, Ajmone PF, Axtell D, Blagowidow N, Cereda A, Costantino A, Cormier-Daire V, FitzPatrick D, Grados M, Groves L, Guthrie W, Huisman S, Kaiser FJ, Koekkoek G, Levis M, Mariani M, McCleery JP, Menke LA, Metrena A, O'Connor J, Oliver C, Pie J, Piening S, Potter CJ, Quaglio AL, Redeker E, Richman D, Rigamonti C, Shi A, Tümer Z, Van Balkom IDC, Hennekam RC. Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement. Nat Rev Genet 2018;19:649-66. [PMID: 29995837 DOI: 10.1038/s41576-018-0031-0] [Cited by in Crossref: 146] [Cited by in F6Publishing: 156] [Article Influence: 36.5] [Reference Citation Analysis]
371 Ten Kate FJC, Nieboer D, Ten Kate FJW, Doukas M, Bruno MJ, Spaander MCW, Looijenga LHJ, Biermann K; ProBar study group and Palga Group. Improved Progression Prediction in Barrett's Esophagus With Low-grade Dysplasia Using Specific Histologic Criteria. Am J Surg Pathol 2018;42:918-26. [PMID: 29697438 DOI: 10.1097/PAS.0000000000001066] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
372 Mukaisho KI, Kanai S, Kushima R, Nakayama T, Hattori T, Sugihara H. Barretts's carcinogenesis. Pathol Int 2019;69:319-30. [PMID: 31290583 DOI: 10.1111/pin.12804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
373 Thrumurthy SG, Chaudry MA, Thrumurthy SSD, Mughal M. Oesophageal cancer: risks, prevention, and diagnosis. BMJ. 2019;366:l4373. [PMID: 31289038 DOI: 10.1136/bmj.l4373] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 9.3] [Reference Citation Analysis]
374 Spiceland CM, Elmunzer BJ, Paros S, Roof L, McVey M, Hawes R, Hoffman BJ, Elias PS. Salvage cryotherapy in patients undergoing endoscopic eradication therapy for complicated Barrett's esophagus. Endosc Int Open. 2019;7:E904-E911. [PMID: 31281876 DOI: 10.1055/a-0902-4587] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
375 Bulamu NB, Chen G, Bright T, Ratcliffe J, Chung A, Fraser RJL, Törnqvist B, Watson DI. Preferences for Surveillance of Barrett's Oesophagus: a Discrete Choice Experiment. J Gastrointest Surg 2019;23:1309-17. [PMID: 30478530 DOI: 10.1007/s11605-018-4049-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
376 Scarpignato C, Hunt RH. The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease. Curr Opin Gastroenterol 2019;35:344-55. [PMID: 31045597 DOI: 10.1097/MOG.0000000000000543] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
377 Iwaya Y, Shimamura Y, Goda K, Rodríguez de Santiago E, Coneys JG, Mosko JD, Kandel G, Kortan P, May G, Marcon N, Teshima C. Clinical characteristics of young patients with early Barrett’s neoplasia. World J Gastroenterol 2019; 25(24): 3069-3078 [PMID: 31293342 DOI: 10.3748/wjg.v25.i24.3069] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
378 Vaughan TL, Onstad L, Dai JY. Interactive decision support for esophageal adenocarcinoma screening and surveillance. BMC Gastroenterol 2019;19:109. [PMID: 31248371 DOI: 10.1186/s12876-019-1022-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
379 Amano Y, Nakahara R, Yuki T, Murakami D, Ujihara T, Tomoyuki I, Sagami R, Suehiro S, Katsuyama Y, Hayasaka K, Harada H, Tada Y, Miyaoka Y, Fujishiro H. Relationship between Barrett's esophagus and colonic diseases: a role for colonoscopy in Barrett's surveillance. J Gastroenterol 2019;54:984-93. [PMID: 31240437 DOI: 10.1007/s00535-019-01600-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
380 van der Wel MJ, Coleman HG, Bergman JJ, Jansen M, Meijer SL, on behalf of the BOLERO working group. Histopathologist Features Predictive of Diagnostic Concordance at Expert Level Amongst a Large International Sample of Pathologists Diagnosing Barrett’s Dysplasia Using Digital Pathology.. [DOI: 10.1101/19000174] [Reference Citation Analysis]
381 Britton J, Chatten K, Riley T, Keld RR, Hamdy S, McLaughlin J, Ang Y. Dedicated service improves the accuracy of Barrett's oesophagus surveillance: a prospective comparative cohort study. Frontline Gastroenterol 2019;10:128-34. [PMID: 31205652 DOI: 10.1136/flgastro-2018-101019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
382 Wu PC, Chen YH, Wu FZ, Lin KH, Hsu CL, Chen CS, Chen YH, Lin PH, Mar GY, Yu HC. Risk factors for Barrett's esophagus in young adults who underwent upper gastrointestinal endoscopy in a health examination center. Therap Adv Gastroenterol 2019;12:1756284819853115. [PMID: 31210784 DOI: 10.1177/1756284819853115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
383 Peters Y, Al-kaabi A, Shaheen NJ, Chak A, Blum A, Souza RF, Di Pietro M, Iyer PG, Pech O, Fitzgerald RC, Siersema PD. Barrett oesophagus. Nat Rev Dis Primers 2019;5. [DOI: 10.1038/s41572-019-0086-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 14.0] [Reference Citation Analysis]
384 van der Wel MJ, Klaver E, Duits LC, Pouw RE, Seldenrijk CA, Offerhaus G, Visser M, Ten Kate F, Biermann K, Brosens L, Doukas M, Huysentruyt C, Karrenbeld A, Kats-Ugurlu G, van der Laan JS, van Lijnschoten G, Moll F, Ooms A, Tijssen JG, Bergman J, Meijer SL. Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagus. United European Gastroenterol J 2019;7:889-96. [PMID: 31428413 DOI: 10.1177/2050640619853441] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
385 Husain NS, El-Serag HB. Chemoprevention of Barrett's oesophagus: a step closer with PPIs and aspirin. Nat Rev Clin Oncol 2018;15:728-30. [PMID: 30237519 DOI: 10.1038/s41571-018-0096-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
386 Parekh B, Ghadlyalpatil N, Chandarana EV, Hingmire SS, Sumant G, Agarwala V, Tiwari A, Bhattacharyya GS, Parikh PM. Immunotherapy in esophageal cancer-An update. Int J Mol and ImmuOncol 2019;4:34-40. [DOI: 10.25259/ijmio-11-2019] [Reference Citation Analysis]
387 Kunzmann AT, Thrift AP, Johnston BT, McManus DT, Gavin AT, Turkington RC, Coleman HG. External validation of a model to determine risk of progression of Barrett's oesophagus to neoplasia. Aliment Pharmacol Ther 2019;49:1274-81. [PMID: 30950101 DOI: 10.1111/apt.15235] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
388 Januszewicz W, Fitzgerald RC. Barrett's oesophagus and oesophageal adenocarcinoma. Medicine (Abingdon) 2019;47:275-85. [PMID: 32467662 DOI: 10.1016/j.mpmed.2019.02.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
389 Snyder P, Dunbar K, Cipher DJ, Souza RF, Spechler SJ, Konda VJA. Aberrant p53 Immunostaining in Barrett's Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses. Dig Dis Sci 2019;64:1089-97. [PMID: 30911864 DOI: 10.1007/s10620-019-05586-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
390 Patel A, Gyawali CP. Screening for Barrett's Esophagus: Balancing Clinical Value and Cost-effectiveness. J Neurogastroenterol Motil 2019;25:181-8. [PMID: 30827080 DOI: 10.5056/jnm18156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
391 Waterhouse DJ, Fitzpatrick CRM, Pogue BW, O’connor JPB, Bohndiek SE. A roadmap for the clinical implementation of optical-imaging biomarkers. Nat Biomed Eng 2019;3:339-53. [DOI: 10.1038/s41551-019-0392-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 7.5] [Reference Citation Analysis]
392 Rogerson C, Britton E, Withey S, Hanley N, Ang YS, Sharrocks AD. Identification of a primitive intestinal transcription factor network shared between esophageal adenocarcinoma and its precancerous precursor state. Genome Res 2019;29:723-36. [PMID: 30962179 DOI: 10.1101/gr.243345.118] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
393 Hamade N, Vennelaganti S, Parasa S, Vennalaganti P, Gaddam S, Spaander MCW, van Olphen SH, Thota PN, Kennedy KF, Bruno MJ, Vargo JJ, Mathur S, Cash BD, Sampliner R, Gupta N, Falk GW, Bansal A, Young PE, Lieberman DA, Sharma P. Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett's Esophagus to Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol 2019;17:864-8. [PMID: 30012433 DOI: 10.1016/j.cgh.2018.07.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
394 Toon C, Allanson B, Leslie C, Acott N, Mirzai B, Raftopoulos S, Kumarasinghe MP. Patterns of p53 immunoreactivity in non-neoplastic and neoplastic Barrett's mucosa of the oesophagus: in-depth evaluation in endoscopic mucosal resections. Pathology 2019;51:253-60. [DOI: 10.1016/j.pathol.2018.12.415] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
395 Fitzgerald RC, Corley DA. Will a Proton Pump Inhibitor and an Aspirin Keep the Doctor Away for Patients With Barrett's Esophagus? Gastroenterology 2019;156:1228-31. [PMID: 30849313 DOI: 10.1053/j.gastro.2019.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
396 Montgomery EA, Canto MI, Srivastava A. American Registry of Pathology Expert Opinions: Evaluation and reporting of biopsies from the columnar-lined esophagus and gastro-esophageal junction (GEJ). Annals of Diagnostic Pathology 2019;39:111-7. [DOI: 10.1016/j.anndiagpath.2019.02.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
397 Peerally MF, Bhandari P, Ragunath K, Barr H, Stokes C, Haidry R, Lovat L, Smart H, Harrison R, Smith K, Morris T, de Caestecker JS. Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett's esophagus: a randomized pilot study (BRIDE). Gastrointest Endosc 2019;89:680-9. [PMID: 30076843 DOI: 10.1016/j.gie.2018.07.031] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
398 Sanghi V, Thota PN. Barrett's esophagus: novel strategies for screening and surveillance. Ther Adv Chronic Dis 2019;10:2040622319837851. [PMID: 30937155 DOI: 10.1177/2040622319837851] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
399 Konda VJA, Souza RF. Barrett’s Esophagus and Esophageal Carcinoma: Can Biomarkers Guide Clinical Practice? Curr Gastroenterol Rep 2019;21. [DOI: 10.1007/s11894-019-0685-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
400 Sami SS, Iyer PG, Pophali P, Halland M, di Pietro M, Ortiz-Fernandez-Sordo J, White JR, Johnson M, Guha IN, Fitzgerald RC, Ragunath K. Acceptability, Accuracy, and Safety of Disposable Transnasal Capsule Endoscopy for Barrett's Esophagus Screening. Clin Gastroenterol Hepatol 2019;17:638-646.e1. [PMID: 30081223 DOI: 10.1016/j.cgh.2018.07.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
401 Januszewicz W, Tan WK, Lehovsky K, Debiram-Beecham I, Nuckcheddy T, Moist S, Kadri S, di Pietro M, Boussioutas A, Shaheen NJ, Katzka DA, Dellon ES, Fitzgerald RC; BEST1 and BEST2 study investigators. Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients. Clin Gastroenterol Hepatol 2019;17:647-656.e1. [PMID: 30099104 DOI: 10.1016/j.cgh.2018.07.043] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
402 Donnelly H, Nolan T. Dyspepsia: When to refer for endoscopy. InnovAiT 2019;12:144-148. [DOI: 10.1177/1755738018785984] [Reference Citation Analysis]
403 Nguyen AD, Spechler SJ, Dunbar KB. Barrett's Esophagus. Evidence-based Gastroenterology and Hepatology 4e 2019. [DOI: 10.1002/9781119211419.ch2] [Reference Citation Analysis]
404 Salimian KJ, Waters KM, Eze O, Pezhouh MK, Tarabishy Y, Shin EJ, Canto MI, Voltaggio L, Montgomery EA. Definition of Barrett Esophagus in the United States: Support for Retention of a Requirement for Goblet Cells. Am J Surg Pathol 2018;42:264-8. [PMID: 29016405 DOI: 10.1097/PAS.0000000000000971] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
405 Januszewicz W, Fitzgerald RC. Early detection and therapeutics. Mol Oncol. 2019;13:599-613. [PMID: 30677217 DOI: 10.1002/1878-0261.12458] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
406 Everson MA, Lovat LB, Graham DG, Bassett P, Magee C, Alzoubaidi D, Fernández-Sordo JO, Sweis R, Banks MR, Wani S, Esteban JM, Ragunath K, Bisschops R, Haidry RJ. Virtual chromoendoscopy by using optical enhancement improves the detection of Barrett's esophagus-associated neoplasia. Gastrointest Endosc 2019;89:247-256.e4. [PMID: 30291849 DOI: 10.1016/j.gie.2018.09.032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
407 Alzoubaidi D, Graham D, Bassett P, Magee C, Everson M, Banks M, Novelli M, Jansen M, Lovat LB, Haidry R. Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett's esophagus-related neoplasia. Surg Endosc 2019;33:3665-72. [PMID: 30671663 DOI: 10.1007/s00464-018-06655-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
408 Cholapranee A, Trindade AJ. Challenges in Endoscopic Therapy of Dysplastic Barrett's Esophagus. Curr Treat Options Gastroenterol 2019;17:32-47. [PMID: 30663018 DOI: 10.1007/s11938-019-00215-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
409 Dumic I, Nordin T, Jecmenica M, Stojkovic Lalosevic M, Milosavljevic T, Milovanovic T. Gastrointestinal Tract Disorders in Older Age. Can J Gastroenterol Hepatol 2019;2019:6757524. [PMID: 30792972 DOI: 10.1155/2019/6757524] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 20.5] [Reference Citation Analysis]
410 Pollit V, Graham D, Leonard C, Filby A, McMaster J, Mealing SJ, Lovat LB, Haidry RJ. A cost-effectiveness analysis of endoscopic eradication therapy for management of dysplasia arising in patients with Barrett's oesophagus in the United Kingdom. Curr Med Res Opin 2019;35:805-15. [PMID: 30479169 DOI: 10.1080/03007995.2018.1552407] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
411 Ahadi MS, Gill AJ, Turchini JR, Raftopoulos SC, Kumarasinghe MP. Oesophagus: Inflammatory Patterns. Endoscopic Biopsy Interpretation 2019. [DOI: 10.1007/978-3-319-79117-3_2] [Reference Citation Analysis]
412 Esteban J. What We Have to Do After the Treatment of Metaplasia or Dysplasia in Barrett’s Esophagus? Protocols and Timing of Follow-Up in the Treated Patient. Revisiting Barrett's Esophagus 2019. [DOI: 10.1007/978-3-319-92093-1_17] [Reference Citation Analysis]
413 Shamal' MV, Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus, Varabei AI, Maskalik ZG, Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus, Minsk Regional Clinical Hospital. BARRETT’S ESOPHAGUS: CONTEMPORARY DIAGNOSTIC AND THERAPEUTIC APPROACHES. Hepatol Gastroenterol 2019;3:103-108. [DOI: 10.25298/2616-5546-2019-3-1-103-108] [Reference Citation Analysis]
414 Watson TJ. Controversies in the Definition of Barrett Esophagus. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set 2019. [DOI: 10.1016/b978-0-323-40232-3.00031-5] [Reference Citation Analysis]
415 Waterhouse DJ. Flexible Endoscopy: Early Detection of Dysplasia in Barrett’s Oesophagus. Springer Theses 2019. [DOI: 10.1007/978-3-030-21481-4_2] [Reference Citation Analysis]
416 Falk GW. 2017 David Sun Lecture: Screening and Surveillance of Barrett's Esophagus: Where Are We Now and What Does the Future Hold? Am J Gastroenterol 2019;114:64-70. [PMID: 30361622 DOI: 10.1038/s41395-018-0374-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
417 Conio M, De Ceglie A, Crespi M. First Level Endoscopy in Barrett’s Esophagus: Endoscopic Pictures, Praga Classification, and Biopsy Protocols. Revisiting Barrett's Esophagus 2019. [DOI: 10.1007/978-3-319-92093-1_6] [Reference Citation Analysis]
418 Villanacci V, Geboes K, Salviato T, Bassotti G. Histology: The Different Points of View on Barret’s Esophagus. Revisiting Barrett's Esophagus 2019. [DOI: 10.1007/978-3-319-92093-1_9] [Reference Citation Analysis]
419 Calabrese C, Salice M, Pagano N, Manta R, Rizzello F. Timing and Protocols of Clinical and Endoscopic Surveillance of Barrett’s Esophagus. Revisiting Barrett's Esophagus 2019. [DOI: 10.1007/978-3-319-92093-1_11] [Reference Citation Analysis]
420 Holt B. Endoscopic Ultrasound in Esophageal and Gastric Cancer. Endosonography 2019. [DOI: 10.1016/b978-0-323-54723-9.00008-7] [Reference Citation Analysis]
421 Smithers BM, Thomson I. Ablation for Patients With Barrett or Dysplasia. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set 2019. [DOI: 10.1016/b978-0-323-40232-3.00034-0] [Reference Citation Analysis]
422 Chandrasoma P, Ma Y, Yung EE. Esophageal Mucosa in Health and Disease. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set 2019. [DOI: 10.1016/b978-0-323-40232-3.00003-0] [Reference Citation Analysis]
423 Ishimura N, Yuki M, Yuki T, Komazawa Y, Kushiyama Y, Fujishiro H, Ishihara S, Kinoshita Y. Inter-institutional variations regarding Barrett's esophagus diagnosis. Esophagus 2019;16:71-6. [PMID: 30056606 DOI: 10.1007/s10388-018-0631-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
424 Bell RCW. Historical Perspective: Evolution of the Diagnosis and Management of Barrett’s Esophagus. The SAGES Manual of Foregut Surgery 2019. [DOI: 10.1007/978-3-319-96122-4_25] [Reference Citation Analysis]
425 Yoo AY, Joo MK. Diagnosis and Management of Barrett's Esophagus, Dysplasia and Early Esophageal Adenocarcinoma: Focusing on American and European Guidelines. Korean J Gastroenterol 2019;74:11. [DOI: 10.4166/kjg.2019.74.1.11] [Reference Citation Analysis]
426 Ponchon T, Berr F, Oyama T. Endoscopic Screening and Surveillance: Indications and Standards. Atlas of Early Neoplasias of the Gastrointestinal Tract 2019. [DOI: 10.1007/978-3-030-01114-7_6] [Reference Citation Analysis]
427 Wendling MR, Oelschlager BK. Medical and Surgical Therapy for Gastroesophageal Reflux Disease and Barrett Esophagus. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set 2019. [DOI: 10.1016/b978-0-323-40232-3.00033-9] [Reference Citation Analysis]
428 Fisher OM, Lord RV. Epidemiology of Barrett Esophagus and Risk Factors for Progression. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set 2019. [DOI: 10.1016/b978-0-323-40232-3.00032-7] [Reference Citation Analysis]
429 Gibson JA, Odze RD. Tissue Sampling, Specimen Handling, and Laboratory Processing. Clinical Gastrointestinal Endoscopy 2019. [DOI: 10.1016/b978-0-323-41509-5.00005-0] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
430 Iovino P, Santonicola A, Trudgill NJ. Pathophysiology of Gastroesophageal Reflux Disease and Natural History of Barrett’s Esophagus. Revisiting Barrett's Esophagus 2019. [DOI: 10.1007/978-3-319-92093-1_4] [Reference Citation Analysis]
431 Jajoo K, Borges LF. Epidemiology of Barrett’s Esophagus and Esophageal Cancer. The SAGES Manual of Foregut Surgery 2019. [DOI: 10.1007/978-3-319-96122-4_26] [Reference Citation Analysis]
432 Romiti A, Zagari RM. Definition and Epidemiology of Barrett’s Esophagus. Revisiting Barrett's Esophagus 2019. [DOI: 10.1007/978-3-319-92093-1_3] [Reference Citation Analysis]
433 Falk GW, Wani S. Barrett's Esophagus. Clinical Gastrointestinal Endoscopy 2019. [DOI: 10.1016/b978-0-323-41509-5.00025-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
434 Kumarasinghe MP, Allanson BM, Raftopoulos SC, Lauwers GY. Oesophagus: Neoplastic Patterns and Mimics. Endoscopic Biopsy Interpretation 2019. [DOI: 10.1007/978-3-319-79117-3_3] [Reference Citation Analysis]
435 Komatsu Y, Newhams KM, Jobe BA. Enhancing the Detection of Barrett Esophagus. Thorac Surg Clin. 2018;28:453-464. [PMID: 30268291 DOI: 10.1016/j.thorsurg.2018.07.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
436 Gotink AW, Ten Kate FJ, Doukas M, Wijnhoven BP, Bruno MJ, Looijenga LH, Koch AD, Biermann K. Do pathologists agree with each other on the histological assessment of pT1b oesophageal adenocarcinoma? United European Gastroenterol J 2019;7:261-9. [PMID: 31080611 DOI: 10.1177/2050640618817693] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
437 Matsuzaki J, Suzuki H, Shimoda M, Mori H, Fukuhara S, Miyoshi S, Masaoka T, Iwao Y, Kanai Y, Kanai T. Clinical and endoscopic findings to assist the early detection of duodenal adenoma and adenocarcinoma. United European Gastroenterol J 2019;7:250-60. [PMID: 31080610 DOI: 10.1177/2050640618817689] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
438 Gilani SM, Montgomery E. Barrett's esophagus: a comprehensive review and update. Diagnostic Histopathology 2018;24:479-486. [DOI: 10.1016/j.mpdhp.2018.09.001] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
439 Kandiah K, Chedgy FJQ, Subramaniam S, Longcroft-Wheaton G, Bassett P, Repici A, Sharma P, Pech O, Bhandari P. International development and validation of a classification system for the identification of Barrett's neoplasia using acetic acid chromoendoscopy: the Portsmouth acetic acid classification (PREDICT). Gut 2018;67:2085-91. [PMID: 28970288 DOI: 10.1136/gutjnl-2017-314512] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
440 Li YY, Du LB, Hu XQ, Jaiswal S, Gu SY, Gu YX, Dong HJ. A suggested framework for conducting esophageal cancer screening in China. J Dig Dis 2018;19:722-9. [PMID: 30375169 DOI: 10.1111/1751-2980.12675] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
441 Antony A, Pohanka C, Keogh S, Klein R, Alshelleh M, Lee C, Trindade AJ. Adherence to quality indicators in endoscopic surveillance of Barrett's esophagus and correlation to dysplasia detection rates. Clinics and Research in Hepatology and Gastroenterology 2018;42:591-6. [DOI: 10.1016/j.clinre.2018.06.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
442 Machicado JD, Han S, Yadlapati RH, Simon VC, Qumseya BJ, Sultan S, Kushnir VM, Komanduri S, Rastogi A, Muthusamy VR, Haidry R, Ragunath K, Singh R, Hammad HT, Shaheen NJ, Wani S. A Survey of Expert Practice and Attitudes Regarding Advanced Imaging Modalities in Surveillance of Barrett's Esophagus. Dig Dis Sci 2018;63:3262-71. [PMID: 30178283 DOI: 10.1007/s10620-018-5257-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
443 Sawas T, Killcoyne S, Iyer PG, Wang KK, Smyrk TC, Kisiel JB, Qin Y, Ahlquist DA, Rustgi AK, Costa RJ, Gerstung M, Fitzgerald RC, Katzka DA; OCCAMS Consortium. Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts. Gastroenterology 2018;155:1720-1728.e4. [PMID: 30165050 DOI: 10.1053/j.gastro.2018.08.036] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 9.4] [Reference Citation Analysis]
444 Sharma N, Hui T, Wong HC, Srivastava S, Teh M, Yeoh KG, Ho KY. Risk stratifying the screening of Barrett's esophagus: An Asian perspective. JGH Open 2017;1:68-73. [PMID: 30483537 DOI: 10.1002/jgh3.12013] [Reference Citation Analysis]
445 Duits LC, Lao-Sirieix P, Wolf WA, O'Donovan M, Galeano-Dalmau N, Meijer SL, Offerhaus GJA, Redman J, Crawte J, Zeki S, Pouw RE, Chak A, Shaheen NJ, Bergman JJGHM, Fitzgerald RC. A biomarker panel predicts progression of Barrett's esophagus to esophageal adenocarcinoma. Dis Esophagus 2019;32. [PMID: 30496496 DOI: 10.1093/dote/doy102] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
446 Zeki SS, Bergman JJ, Dunn JM. Endoscopic management of dysplasia and early oesophageal cancer. Best Pract Res Clin Gastroenterol 2018;36-37:27-36. [PMID: 30551853 DOI: 10.1016/j.bpg.2018.11.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
447 Holmberg D, Ness-Jensen E, Mattsson F, Lagergren J. Clinical prediction model for tumor progression in Barrett's esophagus. Surg Endosc 2019;33:2901-8. [PMID: 30456503 DOI: 10.1007/s00464-018-6590-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
448 Britton J, Hamdy S, McLaughlin J, Horne M, Ang Y. Barrett's oesophagus: A qualitative study of patient burden, care delivery experience and follow-up needs. Health Expect 2019;22:21-33. [PMID: 30430714 DOI: 10.1111/hex.12817] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
449 Old OJ, Lloyd GR, Nallala J, Isabelle M, Almond LM, Shepherd NA, Kendall CA, Shore AC, Barr H, Stone N. Rapid infrared mapping for highly accurate automated histology in Barrett's oesophagus. Analyst 2017;142:1227-34. [PMID: 27713951 DOI: 10.1039/c6an01871h] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
450 Waterhouse DJ, Joseph J, Neves AA, di Pietro M, Brindle KM, Fitzgerald RC, Bohndiek SE. Design and validation of a near-infrared fluorescence endoscope for detection of early esophageal malignancy. J Biomed Opt 2016;21:84001. [PMID: 27490221 DOI: 10.1117/1.JBO.21.8.084001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
451 Graham D, Sever N, Magee C, Waddingham W, Banks M, Sweis R, Al-Yousuf H, Mitchison M, Alzoubaidi D, Rodriguez-Justo M, Lovat L, Novelli M, Jansen M, Haidry R. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience. World J Gastroenterol 2018; 24(41): 4698-4707 [PMID: 30416317 DOI: 10.3748/wjg.v24.i41.4698] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
452 Wenker TN, Tan MC, Liu Y, El-Serag HB, Thrift AP. Prior Diagnosis of Barrett's Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival. Dig Dis Sci 2018;63:3112-9. [PMID: 30109579 DOI: 10.1007/s10620-018-5241-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
453 Sawas T, Visrodia KH, Zakko L, Lutzke LS, Leggett CL, Wang KK. Clutch cutter is a safe device for performing endoscopic submucosal dissection of superficial esophageal neoplasms: a western experience. Dis Esophagus 2018;31. [PMID: 29939257 DOI: 10.1093/dote/doy054] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
454 Chettouh H, Mowforth O, Galeano-Dalmau N, Bezawada N, Ross-Innes C, MacRae S, Debiram-Beecham I, O'Donovan M, Fitzgerald RC. Methylation panel is a diagnostic biomarker for Barrett's oesophagus in endoscopic biopsies and non-endoscopic cytology specimens. Gut 2018;67:1942-9. [PMID: 29084829 DOI: 10.1136/gutjnl-2017-314026] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 9.4] [Reference Citation Analysis]
455 Bar N, Schwartz N, Nissim M, Fliss-Isacov N, Zelber-Sagi S, Kariv R. Barrett’s esophagus with high grade dysplasia is associated with non-esophageal cancer. World J Gastroenterol 2018; 24(39): 4472-4481 [PMID: 30356981 DOI: 10.3748/wjg.v24.i39.4472] [Reference Citation Analysis]
456 Edwards P, Davidson M, Calamai V, Cunningham D, Starling N. Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends. Cancer Treat Rev 2018;71:32-8. [PMID: 30343173 DOI: 10.1016/j.ctrv.2018.10.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
457 Felsenreich DM, Langer FB, Prager G. Reply to the Letter to the Editor "Does Sleeve Gastrectomy Cause Barrett's Oesophagus?". Obes Surg 2018;28:4051-2. [PMID: 30317489 DOI: 10.1007/s11695-018-3542-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
458 Montgomery E, Arnold CA, Lam-Himlin D, Salimian K, Waters K. Some observations on Barrett esophagus and associated dysplasia. Ann Diagn Pathol 2018;37:75-82. [PMID: 30312881 DOI: 10.1016/j.anndiagpath.2018.09.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
459 Tsukanov VV, Vasyutin AV, Butorin NN, Tonkikh YL, Peretyatko OV, Pulikov AS. Prevalence and modern aspects of the treatment of patients with Barrett’s esophagus. Med sov 2018. [DOI: 10.21518/2079-701x-2018-14-24-27] [Reference Citation Analysis]
460 Boyle I. Elective surveillance gastroscopy in Barrett's oesophagus: a case study and review of the clinical endoscopist's role. Gastrointestinal Nursing 2018;16:35-44. [DOI: 10.12968/gasn.2018.16.8.35] [Reference Citation Analysis]
461 . UEG Week 2018 Poster Presentations. United European Gastroenterol j 2018;6. [DOI: 10.1177/2050640618792819] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
462 Zaninotto G, Markar S. Early Esophageal Cancer. A Western Perspective. Cirugía Española (English Edition) 2018;96:463-465. [DOI: 10.1016/j.cireng.2017.12.003] [Reference Citation Analysis]
463 Steinemann DC, Müller PC, Schwarz AC, Zerz A, Linke GR, Müller-Stich BP. Feasibility and effectiveness of laparoscopic transgastric stapler-assisted circumferential esophageal mucosectomy and simultaneous fundoplication in a pig model. Dis Esophagus 2018;31. [PMID: 29788275 DOI: 10.1093/dote/doy030] [Reference Citation Analysis]
464 Dong J, Levine DM, Buas MF, Zhang R, Onstad L, Fitzgerald RC, Corley DA, Shaheen NJ, Lagergren J, Hardie LJ, Reid BJ, Iyer PG, Risch HA, Caldas C, Caldas I, Pharoah PD, Liu G, Gammon MD, Chow WH, Bernstein L, Bird NC, Ye W, Wu AH, Anderson LA, MacGregor S, Whiteman DC, Vaughan TL, Thrift AP; Stomach and Oesophageal Cancer Study (SOCS) Consortium. Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Clin Gastroenterol Hepatol 2018;16:1598-1606.e4. [PMID: 29551738 DOI: 10.1016/j.cgh.2018.03.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
465 . UEG Week 2018 Oral Presentations. United European Gastroenterol j 2018;6. [DOI: 10.1177/2050640618792817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
466 Malik S, Sharma G, Sanaka MR, Thota PN. Role of endoscopic therapy in early esophageal cancer. World J Gastroenterol 2018; 24(35): 3965-3973 [PMID: 30254401 DOI: 10.3748/wjg.v24.i35.3965] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
467 Singh T, Sanaka MR, Thota PN. Endoscopic therapy for Barrett’s esophagus and early esophageal cancer: Where do we go from here? World J Gastrointest Endosc 2018; 10(9): 165-174 [PMID: 30283599 DOI: 10.4253/wjge.v10.i9.165] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
468 Braden B, Jones-Morris E. How to get the most out of costly Barrett's oesophagus surveillance. Dig Liver Dis 2018;50:871-7. [PMID: 29730158 DOI: 10.1016/j.dld.2018.04.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
469 Sehgal V, Rosenfeld A, Graham DG, Lipman G, Bisschops R, Ragunath K, Rodriguez-Justo M, Novelli M, Banks MR, Haidry RJ, Lovat LB. Machine Learning Creates a Simple Endoscopic Classification System that Improves Dysplasia Detection in Barrett's Oesophagus amongst Non-expert Endoscopists. Gastroenterol Res Pract. 2018;2018:1872437. [PMID: 30245711 DOI: 10.1155/2018/1872437] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
470 Underwood TJ. Oesophageal cancer. Cancer Prevention and Screening 2018. [DOI: 10.1002/9781118990957.ch21] [Reference Citation Analysis]
471 Shah AK, Hartel G, Brown I, Winterford C, Na R, Cao KL, Spicer BA, Dunstone MA, Phillips WA, Lord RV, Barbour AP, Watson DI, Joshi V, Whiteman DC, Hill MM. Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barrett's Esophagus. Mol Cell Proteomics 2018;17:2324-34. [PMID: 30097534 DOI: 10.1074/mcp.RA118.000734] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
472 Offman J, Muldrew B, O'Donovan M, Debiram-Beecham I, Pesola F, Kaimi I, Smith SG, Wilson A, Khan Z, Lao-Sirieix P, Aigret B, Walter FM, Rubin G, Morris S, Jackson C, Sasieni P, Fitzgerald RC; BEST3 Trial team. Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux. BMC Cancer 2018;18:784. [PMID: 30075763 DOI: 10.1186/s12885-018-4664-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
473 Otaki F, Iyer PG. Point-Counterpoint: Screening and Surveillance for Barrett's Esophagus, Is It Worthwhile? Dig Dis Sci 2018;63:2081-93. [PMID: 29713986 DOI: 10.1007/s10620-018-5065-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
474 Iyer PG, Taylor WR, Johnson ML, Lansing RL, Maixner KA, Yab TC, Simonson JA, Devens ME, Slettedahl SW, Mahoney DW, Berger CK, Foote PH, Smyrk TC, Wang KK, Wolfsen HC, Ahlquist DA. Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's Esophagus. Am J Gastroenterol 2018;113:1156-66. [PMID: 29891853 DOI: 10.1038/s41395-018-0107-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
475 Wright NA. Is Barrett's-Associated Esophageal Adenocarcinoma a Clonal Disease? Dig Dis Sci 2018;63:2022-7. [PMID: 29951796 DOI: 10.1007/s10620-018-5164-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
476 Odze R. Histology of Barrett's Metaplasia: Do Goblet Cells Matter? Dig Dis Sci 2018;63:2042-51. [PMID: 29998421 DOI: 10.1007/s10620-018-5151-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
477 Clermont M, Falk GW. Clinical Guidelines Update on the Diagnosis and Management of Barrett's Esophagus. Dig Dis Sci 2018;63:2122-8. [PMID: 29671159 DOI: 10.1007/s10620-018-5070-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 6.4] [Reference Citation Analysis]
478 Erőss B, Farkas N, Vincze Á, Tinusz B, Szapáry L, Garami A, Balaskó M, Sarlós P, Czopf L, Alizadeh H, Rakonczay Z Jr, Habon T, Hegyi P. Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta-analysis and systematic review. Helicobacter 2018;23:e12504. [PMID: 29938864 DOI: 10.1111/hel.12504] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 7.4] [Reference Citation Analysis]
479 Spechler SJ. Cardiac Metaplasia: Follow, Treat, or Ignore? Dig Dis Sci 2018;63:2052-8. [PMID: 29671160 DOI: 10.1007/s10620-018-5063-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
480 Seewald S, Ang TL, Pouw RE, Bannwart F, Bergman JJ. Management of Early-Stage Adenocarcinoma of the Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection. Dig Dis Sci 2018;63:2146-54. [PMID: 29934725 DOI: 10.1007/s10620-018-5158-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
481 Konda VJA, Souza RF. Biomarkers of Barrett's Esophagus: From the Laboratory to Clinical Practice. Dig Dis Sci 2018;63:2070-80. [PMID: 29713984 DOI: 10.1007/s10620-018-5088-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
482 Grady WM, Yu M. Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus. Dig Dis Sci 2018;63:2059-69. [PMID: 29766388 DOI: 10.1007/s10620-018-5090-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
483 Gorrepati VS, Sharma P. How Should We Report Endoscopic Results in Patient's with Barrett's Esophagus? Dig Dis Sci 2018;63:2115-21. [PMID: 29675664 DOI: 10.1007/s10620-018-5067-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
484 Rogerson C, Britton E, Withey S, Hanley N, Ang YS, Sharrocks AD. Identification of a primitive intestinal transcription factor network shared between oesophageal adenocarcinoma and its pre-cancerous precursor state.. [DOI: 10.1101/373068] [Reference Citation Analysis]
485 Inadomi J, Alastal H, Bonavina L, Gross S, Hunt RH, Mashimo H, di Pietro M, Rhee H, Shah M, Tolone S, Wang DH, Xie SH. Recent advances in Barrett's esophagus. Ann N Y Acad Sci 2018;1434:227-38. [PMID: 29974975 DOI: 10.1111/nyas.13909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
486 Han S, Wani S. Quality Indicators in Barrett's Esophagus: Time to Change the Status Quo. Clin Endosc 2018;51:344-51. [PMID: 30078308 DOI: 10.5946/ce.2018.099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
487 Michopoulos S. Critical appraisal of guidelines for screening and surveillance of Barrett's esophagus. Ann Transl Med 2018;6:259. [PMID: 30094245 DOI: 10.21037/atm.2018.05.09] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
488 Ishihara R, Goda K, Oyama T. Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett's esophagus. J Gastroenterol 2019;54:1-9. [PMID: 29961130 DOI: 10.1007/s00535-018-1491-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
489 Nieto T, Tomlinson CL, Dretzke J, Bayliss S, Price MJ, Dilworth M, Beggs AD, Tucker O. A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma. BMJ Open 2018;8:e020427. [PMID: 29961009 DOI: 10.1136/bmjopen-2017-020427] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
490 Lightdale CJ. A simpler way to do radiofrequency ablation for Barrett's oesophagus. Lancet Gastroenterol Hepatol 2018;3:525-6. [PMID: 29934225 DOI: 10.1016/S2468-1253(18)30174-2] [Reference Citation Analysis]
491 Klavan H, Russell MB, Macklin J, Lee E, Aslanian HR, Muniraj T. Barrett's esophagus: A comprehensive review for the internist. Dis Mon 2018;64:471-87. [PMID: 29880269 DOI: 10.1016/j.disamonth.2018.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
492 Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, Chak A, Iyer PG. The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis. Gastroenterology 2018;154:2068-2086.e5. [PMID: 29458154 DOI: 10.1053/j.gastro.2018.02.022] [Cited by in Crossref: 84] [Cited by in F6Publishing: 89] [Article Influence: 16.8] [Reference Citation Analysis]
493 Aida J, Ishizaki T, Arai T, Takubo K. Prognostication of superficial Barrett’s carcinoma: a Japanese multicenter study. Human Pathology 2018;76:156-66. [DOI: 10.1016/j.humpath.2018.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
494 Itskoviz D, Levi Z, Boltin D, Vilkin A, Snir Y, Gingold-Belfer R, Niv Y, Dotan I, Dickman R. Risk of Neoplastic Progression Among Patients with an Irregular Z Line on Long-Term Follow-Up. Dig Dis Sci 2018;63:1513-7. [PMID: 29327262 DOI: 10.1007/s10620-018-4910-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
495 Sami SS, Haboubi HN, Ang Y, Boger P, Bhandari P, de Caestecker J, Griffiths H, Haidry R, Laasch HU, Patel P, Paterson S, Ragunath K, Watson P, Siersema PD, Attwood SE. UK guidelines on oesophageal dilatation in clinical practice. Gut 2018;67:1000-23. [PMID: 29478034 DOI: 10.1136/gutjnl-2017-315414] [Cited by in Crossref: 72] [Cited by in F6Publishing: 55] [Article Influence: 14.4] [Reference Citation Analysis]
496 Neves AA, Di Pietro M, O'Donovan M, Waterhouse DJ, Bohndiek SE, Brindle KM, Fitzgerald RC. Detection of early neoplasia in Barrett's esophagus using lectin-based near-infrared imaging: an ex vivo study on human tissue. Endoscopy 2018;50:618-25. [PMID: 29342490 DOI: 10.1055/s-0043-124080] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
497 Amlashi FG, Wang X, Davila RE, Maru DM, Bhutani MS, Lee JH, Weston BR, Mizrak Kaya D, Vassilakopoulou M, Harada K, Blum Murphy MA, Rice DC, Hofstetter WL, Davila M, Nguyen QN, Ajani JA. Barrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma. Oncology 2018;95:81-90. [PMID: 29843157 DOI: 10.1159/000488489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
498 Bellizzi AM, Hafezi‐bakhtiari S, Westerhoff M, Marginean EC, Riddell RH. Gastrointestinal pathologists’ perspective on managing risk in the distal esophagus: convergence on a pragmatic approach. Ann N Y Acad Sci 2018;1434:35-45. [DOI: 10.1111/nyas.13680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
499 Lopes CAM, Mesquita M, Cunha AI, Cardoso J, Carapeta S, Laranjeira C, Pinto AE, Pereira-Leal JB, Dias-Pereira A, Bettencourt-Dias M, Chaves P. Centrosome amplification arises before neoplasia and increases upon p53 loss in tumorigenesis. J Cell Biol 2018;217:2353-63. [PMID: 29739803 DOI: 10.1083/jcb.201711191] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 9.2] [Reference Citation Analysis]
500 Waterhouse DJ, Fitzpatrick CRM, di Pietro M, Bohndiek SE. Emerging optical methods for endoscopic surveillance of Barrett's oesophagus. The Lancet Gastroenterology & Hepatology 2018;3:349-62. [DOI: 10.1016/s2468-1253(18)30030-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
501 Pye H, Butt MA, Funnell L, Reinert HW, Puccio I, Rehman Khan SU, Saouros S, Marklew JS, Stamati I, Qurashi M, Haidry R, Sehgal V, Oukrif D, Gandy M, Whitaker HC, Rodriguez-Justo M, Novelli M, Hamoudi R, Yahioglu G, Deonarain MP, Lovat LB. Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression. Oncotarget 2018;9:22945-59. [PMID: 29796164 DOI: 10.18632/oncotarget.25159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
502 Kohoutova D, Haidry R, Banks M, Butt MA, Dunn J, Thorpe S, Lovat L. Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett's oesophagus related neoplasia. Scand J Gastroenterol 2018;53:527-32. [PMID: 29161901 DOI: 10.1080/00365521.2017.1403646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
503 Komanduri S, Muthusamy VR, Wani S. Controversies in Endoscopic Eradication Therapy for Barrett's Esophagus. Gastroenterology 2018;154:1861-1875.e1. [PMID: 29458152 DOI: 10.1053/j.gastro.2017.12.045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
504 Beg S, Mensa M, Fullard M, Finerty E, Richman P, Leahy A. Impact of advanced endoscopic imaging on Barrett's esophagus in daily clinical practice. Gastrointest Endosc 2018;87:1189-94. [PMID: 28958906 DOI: 10.1016/j.gie.2017.09.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
505 Spechler SJ, Katzka DA, Fitzgerald RC. New Screening Techniques in Barrett's Esophagus: Great Ideas or Great Practice? Gastroenterology 2018;154:1594-601. [PMID: 29577931 DOI: 10.1053/j.gastro.2018.03.031] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
506 Maddalo G, Fassan M, Cardin R, Piciocchi M, Marafatto F, Rugge M, Zaninotto G, Pozzan C, Castoro C, Ruol A, Biasiolo A, Farinati F. Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer: A Phase III Study. J Clin Gastroenterol 2018;52:401-6. [PMID: 28422774 DOI: 10.1097/MCG.0000000000000790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
507 Zakko L, Lutzke L, Wang KK. Screening and Preventive Strategies in Esophagogastric Cancer. Surg Oncol Clin N Am 2017;26:163-78. [PMID: 28279462 DOI: 10.1016/j.soc.2016.10.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
508 Zakko L, Visrodia K, Leggett C, Lutzke L, Wang KK. Screening patients for Barrett esophagus: Why, who, and how. Techniques in Gastrointestinal Endoscopy 2018;20:55-61. [DOI: 10.1016/j.tgie.2018.05.001] [Reference Citation Analysis]
509 Klaver E, van der Wel MJ, Meijer SL, Bergman JJ, Pouw RE. Chapter 2: Role of pathologic confirmation for Barrett′s esophagus and dysplasia. Techniques in Gastrointestinal Endoscopy 2018;20:62-9. [DOI: 10.1016/j.tgie.2018.03.002] [Reference Citation Analysis]
510 Everson MA, Ragunath K, Bhandari P, Lovat L, Haidry R. How to Perform a High-Quality Examination in Patients With Barrett's Esophagus. Gastroenterology 2018;154:1222-6. [PMID: 29510131 DOI: 10.1053/j.gastro.2018.03.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
511 Harrison M, Allen JE, Gorrepati VS, López-Jamar JME, Sharma P. Management of Barrett's esophagus with low-grade dysplasia. Dis Esophagus 2018;31. [PMID: 29506235 DOI: 10.1093/dote/doy004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
512 Ireland CJ, Gordon AL, Thompson SK, Watson DI, Whiteman DC, Reed RL, Esterman A. Validation of a risk prediction model for Barrett's esophagus in an Australian population. Clin Exp Gastroenterol 2018;11:135-42. [PMID: 29628770 DOI: 10.2147/CEG.S158627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
513 Barbeiro S, Libânio D, Castro R, Dinis-Ribeiro M, Pimentel-Nunes P. Narrow-Band Imaging: Clinical Application in Gastrointestinal Endoscopy. GE Port J Gastroenterol 2018;26:40-53. [PMID: 30675503 DOI: 10.1159/000487470] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
514 Dunbar KB, Souza RF. Beyond Dysplasia Grade: The Role of Biomarkers in Stratifying Risk. Gastrointest Endosc Clin N Am 2017;27:447-59. [PMID: 28577766 DOI: 10.1016/j.giec.2017.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
515 Kandel P, Wallace MB. The Role of Adjunct Imaging in Endoscopic Detection of Dysplasia in Barrett's Esophagus. Gastrointest Endosc Clin N Am. 2017;27:423-446. [PMID: 28577765 DOI: 10.1016/j.giec.2017.02.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
516 Shah AK, Hartel G, Brown I, Winterford C, Na R, Lê Cao K, Spicer BA, Dunstone M, Phillips WA, Lord RV, Barbour AP, Watson DI, Joshi V, Whiteman DC, Hill MM. Serum glycoprotein biomarker validation for esophageal adenocarcinoma and application to Barrett’s surveillance.. [DOI: 10.1101/281220] [Reference Citation Analysis]
517 Yang CL, Zheng XL, Ye K, Ge H, Sun YN, Lu YF, Fan QX. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway. Int J Biochem Cell Biol 2018;99:43-51. [PMID: 29530788 DOI: 10.1016/j.biocel.2018.03.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
518 van der Wel MJ, Duits LC, Klaver E, Pouw RE, Seldenrijk CA, Offerhaus G, Visser M, Ten Kate F, Tijssen JG, Bergman J, Meijer SL. Development of benchmark quality criteria for assessing whole-endoscopy Barrett's esophagus biopsy cases. United European Gastroenterol J 2018;6:830-7. [PMID: 30023060 DOI: 10.1177/2050640618764710] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
519 Adil Butt M, Pye H, Haidry RJ, Oukrif D, Khan SU, Puccio I, Gandy M, Reinert HW, Bloom E, Rashid M, Yahioglu G, Deonarain MP, Hamoudi R, Rodriguez-Justo M, Novelli MR, Lovat LB. Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate. Oncotarget 2017;8:25080-96. [PMID: 28212575 DOI: 10.18632/oncotarget.15340] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
520 Biswas S, Quante M, Leedham S, Jansen M. The metaplastic mosaic of Barrett's oesophagus. Virchows Arch 2018;472:43-54. [PMID: 29500519 DOI: 10.1007/s00428-018-2317-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
521 Vogt JS, Larsen AC, Sommer T, Ejstrud P. Quality of endoscopic surveillance of Barrett's esophagus. Scand J Gastroenterol 2018;53:256-9. [PMID: 29361878 DOI: 10.1080/00365521.2018.1430251] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
522 Ortiz-Fernandez-Sordo J, Sami SS, Mansilla-Vivar R, Subramanian V, Mannath J, Telakis E, Ragunath K. Evaluation of a novel infra-red endoscopy system in the assessment of early neoplasia in Barretts esophagus: pilot study from a single center. Dis Esophagus 2018;31. [PMID: 29228128 DOI: 10.1093/dote/dox137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
523 Subramaniam S, Kandiah K, Chedgy F, Meredith P, Longcroft-Wheaton G, Bhandari P. The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia. Dis Esophagus 2018;31. [PMID: 29211875 DOI: 10.1093/dote/dox133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
524 Cabibi D, Caruso S, Bazan V, Castiglia M, Bronte G, Ingrao S, Fanale D, Cangemi A, Calò V, Listì A, Incorvaia L, Galvano A, Pantuso G, Fiorentino E, Castorina S, Russo A. Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus. Oncotarget 2016;7:47821-30. [PMID: 27374102 DOI: 10.18632/oncotarget.10291] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
525 Tomizawa Y, Konda VJA, Coronel E, Chapman CG, Siddiqui UD. Efficacy, Durability, and Safety of Complete Endoscopic Mucosal Resection of Barrett Esophagus: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2018;52:210-6. [PMID: 28134635 DOI: 10.1097/MCG.0000000000000800] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
526 van der Wel MJ, Duits LC, Pouw RE, Seldenrijk CA, Offerhaus GJA, Visser M, Ten Kate FJ, Biermann K, Brosens LAA, Doukas M, Huysentruyt C, Karrenbeld A, Kats-Ugurlu G, van der Laan JS, van Lijnschoten GI, Moll FCP, Ooms AHAG, van der Valk H, Tijssen JG, Bergman JJ, Meijer SL. Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical staining. Histopathology 2018;72:1015-23. [PMID: 29314176 DOI: 10.1111/his.13462] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
527 Robinson L, Ilyas M, Ragunath K, Card T, Abradu-Berchie B, Kaye P. MDM2 expression in the progression of Barrett's oesophagus. Histopathology 2018;72:1230-3. [PMID: 29427358 DOI: 10.1111/his.13480] [Reference Citation Analysis]
528 Hölscher AH, Stahl M, Messmann H, Stuschke M, Meyer HJ, Porschen R. [New S3 guideline for esophageal cancer : Important surgical aspects]. Chirurg 2016;87:865-72. [PMID: 27406251 DOI: 10.1007/s00104-016-0214-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
529 di Pietro M, Fitzgerald RC; BSG Barrett's guidelines working group. Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett's oesophagus with low-grade dysplasia. Gut 2018;67:392-3. [PMID: 28389530 DOI: 10.1136/gutjnl-2017-314135] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 11.6] [Reference Citation Analysis]
530 Lastraioli E, Lottini T, Iorio J, Freschi G, Fazi M, Duranti C, Carraresi L, Messerini L, Taddei A, Ringressi MN, Salemme M, Villanacci V, Vindigni C, Tomezzoli A, La Mendola R, Bencivenga M, Compagnoni B, Chiudinelli M, Saragoni L, Manzi I, De Manzoni G, Bechi P, Boni L, Arcangeli A. hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance. Oncotarget. 2016;7:59535-59547. [PMID: 27517748 DOI: 10.18632/oncotarget.11149] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
531 Sun Y, Ma S, Fang L, Wang J, Dong L. Circular stripes were more common in Barrett's esophagus after acetic acid staining. BMC Gastroenterol 2018;18:17. [PMID: 29370762 DOI: 10.1186/s12876-018-0745-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
532 Tan WK, Rattan A, O'Donovan M, Nuckcheddy T, Alias B, Sujendran V, di Pietro M. Comparative outcomes of radiofrequency ablation for Barrett's oesophagus with different baseline histology. United European Gastroenterol J 2018;6:662-8. [PMID: 30083327 DOI: 10.1177/2050640617752183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
533 Sami SS, Iyer PG. Recent Advances in Screening for Barrett's Esophagus. Curr Treat Options Gastroenterol 2018;16:1-14. [PMID: 29330747 DOI: 10.1007/s11938-018-0166-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
534 Chedgy F, Fogg C, Kandiah K, Barr H, Higgins B, McCord M, Dewey A, De Caestecker J, Gadeke L, Stokes C, Poller D, Longcroft-Wheaton G, Bhandari P. Acetic acid-guided biopsies in Barrett's surveillance for neoplasia detection versus non-targeted biopsies (Seattle protocol): A feasibility study for a randomized tandem endoscopy trial. The ABBA study. Endosc Int Open 2018;6:E43-50. [PMID: 29340297 DOI: 10.1055/s-0043-120829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
535 Chandrasoma PT. Esophageal Adenocarcinoma. GERD 2018. [DOI: 10.1016/b978-0-12-809855-4.00012-9] [Reference Citation Analysis]
536 Lam S, Alexandre L, Luben R, Hart AR. The association between physical activity and the risk of symptomatic Barrett's oesophagus: a UK prospective cohort study. Eur J Gastroenterol Hepatol 2018;30:71-5. [PMID: 29064850 DOI: 10.1097/MEG.0000000000000998] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
537 O'Donovan M, Fitzgerald RC. Screening for Barrett's Esophagus: Are New High-Volume Methods Feasible? Dig Dis Sci 2018;63:2105-14. [PMID: 29995243 DOI: 10.1007/s10620-018-5192-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
538 Banerjee R, Reddy DN. Role of Endoscopy and Novel Imaging in GERD. The Rise of Acid Reflux in Asia 2018. [DOI: 10.1007/978-81-322-0846-4_6] [Reference Citation Analysis]
539 Huang Q. The Esophagogastric Junction. Gastric Cardiac Cancer 2018. [DOI: 10.1007/978-3-319-79114-2_1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
540 Chandrasoma PT. Columnar-Lined Esophagus (Microscopic and Visible) and Barrett Esophagus. GERD 2018. [DOI: 10.1016/b978-0-12-809855-4.00011-7] [Reference Citation Analysis]
541 Scarpignato C, Gatta L. Acid Suppression for Management of Gastroesophageal Reflux Disease: Benefits and Risks. Reflux Aspiration and Lung Disease 2018. [DOI: 10.1007/978-3-319-90525-9_23] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
542 Coleman HG, Xie SH, Lagergren J. The Epidemiology of Esophageal Adenocarcinoma. Gastroenterology 2018;154:390-405. [PMID: 28780073 DOI: 10.1053/j.gastro.2017.07.046] [Cited by in Crossref: 283] [Cited by in F6Publishing: 292] [Article Influence: 56.6] [Reference Citation Analysis]
543 di Pietro M, Canto MI, Fitzgerald RC. Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. Gastroenterology 2018;154:421-36. [PMID: 28778650 DOI: 10.1053/j.gastro.2017.07.041] [Cited by in Crossref: 111] [Cited by in F6Publishing: 116] [Article Influence: 22.2] [Reference Citation Analysis]
544 Cinnor B, Mittal C, Wani S. Training in Advanced Endoscopy. Clinical Gastroenterology 2018. [DOI: 10.1007/978-3-319-62993-3_52] [Reference Citation Analysis]
545 Paterson-brown S, Couper GW, Lamb PJ. Anti-Reflux Surgery. Tips and Tricks in Thoracic Surgery 2018. [DOI: 10.1007/978-1-4471-7355-7_32] [Reference Citation Analysis]
546 Zaninotto G, Markar S. Early esophageal cancer. A western perspective. Cir Esp (Engl Ed) 2018;96:463-5. [PMID: 29289342 DOI: 10.1016/j.ciresp.2017.08.014] [Reference Citation Analysis]
547 Khan T, Sharma P. Endoscopic Management of Barrett’s Esophagus. Clinical Gastroenterology 2018. [DOI: 10.1007/978-3-319-62993-3_6] [Reference Citation Analysis]
548 Valdovinos-andraca F, Bernal-méndez A, Barreto-zúñiga R, Briseño-garcía D, Martínez-lozano J, Romano-munive A, Elizondo-rivera J, Téllez-ávila F. Barrett's esophagus: Ten years of experience at a tertiary care hospital center in Mexico. Revista de Gastroenterología de México (English Edition) 2018;83:25-30. [DOI: 10.1016/j.rgmxen.2017.08.008] [Reference Citation Analysis]
549 Barret M, Coron E. Comment (bien) analyser un oesophage de Barrett ? Acta Endosc 2018. [DOI: 10.3166/acen-2018-0040] [Reference Citation Analysis]
550 Kuipers EJ, Spaander MC. Natural History of Barrett's Esophagus. Dig Dis Sci 2018;63:1997-2004. [PMID: 29905908 DOI: 10.1007/s10620-018-5161-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
551 Spence AD, Cardwell CR, McMenamin ÚC, Hicks BM, Johnston BT, Murray LJ, Coleman HG. Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review. BMC Gastroenterol 2017;17:157. [PMID: 29228909 DOI: 10.1186/s12876-017-0708-4] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 7.8] [Reference Citation Analysis]
552 Costamagna G, Battaglia G, Repici A, Fiocca R, Rugge M, Spada C, Villanacci V. Diagnosis and Endoscopic Management of Barrett's Esophagus: an Italian Experts' Opinion based document. Dig Liver Dis 2017;49:1306-13. [PMID: 28969923 DOI: 10.1016/j.dld.2017.08.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
553 Vergouwe FWT, Wijnen RMH, Bruno MJ, Spaander MCW. Prevalence of Barrett Esophagus in Adolescents and Young Adults With Esophageal Atresia. Annals of Surgery 2017;266:e95-6. [DOI: 10.1097/sla.0000000000001773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
554 Rumiato E, Boldrin E, Malacrida S, Realdon S, Fassan M, Morbin T, Battaglia G, Amadori A, Rugge M, Saggioro D. Detection of genetic alterations in cfDNA as a possible strategy to monitor the neoplastic progression of Barrett's esophagus. Translational Research 2017;190:16-24.e1. [DOI: 10.1016/j.trsl.2017.09.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
555 Upchurch E, Griffiths S, Lloyd GR, Isabelle M, Kendall C, Barr H. Developments in optical imaging for gastrointestinal surgery. Future Oncol 2017;13:2363-82. [PMID: 29121775 DOI: 10.2217/fon-2017-0181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
556 Lindblad M, Bright T, Schloithe A, Mayne GC, Chen G, Bull J, Bampton PA, Fraser RJ, Gatenby PA, Gordon LG, Watson DI. Toward More Efficient Surveillance of Barrett's Esophagus: Identification and Exclusion of Patients at Low Risk of Cancer. World J Surg 2017;41:1023-34. [PMID: 27882416 DOI: 10.1007/s00268-016-3819-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
557 Voltaggio L, Montgomery EA. Diagnosis and Management of Barrett-Related Neoplasia in the Modern Era. Surg Pathol Clin 2017;10:781-800. [PMID: 29103533 DOI: 10.1016/j.path.2017.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
558 Woods YL, Carey FA. Pathology and histology of the oesophagus and stomach. Surgery (Oxford) 2017;35:612-618. [DOI: 10.1016/j.mpsur.2017.08.002] [Reference Citation Analysis]
559 Swager AF, van der Sommen F, Klomp SR, Zinger S, Meijer SL, Schoon EJ, Bergman JJGHM, de With PH, Curvers WL. Computer-aided detection of early Barrett's neoplasia using volumetric laser endomicroscopy. Gastrointest Endosc 2017;86:839-46. [PMID: 28322771 DOI: 10.1016/j.gie.2017.03.011] [Cited by in Crossref: 100] [Cited by in F6Publishing: 93] [Article Influence: 16.7] [Reference Citation Analysis]
560 Beg S, Ragunath K, Wyman A, Banks M, Trudgill N, Pritchard DM, Riley S, Anderson J, Griffiths H, Bhandari P, Kaye P, Veitch A. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS). Gut 2017;66:1886-99. [PMID: 28821598 DOI: 10.1136/gutjnl-2017-314109] [Cited by in Crossref: 149] [Cited by in F6Publishing: 143] [Article Influence: 24.8] [Reference Citation Analysis]
561 Britton J, Gadeke L, Lovat L, Hamdy S, Hawkey C, Mclaughlin J, Ang Y. Research priority setting in Barrett's oesophagus and gastro-oesophageal reflux disease. The Lancet Gastroenterology & Hepatology 2017;2:824-31. [DOI: 10.1016/s2468-1253(17)30250-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
562 Woodland P, Shen Ooi JL, Grassi F, Nikaki K, Lee C, Evans JA, Koukias N, Triantos C, McDonald SA, Peiris M, Aktar R, Blackshaw LA, Sifrim D. Superficial Esophageal Mucosal Afferent Nerves May Contribute to Reflux Hypersensitivity in Nonerosive Reflux Disease. Gastroenterology 2017;153:1230-9. [PMID: 28734832 DOI: 10.1053/j.gastro.2017.07.017] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 8.7] [Reference Citation Analysis]
563 van der Wel MJ, Duits LC, Seldenrijk CA, Offerhaus GJ, Visser M, Ten Kate FJ, de Boer OJ, Tijssen JG, Bergman JJ, Meijer SL. Digital microscopy as valid alternative to conventional microscopy for histological evaluation of Barrett's esophagus biopsies. Dis Esophagus 2017;30:1-7. [PMID: 28881901 DOI: 10.1093/dote/dox078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
564 Ireland CJ, Fielder AL, Thompson SK, Laws TA, Watson DI, Esterman A. Development of a risk prediction model for Barrett's esophagus in an Australian population. Dis Esophagus 2017;30:1-8. [PMID: 28881896 DOI: 10.1093/dote/dox033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
565 Faqih A, Broman KK, Huang LC, Phillips SE, Holzman MD, Pierce RA, Poulose BK, Yachimski PS. Frequency of endoscopic surveillance for Barrett's esophagus is influenced by health insurance status: results from a population-based analysis. Dis Esophagus 2017;30:1-8. [PMID: 28881902 DOI: 10.1093/dote/dox080] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
566 Koo S, Awadelkarim B, Dhar A. The National Oesophagogastric Cancer Awareness Campaign: a locality outcome analysis from County Durham. Frontline Gastroenterol 2017;8:290-4. [PMID: 29067156 DOI: 10.1136/flgastro-2016-100779] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
567 Janmaat VT, van Olphen SH, Biermann KE, Looijenga LHJ, Bruno MB, Spaander MCW. Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis. PLoS One 2017;12:e0186305. [PMID: 29059206 DOI: 10.1371/journal.pone.0186305] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
568 Lamont S, Stanley A. Endoscopic Management of Upper Gastrointestinal Pathology in the Patient with Liver Disease. Endoscopy in Liver Disease 2017. [DOI: 10.1002/9781118660799.ch10] [Reference Citation Analysis]
569 van Putten M, Johnston BT, Murray LJ, Gavin AT, McManus DT, Bhat S, Turkington RC, Coleman HG. 'Missed' oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus patients: A large population-based study. United European Gastroenterol J 2018;6:519-28. [PMID: 29881607 DOI: 10.1177/2050640617737466] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
570 Subramaniam S, Chedgy F, Longcroft-Wheaton G, Kandiah K, Maselli R, Seewald S, Repici A, Bhandari P. Complex early Barrett's neoplasia at 3 Western centers: European Barrett's Endoscopic Submucosal Dissection Trial (E-BEST). Gastrointest Endosc 2017;86:608-18. [PMID: 28159540 DOI: 10.1016/j.gie.2017.01.027] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]
571 Herrera Elizondo J, Monreal Robles R, García Compean D, González Moreno E, Borjas Almaguer O, Maldonado Garza H, González González J. Prevalence of Barrett's esophagus: An observational study from a gastroenterology clinic. Revista de Gastroenterología de México (English Edition) 2017;82:296-300. [DOI: 10.1016/j.rgmxen.2017.07.001] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
572 Srivastava S, Kern F, Sharma N, McKeon F, Xian W, Yeoh KG, Ho KY, Teh M. FABP1 and Hepar expression levels in Barrett's esophagus and associated neoplasia in an Asian population. Dig Liver Dis 2017;49:1104-9. [PMID: 28807490 DOI: 10.1016/j.dld.2017.06.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
573 Britton J, Keld R, Prasad N, Hamdy S, McLaughlin J, Ang Y. Effect of diagnosis, surveillance, and treatment of Barrett's oesophagus on health-related quality of life. Lancet Gastroenterol Hepatol 2018;3:57-65. [PMID: 28970029 DOI: 10.1016/S2468-1253(17)30213-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
574 DE Carli DM, Araujo AF, Fagundes RB. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL. Arq Gastroenterol 2017;54:305-7. [PMID: 28954045 DOI: 10.1590/S0004-2803.201700000-45] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
575 Cotton CC, Wolf WA, Overholt BF, Li N, Lightdale CJ, Wolfsen HC, Pasricha S, Wang KK, Shaheen NJ; AIM Dysplasia Trial Group. Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial. Gastroenterology 2017;153:681-688.e2. [PMID: 28579538 DOI: 10.1053/j.gastro.2017.05.044] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 11.5] [Reference Citation Analysis]
576 Giroux V, Rustgi AK. Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence. Nat Rev Cancer. 2017;17:594-604. [PMID: 28860646 DOI: 10.1038/nrc.2017.68] [Cited by in Crossref: 138] [Cited by in F6Publishing: 145] [Article Influence: 23.0] [Reference Citation Analysis]
577 Quante M, Baumeister T. Pathogenese und Prävention von ösophagealen Adenokarzinomen. Gastroenterologe 2017;12:376-387. [DOI: 10.1007/s11377-017-0186-9] [Reference Citation Analysis]
578 Katz-Summercorn A, Anand S, Ingledew S, Huang Y, Roberts T, Galeano-Dalmau N, O'Donovan M, Liu H, Fitzgerald RC. Application of a multi-gene next-generation sequencing panel to a non-invasive oesophageal cell-sampling device to diagnose dysplastic Barrett's oesophagus. J Pathol Clin Res 2017;3:258-67. [PMID: 29085666 DOI: 10.1002/cjp2.80] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
579 Sreedharan L, Mayne GC, Watson DI, Bright T, Lord RV, Ansar A, Wang T, Kist J, Astill DS, Hussey DJ. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett’s esophagus. World J Gastroenterol 2017; 23(30): 5508-5518 [PMID: 28852310 DOI: 10.3748/wjg.v23.i30.5508] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
580 Adachi K, Mishiro T, Tanaka S, Kinoshita Y. Circumferential Locations of Different Shapes of Short-segment Barrett's Esophagus. Intern Med 2017;56:1937-42. [PMID: 28768960 DOI: 10.2169/internalmedicine.56.8260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
581 Spechler SJ. Cardiac mucosa, Barrett's oesophagus and cancer of the gastro-oesophageal junction: what's in a name? Gut 2017;66:1355-7. [PMID: 27196579 DOI: 10.1136/gutjnl-2016-311948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
582 Arnold M, Laversanne M, Brown LM, Devesa SS, Bray F. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030. Am J Gastroenterol 2017;112:1247-55. [PMID: 28585555 DOI: 10.1038/ajg.2017.155] [Cited by in Crossref: 216] [Cited by in F6Publishing: 222] [Article Influence: 36.0] [Reference Citation Analysis]
583 Amadi C, Gatenby P. Barrett’s oesophagus: Current controversies. World J Gastroenterol 2017; 23(28): 5051-5067 [PMID: 28811703 DOI: 10.3748/wjg.v23.i28.5051] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
584 Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, Cunningham D. Oesophageal cancer. Nat Rev Dis Primers. 2017;3:17048. [PMID: 28748917 DOI: 10.1038/nrdp.2017.48] [Cited by in Crossref: 390] [Cited by in F6Publishing: 438] [Article Influence: 65.0] [Reference Citation Analysis]
585 Soucy G, Onstad L, Vaughan TL, Odze RD. Histologic Features Associated With Columnar-lined Esophagus in Distal Esophageal and Gastroesophageal Junction (GEJ) Biopsies From GERD Patients: A Community-based Population Study. Am J Surg Pathol 2016;40:827-35. [PMID: 26927889 DOI: 10.1097/PAS.0000000000000623] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
586 Peitz U, Vieth M, Evert M, Arand J, Roessner A, Malfertheiner P. The prevalence of gastric heterotopia of the proximal esophagus is underestimated, but preneoplasia is rare - correlation with Barrett's esophagus. BMC Gastroenterol. 2017;17:87. [PMID: 28701149 DOI: 10.1186/s12876-017-0644-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
587 Herrera Elizondo JL, Monreal Robles R, García Compean D, González Moreno EI, Borjas Almaguer OD, Maldonado Garza HJ, González González JA. Prevalence of Barrett's esophagus: An observational study from a gastroenterology clinic. Rev Gastroenterol Mex 2017;82:296-300. [PMID: 28687434 DOI: 10.1016/j.rgmx.2017.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
588 Pana M, Sansone S, Fernandez-sordo JO, Ragunath K. Endoscopic treatment for Barrett's oesophagus dysplasia and early cancer. Gastrointestinal Nursing 2017;15:18-25. [DOI: 10.12968/gasn.2017.15.6.18] [Reference Citation Analysis]
589 Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, Bergman J, Chak A, Chang K, Das A, Dumot J, Edmundowicz SA, Eisen G, Falk GW, Fennerty MB, Gerson L, Ginsberg GG, Grande D, Hall M, Harnke B, Inadomi J, Jankowski J, Lightdale CJ, Makker J, Odze RD, Pech O, Sampliner RE, Spechler S, Triadafilopoulos G, Wallace MB, Wang K, Waxman I, Komanduri S. Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium. Am J Gastroenterol 2017;112:1032-48. [PMID: 28570552 DOI: 10.1038/ajg.2017.166] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
590 Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, Bergman J, Chak A, Chang K, Das A, Dumot J, Edmundowicz SA, Eisen G, Falk GW, Fennerty MB, Gerson L, Ginsberg GG, Grande D, Hall M, Harnke B, Inadomi J, Jankowski J, Lightdale CJ, Makker J, Odze RD, Pech O, Sampliner RE, Spechler S, Triadafilopoulos G, Wallace MB, Wang K, Waxman I, Komanduri S. Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium. Gastrointest Endosc 2017;86:1-17.e3. [PMID: 28576294 DOI: 10.1016/j.gie.2017.03.010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
591 Sharma N, Srivastava S, Kern F, Xian W, Yeoh KG, Ming T, McKeon F, Ho KY. CEACAM 6, a novel marker for the diagnosis of Barrett's esophagus. Dis Esophagus 2017;30:1-5. [PMID: 28475729 DOI: 10.1093/dote/dox026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
592 Filby A, Taylor M, Lipman G, Lovat L, Haidry R. Cost–effectiveness analysis of endoscopic eradication therapy for treatment of high-grade dysplasia in Barrett’s esophagus. Journal of Comparative Effectiveness Research 2017;6:425-36. [DOI: 10.2217/cer-2016-0089] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
593 Phoa KN, Rosmolen WD, Weusten BLAM, Bisschops R, Schoon EJ, Das S, Ragunath K, Fullarton G, DiPietro M, Ravi N, Tijssen JGP, Dijkgraaf MGW, Bergman JJGHM; SURF investigators. The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia: results from a randomized controlled trial (SURF trial). Gastrointest Endosc 2017;86:120-129.e2. [PMID: 27956164 DOI: 10.1016/j.gie.2016.12.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
594 Wani S, Gaddam S. Editorial: Best Practices in Surveillance of Barrett's Esophagus. Am J Gastroenterol 2017;112:1056-60. [PMID: 28725066 DOI: 10.1038/ajg.2017.117] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
595 Hoffman A, Manner H, Rey JW, Kiesslich R. A guide to multimodal endoscopy imaging for gastrointestinal malignancy - an early indicator. Nat Rev Gastroenterol Hepatol 2017;14:421-34. [PMID: 28611477 DOI: 10.1038/nrgastro.2017.46] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
596 Siau K, Yew AC, Hingley S, Rees J, Trudgill NJ, Veitch AM, Fisher NC. The 2015 upper gastrointestinal "Be Clear on Cancer" campaign: its impact on gastroenterology services and malignant and premalignant diagnoses. Frontline Gastroenterol 2017;8:284-9. [PMID: 29067155 DOI: 10.1136/flgastro-2017-100820] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
597 Chen Z, Liu L, Tu J, Qin G, Su W, Geng X, Chen X, Wu H, Pan W. Improvement of atropine on esophagogastric junction observation during sedative esophagogastroduodenoscopy. PLoS One 2017;12:e0179490. [PMID: 28654639 DOI: 10.1371/journal.pone.0179490] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
598 Eluri S, Shaheen NJ. Endoscopic Eradication Therapy in Barrett's Esophagus. Tech Gastrointest Endosc. 2017;19:137-142. [PMID: 29269998 DOI: 10.1016/j.tgie.2017.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
599 Luo Y, Guda K, Markowitz SD, Chak A, Kaz AM, Grady WM. Esophageal Cancer Biomarkers. Biomarkers in Cancer Screening and Early Detection 2017. [DOI: 10.1002/9781118468869.ch9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
600 Chadwick G, Varagunam M, Brand C, Riley SA, Maynard N, Crosby T, Michalowski J, Cromwell DA. Coding of Barrett's oesophagus with high-grade dysplasia in national administrative databases: a population-based cohort study. BMJ Open 2017;7:e014281. [PMID: 28600361 DOI: 10.1136/bmjopen-2016-014281] [Reference Citation Analysis]
601 Qumseya BJ, Wani S, Gendy S, Harnke B, Bergman JJ, Wolfsen H. Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis. Am J Gastroenterol 2017;112:849-65. [PMID: 28374819 DOI: 10.1038/ajg.2017.70] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 9.5] [Reference Citation Analysis]
602 Fujii-Lau LL, Cinnor B, Shaheen N, Gaddam S, Komanduri S, Muthusamy VR, Das A, Wilson R, Simon VC, Kushnir V, Mullady D, Edmundowicz SA, Early DS, Wani S. Recurrence of intestinal metaplasia and early neoplasia after endoscopic eradication therapy for Barrett's esophagus: a systematic review and meta-analysis. Endosc Int Open 2017;5:E430-49. [PMID: 28573176 DOI: 10.1055/s-0043-106578] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
603 Valdovinos-Andraca F, Bernal-Méndez AR, Barreto-Zúñiga R, Briseño-García D, Martínez-Lozano JA, Romano-Munive AF, Elizondo-Rivera J, Téllez-Ávila FI. Barrett's esophagus: Ten years of experience at a tertiary care hospital center in Mexico. Rev Gastroenterol Mex (Engl Ed) 2018;83:25-30. [PMID: 28551084 DOI: 10.1016/j.rgmx.2017.03.007] [Reference Citation Analysis]
604 Allanson BM, Bonavita J, Mirzai B, Khor TS, Raftopoulos SC, de Boer WB, Brown IS, Kumarasinghe MP. Early Barrett esophagus-related neoplasia in segments 1 cm or longer is always associated with intestinal metaplasia. Mod Pathol 2017;30:1170-6. [DOI: 10.1038/modpathol.2017.36] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
605 Old O, Lloyd G, Isabelle M, Almond LM, Kendall C, Baxter K, Shepherd N, Shore A, Stone N, Barr H. Automated cytological detection of Barrett's neoplasia with infrared spectroscopy. J Gastroenterol 2018;53:227-35. [PMID: 28501919 DOI: 10.1007/s00535-017-1344-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
606 Baldaque-Silva F, Vieth M, Debel M, Håkanson B, Thorell A, Lunet N, Song H, Mascarenhas-Saraiva M, Pereira G, Lundell L, Marschall HU. Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett’s esophagus. World J Gastroenterol 2017; 23(17): 3174-3183 [PMID: 28533674 DOI: 10.3748/wjg.v23.i17.3174] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
607 Srivastava A, Appelman H, Goldsmith JD, Davison JM, Hart J, Krasinskas AM. The Use of Ancillary Stains in the Diagnosis of Barrett Esophagus and Barrett Esophagus–associated Dysplasia: Recommendations From the Rodger C. Haggitt Gastrointestinal Pathology Society. American Journal of Surgical Pathology 2017;41:e8-e21. [DOI: 10.1097/pas.0000000000000819] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
608 Terheggen G, Horn EM, Vieth M, Gabbert H, Enderle M, Neugebauer A, Schumacher B, Neuhaus H. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett's neoplasia. Gut 2017;66:783-93. [PMID: 26801885 DOI: 10.1136/gutjnl-2015-310126] [Cited by in Crossref: 151] [Cited by in F6Publishing: 132] [Article Influence: 25.2] [Reference Citation Analysis]
609 Eluri S, Shaheen NJ. Barrett's esophagus: diagnosis and management. Gastrointest Endosc 2017;85:889-903. [PMID: 28109913 DOI: 10.1016/j.gie.2017.01.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
610 Ciocîrlan M. Endoscopic screening for Barrett's esophagus: while we're in, do we also need to see the stomach and the duodenum? Endosc Int Open 2017;5:E345-7. [PMID: 28484735 DOI: 10.1055/s-0043-102937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
611 Altaf K, Xiong JJ, Iglesia DDl, Hickey L, Kaul A. Meta-analysis of biomarkers predicting risk of malignant progression in Barrett's oesophagus. Br J Surg. 2017;104:493-502. [PMID: 28295252 DOI: 10.1002/bjs.10484] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
612 Han S, Wani S. Quality Indicators in Endoscopic Ablation for Barrett's Esophagus. Curr Treat Options Gastroenterol 2017;15:241-55. [PMID: 28421454 DOI: 10.1007/s11938-017-0136-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
613 Levert-Mignon A, Bourke MJ, Lord SJ, Taylor AC, Wettstein AR, Edwards M, Botelho NK, Sonson R, Jayasekera C, Fisher OM, Thomas ML, Macrae F, Hussey DJ, Watson DI, Lord RV. Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinoma. United European Gastroenterol J 2017;5:13-20. [PMID: 28405317 DOI: 10.1177/2050640616650794] [Reference Citation Analysis]
614 Duits LC, van der Wel MJ, Cotton CC, Phoa KN, Ten Kate FJW, Seldenrijk CA, Offerhaus GJA, Visser M, Meijer SL, Mallant-Hent RC, Krishnadath KK, Pouw RE, Tijssen JGP, Shaheen NJ, Bergman JJGHM. Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia. Gastroenterology 2017;152:993-1001.e1. [PMID: 28012849 DOI: 10.1053/j.gastro.2016.12.008] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 12.5] [Reference Citation Analysis]
615 Thota PN, Vennalaganti P, Vennelaganti S, Young P, Gaddam S, Gupta N, Lieberman D, Sampliner R, Falk GW, Mathur S, Kennedy K, Cash BD, Moawad F, Bansal A, Spaander MC, Bruno MJ, Vargo J, Sharma P. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy. Gastroenterology 2017;152:987-92. [PMID: 27988383 DOI: 10.1053/j.gastro.2016.12.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
616 Holmberg D, Ness-jensen E, Mattsson F, El-serag HB, Lagergren J. Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus. European Journal of Cancer 2017;75:41-6. [DOI: 10.1016/j.ejca.2016.12.037] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
617 Gomez G. The Evaluation and Management of Suspicious Gastric Lesions Following Bariatric Surgery. Surg Clin North Am 2017;97:467-74. [PMID: 28325198 DOI: 10.1016/j.suc.2016.12.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
618 Rajendra S, Sharma P. Barrett Esophagus and Intramucosal Esophageal Adenocarcinoma. Hematol Oncol Clin North Am 2017;31:409-26. [PMID: 28501084 DOI: 10.1016/j.hoc.2017.01.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
619 Blevins CH, Iyer PG. Who Deserves Endoscopic Screening for Esophageal Neoplasia? Gastrointest Endosc Clin N Am. 2017;27:365-378. [PMID: 28577762 DOI: 10.1016/j.giec.2017.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
620 Dilworth M, Nieto T, Stockton J, Whalley C, Tee L, James J, Hallissey M, Hejmadi R, Trugdill N, Tucker O, Beggs A. Whole genome methylation analysis of non-dysplastic Barretts oesophagus that progresses to invasive cancer.. [DOI: 10.1101/114298] [Reference Citation Analysis]
621 Guerrero Garcia Hall M, Wenner J, Öberg S. The normal squamocolumnar junction is circumferentially even and minimal irregularities are manifestations of gastroesophageal acid reflux. Scand J Gastroenterol 2017;52:270-5. [PMID: 27825279 DOI: 10.1080/00365521.2016.1249402] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
622 Jain S, Dhingra S. Pathology of esophageal cancer and Barrett's esophagus. Ann Cardiothorac Surg. 2017;6:99-109. [PMID: 28446998 DOI: 10.21037/acs.2017.03.06] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 8.8] [Reference Citation Analysis]
623 Wald O, Smaglo B, Mok H, Groth SS. Future directions in esophageal cancer therapy. Ann Cardiothorac Surg 2017;6:159-66. [PMID: 28447005 DOI: 10.21037/acs.2017.02.01] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
624 Bratlie SO, Casselbrant A, Edebo A, Fändriks L. Support for involvement of the renin-angiotensin system in dysplastic Barrett's esophagus. Scand J Gastroenterol 2017;52:338-43. [PMID: 27846743 DOI: 10.1080/00365521.2016.1256423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
625 Tan WK, di Pietro M, Fitzgerald RC. Past, present and future of Barrett's oesophagus. Eur J Surg Oncol 2017;43:1148-60. [PMID: 28256346 DOI: 10.1016/j.ejso.2017.02.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
626 van Olphen SH, Ten Kate FJC, Doukas M, Kastelein F, Steyerberg EW, Stoop HA, Spaander MC, Looijenga LHJ, Bruno MJ, Biermann K; ProBar-Study Group. Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case-control study. Medicine (Baltimore) 2016;95:e5402. [PMID: 27893678 DOI: 10.1097/MD.0000000000005402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
627 Lipman G, Haidry RJ. Endoscopic management of Barrett's and early oesophageal neoplasia. Frontline Gastroenterol 2017;8:138-42. [PMID: 28839898 DOI: 10.1136/flgastro-2016-100763] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
628 Vennalaganti P, Kanakadandi V, Goldblum JR, Mathur SC, Patil DT, Offerhaus GJ, Meijer SL, Vieth M, Odze RD, Shreyas S, Parasa S, Gupta N, Repici A, Bansal A, Mohammad T, Sharma P. Discordance Among Pathologists in the United States and Europe in Diagnosis of Low-Grade Dysplasia for Patients With Barrett's Esophagus. Gastroenterology 2017;152:564-570.e4. [PMID: 27818167 DOI: 10.1053/j.gastro.2016.10.041] [Cited by in Crossref: 81] [Cited by in F6Publishing: 110] [Article Influence: 13.5] [Reference Citation Analysis]
629 Yantiss RK, Odze RD. Neoplastic precursor lesions of the upper gastrointestinal tract. Diagnostic Histopathology 2017;23:43-61. [DOI: 10.1016/j.mpdhp.2017.03.005] [Reference Citation Analysis]
630 Matsuhashi N, Sakai E, Ohata K, Ishimura N, Fujisaki J, Shimizu T, Iijima K, Koike T, Endo T, Kikuchi T, Inayoshi T, Amano Y, Furuta T, Haruma K, Kinoshita Y. Surveillance of patients with long-segment Barrett's esophagus: A multicenter prospective cohort study in Japan. J Gastroenterol Hepatol 2017;32:409-14. [PMID: 27416773 DOI: 10.1111/jgh.13491] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
631 Old OJ, Isabelle M, Barr H. Staging Early Esophageal Cancer. Adv Exp Med Biol 2016;908:161-81. [PMID: 27573772 DOI: 10.1007/978-3-319-41388-4_9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
632 Hu Q, Sun TT, Hong J, Fang JY, Xiong H, Meltzer SJ. Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis. PLoS One 2017;12:e0169691. [PMID: 28072858 DOI: 10.1371/journal.pone.0169691] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
633 Kashin SV, Vidyaeva NS, Kuvaev RO, Krainova EA, Haidri R, Ragunat K, Manner H. The treatment of the patients presenting with Barrett's oesophagus. Dok gastroenterol 2017;6:59. [DOI: 10.17116/dokgastro20176459-77] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
634 Zakko L, Iyer P, Visrodia K, Wang KK. Cytosponge use in risk stratification of Barrett's oesophagus. The Lancet Gastroenterology & Hepatology 2017;2:3-4. [DOI: 10.1016/s2468-1253(16)30176-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
635 Kaibysheva VO, Shapoval’yants SG. The role of functional study methods in diagnostics and the choice of treatment of gastroesophageal reflux disease and its complications. Dok gastroenterol 2017;6:9. [DOI: 10.17116/dokgastro2017639-18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
636 Pouw RE, Weusten BLAM. Endoscopic Treatment of Early Esophageal Cancer. Minimally Invasive Surgery for Upper Abdominal Cancer 2017. [DOI: 10.1007/978-3-319-54301-7_3] [Reference Citation Analysis]
637 Byrne KR, Adler DG. Diagnosis and Management of Barrett’s Esophagus. Upper Endoscopy for GI Fellows 2017. [DOI: 10.1007/978-3-319-49041-0_5] [Reference Citation Analysis]
638 Fang M, Wan Y, Li J. Research Progress of HOXA13/HOTTIP Gene and Digestive Tract Cancer. JCT 2017;08:1234-1240. [DOI: 10.4236/jct.2017.813104] [Reference Citation Analysis]
639 Brimhall B, Wani S. Current Endoscopic Approaches for the Treatment of Barrett Esophagus. J Clin Gastroenterol 2017;51:2-11. [PMID: 27941583 DOI: 10.1097/MCG.0000000000000742] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
640 Januszewicz W, Kaminski MF, Wieszczy P, Wronska E, Bielasik A, Wojciechowska U, Didkowska J, Orlowska J, Regula J. Adenocarcinoma risk in patients registered with Polish Barrett's Oesophagus Registry. Dis Esophagus 2017;30:1-6. [PMID: 27377059 DOI: 10.1111/dote.12483] [Reference Citation Analysis]
641 Thota PN. Ablation Techniques for Barrett’s Esophagus and Dysplasia. Adenocarcinoma of the Esophagogastric Junction 2017. [DOI: 10.1007/978-3-319-28776-8_4] [Reference Citation Analysis]
642 Tan MC, Murrey-Ittmann J, Nguyen T, Ketwaroo GA, El-Serag HB, Thrift AP. Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases. PLoS One 2016;11:e0169250. [PMID: 28036381 DOI: 10.1371/journal.pone.0169250] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
643 Kumarasinghe MP, Brown I, Raftopoulos S, Bourke MJ, Charlton A, de Boer WB, Eckstein R, Epari K, Gill AJ, Lam AK, Price T, Streutker C, Lauwers GY. Standardised reporting protocol for endoscopic resection for Barrett oesophagus associated neoplasia: expert consensus recommendations. Pathology 2014;46:473-80. [PMID: 25158823 DOI: 10.1097/PAT.0000000000000160] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
644 Gatenby P, Bhattacharjee S, Wall C, Caygill C, Watson A. Risk stratification for malignant progression in Barrett’s esophagus: Gender, age, duration and year of surveillance. World J Gastroenterol 2016; 22(48): 10592-10600 [PMID: 28082811 DOI: 10.3748/wjg.v22.i48.10592] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
645 Qiao YM, Zhang Y. Immunotherapy for esophageal cancer: Current studies and future perspectives. Shijie Huaren Xiaohua Zazhi 2016; 24(36): 4739-4751 [DOI: 10.11569/wcjd.v24.i36.4739] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
646 Evans RPT, Mourad MM, Fisher SG, Bramhall SR. Evolving management of metaplasia and dysplasia in Barrett's epithelium. World J Gastroenterol 2016; 22(47): 10316-10324 [PMID: 28058012 DOI: 10.3748/wjg.v22.i47.10316] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
647 Nieto T, Tomlinson CL, Dretzke J, Bayliss S, Dilworth M, Beggs AD, Tucker O. Epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma: a systematic review protocol. BMJ Open 2016;6:e013361. [PMID: 27927666 DOI: 10.1136/bmjopen-2016-013361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
648 Koutsoumpas A, Wang LM, Bailey AA, Gillies R, Marshall R, Booth M, Sgromo B, Maynard N, Braden B. Non-radical, stepwise complete endoscopic resection of Barrett's epithelium in short segment Barrett's esophagus has a low stricture rate. Endosc Int Open 2016;4:E1292-7. [PMID: 27995191 DOI: 10.1055/s-0042-118282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
649 Omidvari AH, Meester RG, Lansdorp-Vogelaar I. Cost effectiveness of surveillance for GI cancers. Best Pract Res Clin Gastroenterol 2016;30:879-91. [PMID: 27938783 DOI: 10.1016/j.bpg.2016.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
650 Shamali A, McCrudden R, Bhandari P, Shek F, Barnett E, Bateman A, Abu Hilal M. Pancreaticoduodenectomy for nonampullary duodenal lesions: indications and results. Eur J Gastroenterol Hepatol 2016;28:1388-93. [PMID: 27603299 DOI: 10.1097/MEG.0000000000000738] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
651 Mannath J, Ragunath K. Role of endoscopy in early oesophageal cancer. Nat Rev Gastroenterol Hepatol 2016;13:720-30. [PMID: 27807370 DOI: 10.1038/nrgastro.2016.148] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
652 Maes S, Sharma P, Bisschops R. Review: Surveillance of patients with Barrett oesophagus. Best Pract Res Clin Gastroenterol 2016;30:901-12. [PMID: 27938785 DOI: 10.1016/j.bpg.2016.09.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
653 Scarpignato C, Gatta L, Zullo A, Blandizzi C; SIF-AIGO-FIMMG Group; Italian Society of Pharmacology, the Italian Association of Hospital Gastroenterologists, and the Italian Federation of General Practitioners. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016;14:179. [PMID: 27825371 DOI: 10.1186/s12916-016-0718-z] [Cited by in Crossref: 192] [Cited by in F6Publishing: 204] [Article Influence: 27.4] [Reference Citation Analysis]
654 Wani S, Rubenstein JH, Vieth M, Bergman J. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association. Gastroenterology 2016;151:822-35. [PMID: 27702561 DOI: 10.1053/j.gastro.2016.09.040] [Cited by in Crossref: 95] [Cited by in F6Publishing: 100] [Article Influence: 13.6] [Reference Citation Analysis]
655 Crews NR, Johnson ML, Schleck CD, Enders FT, Wongkeesong LM, Wang KK, Katzka DA, Iyer PG. Prevalence and Predictors of Gastroesophageal Reflux Complications in Community Subjects. Dig Dis Sci 2016;61:3221-8. [PMID: 27510751 DOI: 10.1007/s10620-016-4266-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
656 Babic Z, Bogdanovic Z, Dorosulic Z, Petrovic Z, Kujundzic M, Banic M, Marusic M, Heinzl R, Bilić B, Andabak M. One year treatment of Barrett s oesophagus with proton pump inhibitors (a multi-center study). Acta Clinica Belgica 2015;70:408-13. [DOI: 10.1179/2295333715y.0000000050] [Reference Citation Analysis]
657 Moole H, Patel J, Ahmed Z, Duvvuri A, Vennelaganti S, Moole V, Dharmapuri S, Boddireddy R, Yedama P, Bondalapati N, Uppu A, Vennelaganti P, Puli S. Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists. World J Gastroenterol 2016; 22(39): 8831-8843 [PMID: 27818599 DOI: 10.3748/wjg.v22.i39.8831] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
658 Torres-Landa S, Furuzawa-Carballeda J, Coss-Adame E, Valdovinos MA, Alejandro-Medrano E, Ramos-Ávalos B, Martínez-Benítez B, Torres-Villalobos G. Barrett's Oesophagus in an Achalasia Patient: Immunological Analysis and Comparison with a Group of Achalasia Patients. Case Rep Gastrointest Med 2016;2016:5681590. [PMID: 27752370 DOI: 10.1155/2016/5681590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
659 . UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016;4:A157-720. [DOI: 10.1177/2050640616663689] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
660 Bureo Gonzalez A, Bergman JJ, Pouw RE. Endoscopic risk factors for neoplastic progression in patients with Barrett's oesophagus. United European Gastroenterol J 2016;4:657-62. [PMID: 27733907 DOI: 10.1177/2050640616635509] [Reference Citation Analysis]
661 Paterson AL, Lao-Sirieix P, O'Donovan M, Debiram-Beecham I, di Pietro M, Miremadi A, Attwood SE, Walter FM, Sasieni PD, Fitzgerald RC; BEST and BEST2 study groups. Range of pathologies diagnosed using a minimally invasive capsule sponge to evaluate patients with reflux symptoms. Histopathology 2017;70:203-10. [PMID: 27417524 DOI: 10.1111/his.13039] [Cited by in Crossref: 13] [Cited by in F6Publishing: 44] [Article Influence: 1.9] [Reference Citation Analysis]
662 Critchley-Thorne RJ, Davison JM, Prichard JW, Reese LM, Zhang Y, Repa K, Li J, Diehl DL, Jhala NC, Ginsberg GG, DeMarshall M, Foxwell T, Jobe BA, Zaidi AH, Duits LC, Bergman JJ, Rustgi A, Falk GW. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus. Cancer Epidemiol Biomarkers Prev 2017;26:240-8. [PMID: 27729357 DOI: 10.1158/1055-9965.EPI-16-0640] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
663 Golger D, Probst A, Messmann H. Barrett's esophagus: lessons from recent clinical trials. Ann Gastroenterol 2016;29:417-23. [PMID: 27708506 DOI: 10.20524/aog.2016.0070] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
664 Whiteman DC, Kendall BJ. Barrett's oesophagus: epidemiology, diagnosis and clinical management. Medical Journal of Australia 2016;205:317-24. [DOI: 10.5694/mja16.00796] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
665 Feuerstein JD, Castillo NE, Akbari M, Belkin E, Lewandowski JJ, Hurley CM, Lloyd S, Leffler DA, Cheifetz AS. Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005-2013) for Barrett's Esophagus. Dig Dis Sci 2016;61:2812-22. [PMID: 27307064 DOI: 10.1007/s10620-016-4222-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
666 Timmer MR, Martinez P, Lau CT, Westra WM, Calpe S, Rygiel AM, Rosmolen WD, Meijer SL, Ten Kate FJ, Dijkgraaf MG, Mallant-Hent RC, Naber AH, van Oijen AH, Baak LC, Scholten P, Böhmer CJ, Fockens P, Maley CC, Graham TA, Bergman JJ, Krishnadath KK. Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study. Gut 2016;65:1602-10. [PMID: 26104750 DOI: 10.1136/gutjnl-2015-309642] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
667 Schoofs N, Bisschops R, Prenen H. Progression of Barrett's esophagus toward esophageal adenocarcinoma: an overview. Ann Gastroenterol. 2017;30:1-6. [PMID: 28042232 DOI: 10.20524/aog.2016.0091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
668 Ko MS, Fung KZ, Shi Y, Espaldon R, Shergill A, Walter LC. Barrett's Esophagus Commonly Diagnosed in Elderly Men with Limited Life Expectancy. J Am Geriatr Soc 2016;64:e109-11. [PMID: 27685424 DOI: 10.1111/jgs.14409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
669 Barros R, Pereira D, Callé C, Camilo V, Cunha AI, David L, Almeida R, Dias-Pereira A, Chaves P. Dynamics of SOX2 and CDX2 Expression in Barrett's Mucosa. Dis Markers 2016;2016:1532791. [PMID: 27766003 DOI: 10.1155/2016/1532791] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
670 Duggan SP, Behan FM, Kirca M, Zaheer A, McGarrigle SA, Reynolds JV, Vaz GM, Senge MO, Kelleher D. The characterization of an intestine-like genomic signature maintained during Barrett's-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival. Sci Rep 2016;6:32638. [PMID: 27586588 DOI: 10.1038/srep32638] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
671 Bibbò S, Ianiro G, Ricci R, Arciuolo D, Petruzziello L, Spada C, Larghi A, Riccioni ME, Gasbarrini A, Costamagna G, Cammarota G. Barrett's oesophagus and associated dysplasia are not equally distributed within the esophageal circumference. Dig Liver Dis 2016;48:1043-7. [PMID: 27436487 DOI: 10.1016/j.dld.2016.06.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
672 Fock KM, Talley N, Goh KL, Sugano K, Katelaris P, Holtmann G, Pandolfino JE, Sharma P, Ang TL, Hongo M, Wu J, Chen M, Choi MG, Law NM, Sheu BS, Zhang J, Ho KY, Sollano J, Rani AA, Kositchaiwat C, Bhatia S. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus. Gut 2016;65:1402-15. [PMID: 27261337 DOI: 10.1136/gutjnl-2016-311715] [Cited by in Crossref: 101] [Cited by in F6Publishing: 86] [Article Influence: 14.4] [Reference Citation Analysis]
673 Savarino E, Villanacci V. Barrett's esophagus detection: Multiple biopsies are useful, even better if you have an "X" on your map. Dig Liver Dis 2016;48:1041-2. [PMID: 27352982 DOI: 10.1016/j.dld.2016.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
674 Cardoso J, Mesquita M, Dias Pereira A, Bettencourt-Dias M, Chaves P, Pereira-Leal JB. CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett's Esophagus Malignant Progression. PLoS One 2016;11:e0161967. [PMID: 27583562 DOI: 10.1371/journal.pone.0161967] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
675 Pech O. Endoscopic Treatment of Early Barrett's Neoplasia: Expanding Indications, New Challenges. Adv Exp Med Biol 2016;908:99-109. [PMID: 27573769 DOI: 10.1007/978-3-319-41388-4_6] [Reference Citation Analysis]
676 Naini BV, Souza RF, Odze RD. Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists. Am J Surg Pathol. 2016;40:e45-e66. [PMID: 26813745 DOI: 10.1097/pas.0000000000000598] [Cited by in Crossref: 77] [Cited by in F6Publishing: 109] [Article Influence: 11.0] [Reference Citation Analysis]
677 Smirnov AA, Vasilevskiy DI, Lapshin AS, Dvoretskiy SY, Filippov DI, Tsitskarava AZ, Bagnenko SF. ANTIREFLUX RESECTION OF MUCOUS MEMBRANE OF ESOPHAGOGASTRIC ANASTOMOSIS IN TREATMENT OF BARRETT’S ESOPHAGUS: INITIAL EXPERIENCE. VESTNIK KHIRURGII IMENI I I GREKOVA 2016;175:59-61. [DOI: 10.24884/0042-4625-2016-175-4-59-61] [Reference Citation Analysis]
678 Bisschops R, Areia M, Coron E, Dobru D, Kaskas B, Kuvaev R, Pech O, Ragunath K, Weusten B, Familiari P, Domagk D, Valori R, Kaminski MF, Spada C, Bretthauer M, Bennett C, Senore C, Dinis-Ribeiro M, Rutter MD. Performance measures for upper gastrointestinal endoscopy: A European Society of Gastrointestinal Endoscopy quality improvement initiative. United European Gastroenterol J. 2016;4:629-656. [PMID: 27733906 DOI: 10.1177/2050640616664843] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
679 Martinez P, Timmer MR, Lau CT, Calpe S, Sancho-Serra Mdel C, Straub D, Baker AM, Meijer SL, Kate FJ, Mallant-Hent RC, Naber AH, van Oijen AH, Baak LC, Scholten P, Böhmer CJ, Fockens P, Bergman JJ, Maley CC, Graham TA, Krishnadath KK. Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus. Nat Commun 2016;7:12158. [PMID: 27538785 DOI: 10.1038/ncomms12158] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 8.9] [Reference Citation Analysis]
680 Thota PN, Kistangari G, Esnakula AK, Gonzalo DH, Liu XL. Clinical significance and management of Barrett’s esophagus with epithelial changes indefinite for dysplasia. World J Gastrointest Pharmacol Ther 2016; 7(3): 406-411 [PMID: 27602241 DOI: 10.4292/wjgpt.v7.i3.406] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
681 Smith J, Garcia A, Zhang R, DeMeester S, Vallone J, Chandrasoma P. Intestinal Metaplasia is Present in Most if Not All Patients Who Have Undergone Endoscopic Mucosal Resection for Esophageal Adenocarcinoma. Am J Surg Pathol 2016;40:537-43. [PMID: 26813746 DOI: 10.1097/PAS.0000000000000601] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
682 Ghaus S, Neumann H, Muhammad H, Tontini GE, Ishaq S. Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide. Dig Dis Sci 2016;61:2185-93. [PMID: 27038446 DOI: 10.1007/s10620-016-4138-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
683 El-Serag HB, Naik AD, Duan Z, Shakhatreh M, Helm A, Pathak A, Hinojosa-Lindsey M, Hou J, Nguyen T, Chen J, Kramer JR. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus. Gut 2016;65:1252-60. [PMID: 26311716 DOI: 10.1136/gutjnl-2014-308865] [Cited by in Crossref: 90] [Cited by in F6Publishing: 64] [Article Influence: 12.9] [Reference Citation Analysis]
684 Rajendra S, Sharma P. Barrett's Esophagus. Practical Gastroenterology and Hepatology Board Review Toolkit 2016. [DOI: 10.1002/9781119127437.ch15] [Reference Citation Analysis]
685 Sengupta N, Sawhney MS. Advances in Imaging and Endoluminal Therapies for Early Esophageal and Gastric Cancers. Ann Surg Oncol 2016;23:3774-9. [PMID: 27464607 DOI: 10.1245/s10434-016-5425-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
686 Gregson EM, Bornschein J, Fitzgerald RC. Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma. Br J Cancer 2016;115:403-10. [PMID: 27441494 DOI: 10.1038/bjc.2016.219] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
687 Hui YY, Chen X, Wang BM. Yesterday and today of Barrett's esophagus: Historical evolution and research hotspots. Shijie Huaren Xiaohua Zazhi 2016; 24(20): 3077-3086 [DOI: 10.11569/wcjd.v24.i20.3077] [Reference Citation Analysis]
688 Kalatskaya I. Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma. Ann N Y Acad Sci 2016;1381:74-91. [PMID: 27415609 DOI: 10.1111/nyas.13134] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
689 Chedgy FJQ, Subramaniam S, Kandiah K, Thayalasekaran S, Bhandari P. Acetic acid chromoendoscopy: Improving neoplasia detection in Barrett's esophagus. World J Gastroenterol 2016; 22(25): 5753-5760 [PMID: 27433088 DOI: 10.3748/wjg.v22.i25.5753] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
690 Hendy P. Radiofrequency ablation is associated with decreased neoplastic progression in patients with Barrett's oesophagus and confirmed low-grade dysplasia. Frontline Gastroenterol 2016;7:156-7. [PMID: 28839852 DOI: 10.1136/flgastro-2015-100649] [Reference Citation Analysis]
691 Abdelmessih R, Packey CD, Lawlor G. Endoscopy in the Elderly: a Cautionary Approach, When to Stop. Curr Treat Options Gastro 2016;14:305-14. [DOI: 10.1007/s11938-016-0101-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
692 Nian YY, Feng C, Jing FC, Wang XQ, Zhang J. Reflux characteristics of 113 GERD patients with abnormal 24-h multichannel intraluminal impedance-pH tests. J Zhejiang Univ Sci B 2015;16:805-10. [PMID: 26365123 DOI: 10.1631/jzus.B1500027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
693 Voltaggio L, Cimino-Mathews A, Bishop JA, Argani P, Cuda JD, Epstein JI, Hruban RH, Netto GJ, Stoler MH, Taube JM, Vang R, Westra WH, Montgomery EA. Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system. CA Cancer J Clin 2016;66:408-36. [PMID: 27270763 DOI: 10.3322/caac.21350] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
694 Zhao Z, Pu Z, Yin Z, Yu P, Hao Y, Wang Q, Guo M, Zhao Q. Dietary fruit, vegetable, fat, and red and processed meat intakes and Barrett's esophagus risk: a systematic review and meta-analysis. Sci Rep 2016;6:27334. [PMID: 27256629 DOI: 10.1038/srep27334] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
695 Lavery DL, Martinez P, Gay LJ, Cereser B, Novelli MR, Rodriguez-Justo M, Meijer SL, Graham TA, McDonald SA, Wright NA, Jansen M. Evolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett's oesophagus. Gut 2016;65:907-13. [PMID: 26701877 DOI: 10.1136/gutjnl-2015-310748] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
696 Critchley-Thorne RJ, Duits LC, Prichard JW, Davison JM, Jobe BA, Campbell BB, Zhang Y, Repa KA, Reese LM, Li J, Diehl DL, Jhala NC, Ginsberg G, DeMarshall M, Foxwell T, Zaidi AH, Lansing Taylor D, Rustgi AK, Bergman JJ, Falk GW. A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus. Cancer Epidemiol Biomarkers Prev. 2016;25:958-968. [PMID: 27197290 DOI: 10.1158/1055-9965.epi-15-1164] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
697 Martinucci I, de Bortoli N, Russo S, Bertani L, Furnari M, Mokrowiecka A, Malecka-Panas E, Savarino V, Savarino E, Marchi S. Barrett’s esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther 2016; 7(2): 190-206 [PMID: 27158534 DOI: 10.4292/wjgpt.v7.i2.190] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
698 Macías-García F, Domínguez-Muñoz JE. Update on management of Barrett's esophagus. World J Gastrointest Pharmacol Ther 2016; 7(2): 227-234 [PMID: 27158538 DOI: 10.4292/wjgpt.v7.i2.227] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
699 Graham D, Lipman G, Sehgal V, Lovat LB. Monitoring the premalignant potential of Barrett's oesophagus'. Frontline Gastroenterol 2016;7:316-22. [PMID: 27761232 DOI: 10.1136/flgastro-2016-100712] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
700 Tan C, Qian X, Guan Z, Yang B, Ge Y, Wang F, Cai J. Potential biomarkers for esophageal cancer. Springerplus. 2016;5:467. [PMID: 27119071 DOI: 10.1186/s40064-016-2119-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
701 Das A, Callenberg KM, Styn MA, Jackson SA. Endoscopic ablation is a cost-effective cancer preventative therapy in patients with Barrett's esophagus who have elevated genomic instability. Endosc Int Open 2016;4:E549-59. [PMID: 27227114 DOI: 10.1055/s-0042-103415] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
702 Kaye PV, Ilyas M, Soomro I, Haider SA, Atwal G, Menon S, Gill S, Richards C, Harrison R, West K, Ragunath K. Dysplasia in Barrett's oesophagus: p53 immunostaining is more reproducible than haematoxylin and eosin diagnosis and improves overall reliability, while grading is poorly reproducible. Histopathology 2016;69:431-40. [PMID: 26918780 DOI: 10.1111/his.12956] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
703 Kastelein F, van Olphen SH, Steyerberg EW, Spaander MC, Bruno MJ; ProBar-Study Group. Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression. Gut 2016;65:548-54. [PMID: 25903690 DOI: 10.1136/gutjnl-2014-308802] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
704 Chadwick G, Groene O, Taylor A, Riley S, Hardwick RH, Crosby T, Greenaway K, Cromwell DA. Management of Barrett's high-grade dysplasia: initial results from a population-based national audit. Gastrointest Endosc 2016;83:736-42.e1. [PMID: 26283273 DOI: 10.1016/j.gie.2015.08.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
705 Parasa S, Sharma P. Measuring quality of endoscopic eradication therapy in Barrett's esophagus. Gastrointest Endosc 2016;83:743-5. [PMID: 26975281 DOI: 10.1016/j.gie.2015.12.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
706 Greene CL, Worrell SG, Attwood SE, Chandrasoma P, Chang K, DeMeester TR, Lord RV, Montgomery E, Pech O, Vallone J, Vieth M, Wang KK, DeMeester SR. Emerging Concepts for the Endoscopic Management of Superficial Esophageal Adenocarcinoma. J Gastrointest Surg 2016;20:851-60. [PMID: 26691147 DOI: 10.1007/s11605-015-3056-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
707 Thoguluva Chandrasekar V, Vennalaganti P, Sharma P. Management of Barrett's esophagus: Screening to newer treatments. Revista de Gastroenterología de México (English Edition) 2016;81:91-102. [DOI: 10.1016/j.rgmxen.2016.03.002] [Reference Citation Analysis]
708 Rayner-Hartley E, Takach O, Galorport C, Enns RA. Diagnosis and Management of Barrett's Esophagus: A Retrospective Study Comparing the Endoscopic Assessment of Early Esophageal Lesions in the Community versus a Specialized Center. Can J Gastroenterol Hepatol 2016;2016:5749573. [PMID: 27446850 DOI: 10.1155/2016/5749573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
709 Knabe M, May A, Ell C. Endoscopic Therapy of Early Carcinoma of the Oesophagus. Viszeralmedizin 2015;31:320-5. [PMID: 26989386 DOI: 10.1159/000441075] [Reference Citation Analysis]
710 Naveed M, Dunbar KB. Endoscopic imaging of Barrett’s esophagus. World J Gastrointest Endosc 2016; 8(5): 259-266 [PMID: 26981177 DOI: 10.4253/wjge.v8.i5.259] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
711 Thoguluva Chandrasekar V, Vennalaganti P, Sharma P. Management of Barrett's esophagus: From screening to newer treatments. Rev Gastroenterol Mex 2016;81:91-102. [PMID: 26964773 DOI: 10.1016/j.rgmx.2015.07.007] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
712 Waterhouse DJ, Joseph J, Neves AA, di Pietro M, Brindle KM, Fitzgerald RC, Bohndiek SE. Design and validation of a near-infrared fluorescence endoscope for detection of early esophageal malignancy using a targeted imaging probe. SPIE Proceedings 2016. [DOI: 10.1117/12.2209582] [Reference Citation Analysis]
713 Westwood C, Mcconnell S. Technological and organisational innovation in endoscopy. Gastrointestinal Nursing 2016;14:30-37. [DOI: 10.12968/gasn.2016.14.2.30] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
714 Di Caro S, Cheung WH, Fini L, Keane MG, Theis B, Haidry R, Di Renzo L, De Lorenzo A, Lovat L, Batterham RL, Banks M. Role of body composition and metabolic profile in Barrett's oesophagus and progression to cancer. Eur J Gastroenterol Hepatol 2016;28:251-60. [PMID: 26671515 DOI: 10.1097/MEG.0000000000000536] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
715 Theron BT, Padmanabhan H, Aladin H, Smith P, Campbell E, Nightingale P, Cooper BT, Trudgill NJ. The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort. United European Gastroenterol J 2016;4:754-61. [PMID: 28408992 DOI: 10.1177/2050640616632419] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
716 Chadwick G, Riley S, Hardwick RH, Crosby T, Hoare J, Hanna G, Greenaway K, Varagunam M, Cromwell DA, Groene O. Population-based cohort study of the management and survival of patients with early-stage oesophageal adenocarcinoma in England. Br J Surg 2016;103:544-52. [PMID: 26865114 DOI: 10.1002/bjs.10116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
717 Ma M, Shroff S, Feldman M, DeMarshall M, Price C, Tierney A, Falk GW. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia. Dis Esophagus 2017;30:1-5. [PMID: 28184470 DOI: 10.1093/dote/dow025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
718 Asanuma K, Iijima K, Shimosegawa T. Gender difference in gastro-esophageal reflux diseases. World J Gastroenterol 2016; 22(5): 1800-1810 [PMID: 26855539 DOI: 10.3748/wjg.v22.i5.1800] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
719 Ireland CJ, Thompson SK, Laws TA, Esterman A. Risk factors for Barrett’s esophagus: a scoping review. Cancer Causes Control 2016;27:301-23. [DOI: 10.1007/s10552-015-0710-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
720 Huynh Trudeau V, Maynard S, Terzic T, Soucy G, Bouin M. Dysphagia among adult patients who underwent surgery for esophageal atresia at birth. Can J Gastroenterol Hepatol. 2015;29:91-94. [PMID: 25803019 DOI: 10.1155/2015/787069] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
721 Ortiz-Fernández-Sordo J, Sami S, Mansilla-Vivar R, De Caestecker J, Cole A, Ragunath K. Incidence of metachronous visible lesions in patients referred for radiofrequency ablation (RFA) therapy for early Barrett's neoplasia: a single-centre experience. Frontline Gastroenterol 2016;7:24-9. [PMID: 26834956 DOI: 10.1136/flgastro-2015-100561] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
722 Pohl H, Pech O, Arash H, Stolte M, Manner H, May A, Kraywinkel K, Sonnenberg A, Ell C. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma. Gut 2016;65:196-201. [PMID: 26113177 DOI: 10.1136/gutjnl-2015-309220] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 10.3] [Reference Citation Analysis]
723 Shariff MK, Varghese S, O'Donovan M, Abdullahi Z, Liu X, Fitzgerald RC, di Pietro M. Pilot randomized crossover study comparing the efficacy of transnasal disposable endosheath with standard endoscopy to detect Barrett's esophagus. Endoscopy 2016;48:110-6. [PMID: 26535563 DOI: 10.1055/s-0034-1393310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
724 de Jonge PJ, Hvid-Jensen F. Barrett's oesophagus: size does matter. Gut 2016;65:189-90. [PMID: 26246246 DOI: 10.1136/gutjnl-2015-310091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
725 Moyes LH, Oien KA, Foulis AK, Fullarton GM, Going JJ. Prevalent low-grade dysplasia: the strongest predictor of malignant progression in Barrett's columnar-lined oesophagus. Gut 2016;65:360-1. [PMID: 26085438 DOI: 10.1136/gutjnl-2015-309978] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
726 Chedgy FJ, Kandiah K, Thayalasekaran S, Subramaniam S, Bhandari P. Advances in the endoscopic diagnosis and treatment of Barrett's neoplasia. F1000Res 2016;5:F1000 Faculty Rev-113. [PMID: 26918175 DOI: 10.12688/f1000research.6996.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
727 Dunn SJ, Neilson LJ, Hassan C, Sharma P, Guy C, Rees CJ. ESGE Survey: worldwide practice patterns amongst gastroenterologists regarding the endoscopic management of Barrett's esophagus. Endosc Int Open 2016;4:E36-41. [PMID: 26793783 DOI: 10.1055/s-0034-1393247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
728 Triadafilopoulos G, Akiyama J. Emerging endoscopic techniques for the identification of esophageal disease. Expert Rev Gastroenterol Hepatol 2016;10:605-13. [PMID: 26753504 DOI: 10.1586/17474124.2016.1140037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
729 Fukui S, Watari J, Tomita T, Yamasaki T, Okugawa T, Kondo T, Kono T, Tozawa K, Ikehara H, Ohda Y, Oshima T, Fukui H, Das KM, Miwa H. Localization of specialized intestinal metaplasia and the molecular alterations in Barrett esophagus in a Japanese population: an analysis of biopsy samples based on the "Seattle" biopsy protocol. Hum Pathol 2016;51:32-40. [PMID: 27067780 DOI: 10.1016/j.humpath.2015.12.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
730 Evans JA, McDonald SA. The Complex, Clonal, and Controversial Nature of Barrett's Esophagus. Adv Exp Med Biol 2016;908:27-40. [PMID: 27573766 DOI: 10.1007/978-3-319-41388-4_3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
731 Coletta M, Sami SS, Nachiappan A, Fraquelli M, Casazza G, Ragunath K. Acetic acid chromoendoscopy for the diagnosis of early neoplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis. Gastrointest Endosc 2016;83:57-67.e1. [PMID: 26371851 DOI: 10.1016/j.gie.2015.07.023] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 9.4] [Reference Citation Analysis]
732 Bahin FF, Jayanna M, Hourigan LF, Lord RV, Whiteman D, Williams SJ, Lee EY, Bourke MJ. Long-term outcomes of a primary complete endoscopic resection strategy for short-segment Barrett's esophagus with high-grade dysplasia and/or early esophageal adenocarcinoma. Gastrointest Endosc 2016;83:68-77. [PMID: 26096759 DOI: 10.1016/j.gie.2015.04.044] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
733 Lowes H, Somarathna T, Shepherd NA. Definition, Derivation, and Diagnosis of Barrett’s Esophagus: Pathological Perspectives. Advances in Experimental Medicine and Biology 2016. [DOI: 10.1007/978-3-319-41388-4_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
734 Yachimski P. Complications of Gastroesophageal Reflux Disease. Diagnosis and Treatment of Gastroesophageal Reflux Disease 2016. [DOI: 10.1007/978-3-319-19524-7_2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
735 van der Wel MJ, Jansen M, Vieth M, Meijer SL. What Makes an Expert Barrett’s Histopathologist? Advances in Experimental Medicine and Biology 2016. [DOI: 10.1007/978-3-319-41388-4_8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
736 Schneider A, Chak A, Podugu A. Diagnosis of Barrett’s Esophagus. Barrett's Esophagus 2016. [DOI: 10.1016/b978-0-12-802511-6.00005-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
737 Higa JT, Hwang JH. History of Ablative Therapies for Barrett’s and Superficial Adenocarcinoma. Barrett's Esophagus. Elsevier; 2016. pp. 133-49. [DOI: 10.1016/b978-0-12-802511-6.00010-7] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
738 Katz-summercorn AC, Frankell AM, Fitzgerald RC. Genetics and Biomarkers in Barrett’s Esophagus and Esophageal Adenocarcinoma. Barrett's Esophagus 2016. [DOI: 10.1016/b978-0-12-802511-6.00004-1] [Reference Citation Analysis]
739 Shaheen NJ, Falk GW, Iyer PG, Gerson LB; American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol 2016;111:30-50; quiz 51. [PMID: 26526079 DOI: 10.1038/ajg.2015.322] [Cited by in Crossref: 990] [Cited by in F6Publishing: 990] [Article Influence: 141.4] [Reference Citation Analysis]
740 Çolak Y, Erim T, Pleskow DK. A Disease Entity Is Identified. Barrett's Esophagus 2016. [DOI: 10.1016/b978-0-12-802511-6.00001-6] [Reference Citation Analysis]
741 Kim JG, Kim GH. Does the Risk of Esophageal Adenocarcinoma Increase as the Length of Barrett's Esophagus Becomes Long? Korean J Gastroenterol 2016;67:344. [DOI: 10.4166/kjg.2016.67.6.344] [Reference Citation Analysis]
742 Sharma N, Srivastava S, Kern F, Xian W, Ming T, McKeon F, Ho KY. Endoscopic modalities for the diagnosis of Barrett's oesophagus. United European Gastroenterol J 2016;4:733-40. [PMID: 28408990 DOI: 10.1177/2050640615619281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
743 Noorani A, Fitzgerald RC. Molecular biology of Barrett's esophagus and esophageal adenocarcinoma. Esophageal cancer and barrett's esophagus 2015. [DOI: 10.1002/9781118655153.ch6] [Reference Citation Analysis]
744 Sami SS, Ragunath K. Screening and surveillance. Esophageal cancer and barrett's esophagus 2015. [DOI: 10.1002/9781118655153.ch9] [Reference Citation Analysis]
745 Sharma N, Ho KY. Columnar lined Barrett's oesophagus. Br J Hosp Med (Lond) 2015;76:703-6. [PMID: 26646332 DOI: 10.12968/hmed.2015.76.12.703] [Reference Citation Analysis]
746 Qiao Y, Hyder A, Bae SJ, Zarin W, O'Neill TJ, Marcon NE, Stein L, Thein HH. Surveillance in Patients With Barrett's Esophagus for Early Detection of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol 2015;6:e131. [PMID: 26658838 DOI: 10.1038/ctg.2015.58] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
747 Greene CL, Worrell SG, Demeester TR. Rat Reflux Model of Esophageal Cancer and Its Implication in Human Disease. Annals of Surgery 2015;262:910-24. [DOI: 10.1097/sla.0000000000001207] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
748 Chung CS, Lee YC, Wu MS. Prevention strategies for esophageal cancer: Perspectives of the East vs. West. Best Pract Res Clin Gastroenterol 2015;29:869-83. [PMID: 26651249 DOI: 10.1016/j.bpg.2015.09.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
749 Wolf WA, Pasricha S, Cotton C, Li N, Triadafilopoulos G, Muthusamy VR, Chmielewski GW, Corbett FS, Camara DS, Lightdale CJ, Wolfsen H, Chang KJ, Overholt BF, Pruitt RE, Ertan A, Komanduri S, Infantolino A, Rothstein RI, Shaheen NJ. Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus. Gastroenterology 2015;149:1752-1761.e1. [PMID: 26327132 DOI: 10.1053/j.gastro.2015.08.048] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 7.0] [Reference Citation Analysis]
750 Mastracci L, Piol N, Molinaro L, Pitto F, Tinelli C, De Silvestri A, Fiocca R, Grillo F; ABRAM Study Group. Interobserver reproducibility in pathologist interpretation of columnar-lined esophagus. Virchows Arch. 2016;468:159-167. [PMID: 26563401 DOI: 10.1007/s00428-015-1878-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
751 Beg S, Wilson A, Ragunath K. The use of optical imaging techniques in the gastrointestinal tract. Frontline Gastroenterol 2016;7:207-15. [PMID: 27429735 DOI: 10.1136/flgastro-2015-100563] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
752 Schölvinck DW, Goto O, Seldenrijk CA, Bisschops R, Horii J, Ochiai Y, Schoon EJ, Schenk BE, Uraoka T, van Oijen MGH, Bergman JJGHM, Yahagi N, Weusten BLAM. Detection of palisade vessels as a landmark for Barrett’s esophagus in a Western population. J Gastroenterol 2016;51:682-90. [DOI: 10.1007/s00535-015-1136-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
753 Sharma P, Katzka DA, Gupta N, Ajani J, Buttar N, Chak A, Corley D, El-Serag H, Falk GW, Fitzgerald R, Goldblum J, Gress F, Ilson DH, Inadomi JM, Kuipers EJ, Lynch JP, McKeon F, Metz D, Pasricha PJ, Pech O, Peek R, Peters JH, Repici A, Seewald S, Shaheen NJ, Souza RF, Spechler SJ, Vennalaganti P, Wang K. Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. Gastroenterology 2015;149:1599-606. [PMID: 26296479 DOI: 10.1053/j.gastro.2015.08.007] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 8.1] [Reference Citation Analysis]
754 Shiota S, Singh S, Anshasi A, El-Serag HB. Prevalence of Barrett's Esophagus in Asian Countries: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2015;13:1907-18. [PMID: 26260107 DOI: 10.1016/j.cgh.2015.07.050] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
755 Sturm MB, Wang TD. Emerging optical methods for surveillance of Barrett's oesophagus. Gut 2015;64:1816-23. [PMID: 25975605 DOI: 10.1136/gutjnl-2013-306706] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 6.6] [Reference Citation Analysis]
756 di Pietro M, Bird-Lieberman EL, Liu X, Nuckcheddy-Grant T, Bertani H, O'Donovan M, Fitzgerald RC. Autofluorescence-Directed Confocal Endomicroscopy in Combination With a Three-Biomarker Panel Can Inform Management Decisions in Barrett's Esophagus. Am J Gastroenterol 2015;110:1549-58. [PMID: 26416188 DOI: 10.1038/ajg.2015.295] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
757 Rubenstein JH, Lieberman D, Fennerty B, Gellad ZF. Measuring the quality of Barrett's esophagus management with measures that are high quality. Gastroenterology 2015;149:1298-301. [PMID: 26385076 DOI: 10.1053/j.gastro.2015.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
758 Derakhshan MH, Robertson EV, Yeh Lee Y, Harvey T, Ferrier RK, Wirz AA, Orange C, Ballantyne SA, Hanvey SL, Going JJ, McColl KE. In healthy volunteers, immunohistochemistry supports squamous to columnar metaplasia as mechanism of expansion of cardia, aggravated by central obesity. Gut 2015;64:1705-14. [PMID: 25753030 DOI: 10.1136/gutjnl-2014-308914] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
759 Veitch AM, Uedo N, Yao K, East JE. Optimizing early upper gastrointestinal cancer detection at endoscopy. Nat Rev Gastroenterol Hepatol 2015;12:660-7. [PMID: 26260369 DOI: 10.1038/nrgastro.2015.128] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 8.1] [Reference Citation Analysis]
760 Pereira AD, Chaves P. Low risk of adenocarcinoma and high-grade dysplasia in patients with non-dysplastic Barrett's esophagus: Results from a cohort from a country with low esophageal adenocarcinoma incidence. United European Gastroenterol J 2016;4:343-52. [PMID: 27403300 DOI: 10.1177/2050640615612409] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
761 Balmadrid B, Hwang JH. Endoscopic resection of gastric and esophageal cancer. Gastroenterol Rep (Oxf) 2015;3:330-8. [PMID: 26510452 DOI: 10.1093/gastro/gov050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
762 Haidry R, Lovat L, Sharma P. Radiofrequency ablation for Barrett's dysplasia: past, present and the future? Curr Gastroenterol Rep 2015;17:13. [PMID: 25740248 DOI: 10.1007/s11894-015-0433-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
763 van Olphen S, Biermann K, Spaander MC, Kastelein F, Steyerberg EW, Stoop HA, Bruno MJ, Looijenga LH. SOX2 as a novel marker to predict neoplastic progression in Barrett's esophagus. Am J Gastroenterol 2015;110:1420-8. [PMID: 26323187 DOI: 10.1038/ajg.2015.260] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
764 Wang A, Shaukat A, Acosta RD, Bruining DH, Chandrasekhara V, Chathadi KV, Eloubeidi MA, Fanelli RD, Faulx AL, Fonkalsrud L, Gurudu SR, Kelsey LR, Khashab MA, Kothari S, Lightdale JR, Muthusamy VR, Pasha S, Saltzman JR, Yang J, Cash BD, DeWitt JM; ASGE Standards of Practice Committee. Race and ethnicity considerations in GI endoscopy. Gastrointest Endosc 2015;82:593-9. [PMID: 26260384 DOI: 10.1016/j.gie.2015.06.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
765 Pasricha S, Cotton C, Hathorn KE, Li N, Bulsiewicz WJ, Wolf WA, Muthusamy VR, Komanduri S, Wolfsen HC, Pruitt RE, Ertan A, Chmielewski GW, Shaheen NJ. Effects of the Learning Curve on Efficacy of Radiofrequency Ablation for Barrett's Esophagus. Gastroenterology 2015;149:890-6.e2. [PMID: 26116806 DOI: 10.1053/j.gastro.2015.06.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
766 Rugge M, Pizzi M, Castoro C. Definition of Barrett's esophagus dysplasia: are we speaking the same language? World J Surg 2015;39:559-65. [PMID: 25015727 DOI: 10.1007/s00268-014-2692-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
767 Gregson EM, Fitzgerald RC. Biomarkers for dysplastic Barrett's: ready for prime time? World J Surg 2015;39:568-77. [PMID: 24844657 DOI: 10.1007/s00268-014-2640-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
768 Townsend D, Miljković M, Bird B, Lenau K, Old O, Almond M, Kendall C, Lloyd G, Shepherd N, Barr H, Stone N, Diem M. Infrared micro-spectroscopy for cyto-pathological classification of esophageal cells. Analyst 2015;140:2215-23. [PMID: 25594077 DOI: 10.1039/c4an01884b] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
769 Pioche M, O'Brien M, Rivory J. Please provide us with a reasonable definition for curative R0 resection in Barrett's esophagus neoplasia; which one should we choose? Endosc Int Open 2015;3:E566-8. [PMID: 26716113 DOI: 10.1055/s-0034-1392648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
770 Small AJ, Araujo JL, Leggett CL, Mendelson AH, Agarwalla A, Abrams JA, Lightdale CJ, Wang TC, Iyer PG, Wang KK, Rustgi AK, Ginsberg GG, Forde KA, Gimotty PA, Lewis JD, Falk GW, Bewtra M. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia. Gastroenterology 2015;149:567-76.e3; quiz e13-4. [PMID: 25917785 DOI: 10.1053/j.gastro.2015.04.013] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 7.5] [Reference Citation Analysis]
771 Hewett R, Chhaya V, Chan D, Kang JY, Poullis A. Differences in intestinal metaplasia in Barrett's esophagus patients in an ethnically diverse south London population. Indian J Gastroenterol 2015;34:399-403. [PMID: 26541341 DOI: 10.1007/s12664-015-0597-9] [Reference Citation Analysis]
772 Palmer WC, Di Leo M, Jovani M, Heckman MG, Diehl NN, Iyer PG, Wolfsen HC, Wallace MB. Management of high grade dysplasia in Barrett's oesophagus with underlying oesophageal varices: A retrospective study. Dig Liver Dis 2015;47:763-8. [PMID: 26066379 DOI: 10.1016/j.dld.2015.05.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
773 Barnes JA, Willingham FF. Endoscopic Management of Early Esophageal Cancer. J Clin Gastroenterol 2015;49:638-46. [PMID: 26125458 DOI: 10.1097/MCG.0000000000000353] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
774 Skelton D, Barnes J, French J. A case of severe necrotising pancreatitis following ampullary biopsy. Ann R Coll Surg Engl 2015;97:e61-3. [PMID: 26263955 DOI: 10.1308/003588415X14181254789646] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
775 Krishnamoorthi R, Iyer PG. Molecular biomarkers added to image-enhanced endoscopic imaging: Will they further improve diagnostic accuracy? Best Practice & Research Clinical Gastroenterology 2015;29:561-573. [DOI: 10.1016/j.bpg.2015.05.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
776 Beg S, Ragunath K. Image-enhanced endoscopy technology in the gastrointestinal tract: what is available? Best Pract Res Clin Gastroenterol 2015;29:627-38. [PMID: 26381307 DOI: 10.1016/j.bpg.2015.05.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
777 Pasricha S, Li N, Bulsiewicz WJ, Rothstein RI, Infantolino A, Ertan A, Camara DS, Dellon ES, Triadafilopoulos G, Lightdale CJ, Madanick RD, Lyday WD, Muthusamy RV, Overholt BF, Shaheen NJ. Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry. Gastrointest Endosc 2015;82:276-84. [PMID: 25841575 DOI: 10.1016/j.gie.2015.01.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
778 Haidry RJ, Butt MA, Dunn JM, Gupta A, Lipman G, Smart HL, Bhandari P, Smith L, Willert R, Fullarton G, Di Pietro M, Gordon C, Penman I, Barr H, Patel P, Kapoor N, Hoare J, Narayanasamy R, Ang Y, Veitch A, Ragunath K, Novelli M, Lovat LB; UK RFA Registry. Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut 2015;64:1192-9. [PMID: 25539672 DOI: 10.1136/gutjnl-2014-308501] [Cited by in Crossref: 70] [Cited by in F6Publishing: 53] [Article Influence: 8.8] [Reference Citation Analysis]
779 Matsuzaki J, Suzuki H, Kobayakawa M, Inadomi JM, Takayama M, Makino K, Iwao Y, Sugino Y, Kanai T. Association of Visceral Fat Area, Smoking, and Alcohol Consumption with Reflux Esophagitis and Barrett's Esophagus in Japan. PLoS One 2015;10:e0133865. [PMID: 26225858 DOI: 10.1371/journal.pone.0133865] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
780 Parker C, Alexandridis E, Plevris J, O'Hara J, Panter S. Transnasal endoscopy: no gagging no panic! Frontline Gastroenterol 2016;7:246-56. [PMID: 28839865 DOI: 10.1136/flgastro-2015-100589] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
781 Barret M, Beye B, Leblanc S, Beuvon F, Chaussade S, Batteux F, Prat F. Systematic review: the prevention of oesophageal stricture after endoscopic resection. Aliment Pharmacol Ther 2015;42:20-39. [PMID: 25982288 DOI: 10.1111/apt.13254] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
782 Tham TC, Gleeson D, Greenfield SM, Harris A, Cort S. British Society of Gastroenterology policy and processes for the development of guidelines. Gut 2015;64:1184-5. [PMID: 25666194 DOI: 10.1136/gutjnl-2015-309164] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
783 Knabe M, May A, Ell C. Endoscopic therapy in early adenocarcinomas (Barrett's cancer) of the esophagus. J Dig Dis 2015;16:363-9. [PMID: 26031930 DOI: 10.1111/1751-2980.12264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
784 Ruiz-romero D, Téllez-ávila FI, Barreto-zúñiga R, Zamora-nava. LE. Prevención, escrutinio y seguimiento endoscópico de lesiones premalignas del tracto digestivo superior y medio. Endoscopia 2015;27:135-145. [DOI: 10.1016/j.endomx.2015.09.001] [Reference Citation Analysis]
785 Kristo I, Schoppmann S. Diagnosis and treatment of benign inflammatory esophageal diseases. Eur Surg 2015;47:188-98. [DOI: 10.1007/s10353-015-0329-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
786 Haidry R, Lovat L. Long-term durability of radiofrequency ablation for Barrett's-related neoplasia. Curr Opin Gastroenterol 2015;31:316-20. [PMID: 26039723 DOI: 10.1097/MOG.0000000000000190] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
787 Kaye PV, O'Donovan M, Mapstone N, Disep B, Novelli M, Ragunath K. Pathologists are able to differentiate reliably the lamina propria associated with Barrett's musculofibrous anomaly from submucosa in oesophageal endoscopic resections. Histopathology 2015;67:914-7. [PMID: 25967252 DOI: 10.1111/his.12736] [Cited by in Crossref: 5] [Cited by in F6Publishing: 33] [Article Influence: 0.6] [Reference Citation Analysis]
788 Del Portillo A, Lagana SM, Yao Y, Uehara T, Jhala N, Ganguly T, Nagy P, Gutierrez J, Luna A, Abrams J, Liu Y, Brand R, Sepulveda JL, Falk GW, Sepulveda AR. Evaluation of Mutational Testing of Preneoplastic Barrett's Mucosa by Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Endoscopic Samples for Detection of Concurrent Dysplasia and Adenocarcinoma in Barrett's Esophagus. J Mol Diagn 2015;17:412-9. [PMID: 26068095 DOI: 10.1016/j.jmoldx.2015.02.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
789 Halland M, Katzka D, Iyer PG. Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus. World J Gastroenterol 2015; 21(21): 6479-6490 [PMID: 26074687 DOI: 10.3748/wjg.v21.i21.6479] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
790 Wani S, Sharma P. Challenges with Endoscopic Therapy for Barrett's Esophagus. Gastroenterol Clin North Am 2015;44:355-72. [PMID: 26021199 DOI: 10.1016/j.gtc.2015.02.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
791 Kastelein F, van Olphen S, Steyerberg EW, Sikkema M, Spaander MC, Looman CW, Kuipers EJ, Siersema PD, Bruno MJ, de Bekker-Grob EW; ProBar-study group. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis. Gut 2015;64:864-71. [PMID: 25037191 DOI: 10.1136/gutjnl-2014-307197] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
792 Sami SS, Ragunath K, Iyer PG. Response to Syed et al. Am J Gastroenterol 2015;110:937-8. [PMID: 26052776 DOI: 10.1038/ajg.2015.122] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
793 Peter S, Mönkemüller K. Ablative Endoscopic Therapies for Barrett's-Esophagus-Related Neoplasia. Gastroenterol Clin North Am 2015;44:337-53. [PMID: 26021198 DOI: 10.1016/j.gtc.2015.02.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
794 Runge TM, Abrams JA, Shaheen NJ. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am 2015;44:203-31. [PMID: 26021191 DOI: 10.1016/j.gtc.2015.02.001] [Cited by in Crossref: 136] [Cited by in F6Publishing: 141]</